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1. OVERVIEW 
 
Achieving selectivity in chemical reactivity and controlling the outcome of a reaction will 
always be important goals in synthetic organic chemistry. Considering the advances of 
modern synthetic methods, organometallic chemistry has been established as one of the most 
significant disciplines that offers a broad toolset to perform selective transformatins of 
chemical molecules.1 The first organometallic compound ever synthesized2 is considered to 
be “Cadet´s fuming liquid”, a mixture of Me4As2 (cacodyl) and Me4As2O (cacodyl oxide), 
prepared by Cadet in 1760.3 Since the first report of a carbon-zinc bond, based on 
Frankland’s finding of diethylzinc in the 19th century,4 organometallic species have become 
increasingly valuable intermediates. Another milestone was set by Grignard’s achievements 
on organomagnesium reagents at the beginning of the 20th century.5 Aside from zinc and 
magnesium, several other metals have been examined and a considerable number of 
organometallic reagents have enabled access to new synthetic methods for efficient and 
selective reactions. 
In general the nature of the carbon-metal bond exceedingly influences the reactivity of the 
organometallic reagent. Thus, the reactivity of an organometallic species is proportional to the 
ionic nature of the metal-carbon bond and therefore increases with the difference in 
electronegativity between metal and carbon atom (Scheme 1).6 
 
 
 
Scheme 1: Comparision of metals in organometallic species with respect to their electronegativity 
difference between the metal and carbon atom (according to Allred-Rochow electronegativity scale). 
 
                                                     
1 For general review, see: a) P. Knochel, H. Leuser, L.-Z. Gong, S. Perrone, F. Kneisel in Handbook of 
Functionalized Organometallics, (Eds.: P. Knochel), Wiley-VCH, Weinheim 2005, p. 251. b) P. Knochel, P. 
Millot, A. L. Rodriguez, C. E. Tucker in Organic reactions, (Eds.: L. E. Overman), Wiley & Sons Inc., New 
York, 2001, p. 1. 
2 C. Eschenbroich, Organometallchemie, Wiley-VCH, Weinheim, 2008, p. 1.  
3 a) J.J. Berzelius. Jahresber. 1839, 18, 487. b) J. H. Burns, J. Waser, J. Am. Chem. Soc. 1957, 79, 859. c) D. 
Seyferth, Organometallics 2001, 20, 1488.  
4 a) E. Frankland, Liebigs Ann. Chem. 1848, 71, 171. b) E. Frankland, J. Chem. Soc. 1848, 2, 263. 
5 V. Grignard, C. R. Acad. Sci. 1900, 130, 1322. 
6 A. Boudier, L. O. Bromm, M. Lotz, P. Knochel, Angew. Chem. Int. Ed. 2000, 39, 4414. 
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As a consequence the polar lithium-carbon species displays high reactivity along with low 
functional group tolerance and requires low reaction temperatures.7 Metals such as zinc, tin 
and boron form bonds with increasing covalent character with carbon atoms, which on one 
hand exhibit lower reactivity and often require the use of transition metal catalysts, but on the 
other hand tolerate many functional moieties.8  
Today numerous protocols exists for the synthesis of scaffolds comprising carbon-heteroatom 
bonds via the use of organometallic intermediates. However, the growing demand from the 
chemical industry for novel agrochemicals and pharmaceutical substances9 as well as the 
importance of sustainable chemistry with limited resources and decreasing environmental 
pollution will always be a driving force for science. Therefore the need to discover more 
efficient organometallic methods and reagents in synthetic chemistry still exists and represents 
an exciting challenge. 
 
1.1. Preparation of Organometallic Reagents 
1.1.1. Oxidative Insertion 
 
The most common preparation of organometallic reagents consists of the direct oxidative 
addition of magnesium metal (powder or turnings) to organic halides in an aprotic solvent like 
tetrahydrofuran (THF) or diethyl ether under inert atmosphere due to the sensitivity of 
Grignard reagents to air and moisture (Scheme 2). 
 
 
 
Scheme 2: Preparation of Grignard reagents by oxidative addition and Schlenk equilibrium. 
 
An oxidative insertion was first observed by Frankland in 1848, when he prepared dialkylzinc 
reagents by reacting zinc metal with alkyl halides.4 A few decades later Grignard discovered 
                                                     
7 G. Wu, M. Huang, Chem. Rev. 2006, 106, 2596. 
8 a) P. Knochel, R. D. Singer, Chem. Rev. 1993, 93, 2117. b) P. Knochel, S. Vettel, C. Eisenberg, Appl. 
Organomet. Chem. 1995, 9, 175. c) N. Miyaura, A. Suzuki, Chem. Rev. 1995, 95, 2457. 
9 a) T. Collins, Science 2001, 291, 48. b) C. Okkerse, H. van Bekkum, Green Chem. 1999, 1, 107. 
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in 1900 a convenient preparation of organomagnesium compounds by performing a reaction 
of elemental magnesium and organic halides in diethyl ether.5  
The detailed mechanism of this reaction is not yet fully clarified, but a radical pathway is 
generally accepted.10 In solution, a Grignard reagent (RMgX) is in a so called Schlenk 
equilibrium with R2Mg and MgX2, depending on the solvent, temperature and the anion X
−.11 
The Grignard reagents became one of the most widely used C-C bond forming tools as they 
display several advantages. Firstly, it is an atom economical reaction and, secondly 
magnesium is an inexpensive metal, which exhibits low toxicity. However, for the synthesis 
of functionalized Grignard reagents bearing sensitive functional groups such as ester, keto, 
cyano or nitro groups some modifications are nessesary. Rieke developed highly activated 
metal powders, which also enabled the aforementioned halides bearing functional groups to 
be transformed into Grignard reagents. These Rieke metals can be prepared via reduction of 
an anhydrous metal chloride by an alkali metal such as lithium, sodium or potassium in THF 
(Scheme 3).12 Another option is the direct trapping of Grignard reagents with an electrophile 
(Barbier-conditions) to overcome the stability problems.13 
 
 
Scheme 3: Preparation of functionalized Grignard reagents using “Rieke magnesium“. 
 
Recently, Knochel and coworkers reported a convenient methodology for the generation of 
aryl and heteroaryl magnesium and zinc organometallics from aryl and heteroaryl halides by a 
direct metal insertion in the presence of LiCl (Scheme 4, Scheme 5).14  
                                                     
10 a) H. M. Walborksy, Acc. Chem. Res. 1990, 23, 286. b) J. F. Garst, Acc. Chem. Res. 1991, 24, 95. c) J. F. 
Garst, M. P. Soriaga, Coord. Chem. Rev. 2004, 248, 623. 
11 W. Schlenk, W. Jr. Schlenk, Chem. Ber. 1929, 62, 920. 
12 a) R. D. Rieke, L.-C. Chao, Syn. React. Inorg. Metal-Org. Chem. 1974, 4, 101. b) R. D. Rieke, Acc. Chem. 
Res. 1977, 10, 301. c) R. D. Rieke, Science 1989, 246, 1260. d) L. Zhu, R. M. Wehmeyer, R. D. Rieke, J. Org. 
Chem. 1991, 56, 1445. e) R. D. Rieke, M. V. Hanson, Tetrahedron 1997, 53, 1925. f) J. Lee, R. Velarde-Ortiz, 
A. Guijarro, J. R.Wurst, R. D. Rieke, J. Org. Chem. 2000, 65, 5428. 
13 C. Blomberg, The Barbier Reaction and Related One-Step Processes, Springer, Berlin, Heidelberg, New York, 
1993, p. 1. 
14 Zn reagents: a) A. Krasovskiy, V. Malakhov, A. Gavryushin, P. Knochel, Angew. Chem. Int. Ed. 2006, 45, 
6040. b) N. Boudet, S. Sase, P. Sinha, C.-Y. Liu, A. Krasovskiy, P. Knochel, J. Am. Chem. Soc. 2007, 129, 
12358. c) A. Metzger, M. A. Schade, P. Knochel, Org. Lett. 2008, 10, 1107. Mg reagents: d) F. M. Piller, P. 
Appukkuttan, A. Gavryushin, M. Helm, P. Knochel, Angew. Chem. Int. Ed. 2008, 47, 6802. e) F. M. Piller, A. 
Metzger, M. A. Schade, B. A. Haag, A. Gavryushin, P. Knochel, Chem. Eur. J. 2009, 15, 7192. 
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This salt plays an important role in improving reaction kinetics. Firstly, it solubilizes the 
resulting organomagnesium compound and thus facilitates the formation of a clean metal 
surface. Secondly, the highly ionic character of LiCl solutions facilitates charge separation 
and accelerates the metal insertion.15 This new approach allows more for selective reactions 
which proceeds under mild conditions. 
 
Scheme 4: Selected examples of LiCl promoted Mg insertion. 
 
 
Scheme 5: Selected examples of LiCl promoted Zn insertion. 
 
1.1.2. Halogen-Metal Exchange Reactions 
 
The direct oxidative addition of magnesium is a common procedure for the preparation of 
organomagnesium compounds. However, this approach possesses several drawbacks: metal 
reactivity can lead to the reduction of electrophilic functional groups and can cause 
exothermic reactions. These limitations can be considerably reduced by using a halogen-metal 
exchange reaction.  
                                                     
15 C. Reichardt, Solvents and Solvent Effects in Organic Chemistry, Wiley-VCH, Weinheim, 2003, p. 46.  
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The first examples of this approach were briefly reported by Prévost16 in 1931 and Urion17 in 
1934. The driving force for the halogen-metal exchange reaction is the formation of the more 
stable organometallic species (sp > sp2(alkenyl) > sp2(aryl) > sp3(prim) > sp3(sec)). In 1971, 
Tamborski demonstrated the essential role of the electronic properties of both the halogen 
atom and the organic molecule in the formation rate of the new Grignard reagent.18 The 
reactivity order (I > Br > Cl >> F) is also influenced by the halogen-carbon bond strength, by 
the electronegativity and polarizability of the halide.  
The halogen-lithium exchange reaction discovered by Wittig19 and Gilman20 allows the 
preparation of a broad range of organolithium derivatives and has become of great importance 
for the preparation of aromatic and heteroaromatic compounds, using commercially available 
alkyllithium reagents and corresponding organic halides, mainly bromides and iodides.21 
Although the reaction proceeded very fast, the main drawbacks of the use of lithium reagents 
are the very low temperature required and the moderate functional groups tolerance. In 
contrast, the halogen-magnesium exchange turns out to be a very efficient method for the 
preparation of new functionalized reagents of great synthetic utility.22 
In 1998, Knochel reported remarkable examples of iodine-magnesium exchange reactions at 
low temperatures with excellent functional group tolerance to prepare various functionalized 
aromatic Grignard reagents (Scheme 6).23 
 
Scheme 6: Preparation of polyfunctional Grignard reagents starting from aryl iodides. 
                                                     
16 C. Prévost, Bull. Soc. Chim. Fr. 1931, 49, 1372. 
17 E. Urion, Comp. Rend. Acad. Sci. Paris 1934, 198, 1244. 
18 C. Tamborski, G. J. Moore, J. Organomet. Chem. 1971, 26, 153.  
19 G. Wittig, U. Pockels, H. Dröge, Chem. Ber. 1938, 71, 1903.  
20 a) R. G. Jones, H. Gilman, Org. Reactions 1951, 6, 339.  
21 a) W. E. Parham, L. D. Jones, J. Org. Chem. 1976, 41, 1187. b) W. E. Parham, L. D. Jones, Y. Sayed, J. Org. 
Chem. 1975, 40, 2394. c) W. E. Parham, L. D. Jones, J. Org. Chem. 1976, 41, 2704. d) W. E. Parham, D. W. 
Boykin, J. Org. Chem. 1977, 42, 260. e) W. E. Parham, D. W. Boykin, J. Org. Chem. 1977, 42, 257. f) C. E. 
Tucker,T. N. Majid, P. Knochel, J. Am. Chem. Soc. 1992, 114, 3983.  
22 For a review on functionalized organomagnesium reagents see: P. Knochel, W. Dohle, N. Gommermann, F. F. 
Kneisel, F. Kopp, T. Korn, I. Sapountzis, V. A. Vu, Angew. Chem. Int. Ed. 2003, 42, 4302.  
23 a) L. Boymond, M. Rottländer, G. Cahiez, P. Knochel, Angew. Chem. Int. Ed. 1998, 37, 1701. b) I. 
Sapountzis, P. Knochel, Angew. Chem. Int. Ed. 2002, 41, 1610. 
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However, several unactivated, electron rich aryl bromides show low conversion at ambient 
temperature. To overcome this problem, Knochel developed the reagent iPrMgCl·LiCl (1) to 
improve the bromine-magnesium exchange by adding a stochiometric amount of LiCl, which 
dramatically enhances the reactivity of the Grignard reagent by the formation of magnesium-
lithium ate complexes (Scheme 7). 24 
 
 
Scheme 7: Effect of LiCl on Grignard reagent iPrMgCl. 
 
A tremendous variety of aromatic and heteroaromatic bromides were converted into the 
corresponding organo magnesium reagents and can subsequently be quenched by 
electrophiles (Scheme 8).25 
 
 
Scheme 8: LiCl-mediated bromine-magnesium exchange of various aryl and heteroaryl bromides. 
 
1.1.3. Directed Metalation 
 
The third major way to generate organometallic compounds is the directed metalation of a 
C-H bond using alkyl metals or metal amide bases. In contrast to insertion and exchange 
reactions, in this method there is no need for a halogen-carbon bond. The first deprotonation 
reaction with an organometallic involved the reaction between fluorene and EtLi reported by 
                                                     
24 A. Krasovskiy, P. Knochel, Angew. Chem. Int. Ed. 2004, 43, 3333. 
25 a) A. Krasovskiy, B. F. Straub, P. Knochel, Angew. Chem. Int. Ed. 2006, 45, 159. b) H. Ren, P. Knochel, 
Chem. Commun. 2006, 726. c) C.-Y. Liu, P. Knochel, Org. Lett. 2005, 7, 2543. d) F. Kopp, A. Krasovskiy, P. 
Knochel, Chem. Commun. 2004, 2288. 
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Schlenk in 1928.26 A few years later, Gilman and Bebb27 and Wittig and Fuhrmann28 
discovered the example of anisole ortho deprotonation by n-BuLi. This concept of directed 
ortho-metalation (DoM), which describes the regioselective functionalization of aromatic 
systems in the presence of a directing metalation group (DMG), developed quickly into a new 
conceptual framework in synthetic aromatic chemistry. The most valuable work to expand the 
scope, introduce new DMG´s and characterize their reactivity was done by the groups of 
Hauser,29 as well as by Snieckus.30 The DMG is typically a Lewis basic moiety that interacts 
with the Lewis acidic metal cation allowing deprotonation in ortho-position to the directing 
group (Scheme 9). For instance, amides, carbamides, sulfonamides, esters, cyanide, 
sulfoxides and sulfones are considered to be efficient directing groups in contrast to ethers or 
amines, which are poor directing groups. 
 
Scheme 9: Regioselective lithiation ortho to a carbamate. 
 
Traditionally, strong bases such as alkyllithium reagents like s-BuLi (2) or PhLi have been 
extensively used for these kinds of metalations. Additionally, non-nucleophilic, sterically 
hindered lithium bases (R2NLi) such as lithium diisopropylamide (3: LDA) or TMPLi 
(4: TMP = 2,2,6,6-tetramethylpiperidyl) found broad applications. However, such bases can 
cause complications since they often lead to undesired side reactions due to their high 
reactivity, strong nucleophilicity (e.g. Chichibabin addition31) and low functional group 
tolerance. Therefore such deprotonation reactions have to be carried out at very low 
temperatures (-100 °C to -78 °C). 
 
 
                                                     
26 W. Schlenk, E. Bergmann, Ann. Chem. 1928, 463, 98. 
27 H. Gilman, R. L. Bebb, J. Am. Chem. Soc. 1939, 61, 109. 
28 G. Wittig, G. Fuhrmann, Chem. Ber. 1940, 73, 1197. 
29 a) W. H. Puterbaugh, C.R. Hauser, J. Org. Chem. 1964, 29, 853. b) D. W. Slocum, D. I. Sugarman, Adv. 
Chem. Ser. 1974, 130, 227. 
30 a) V. Snieckus, Pure & Appl. Chem. 1990, 62, 2047. b) T. K. Macklin, J. Panteleev, V. Snieckus, Angew. 
Chem. Int. Ed. 2008, 47, 2097. 
31 L. Kürti, B. Czakó, Strategic Applications of Named Reactions in Organic Synthesis, Elsevier, Burlington, 
2005, p. 80. 
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Alternatively, the use of milder magnesium amide bases is generally preferred when dealing 
with more sensitive functional groups. Based on Meunier’s original discoveries,32 Hauser33 
reported the use of diethyl- and diisopropylaminomagnesium bromide, whereas Eaton and 
later Mulzer used the more sterically demanding bases TMPMgX and TMP2Mg.
34 However, 
these magnesium amides suffer from low solubility and low kinetic basicity due to the 
aggregation and a large excesses of both base and electrophile is needed to overcome these 
limitations.35 
A significant improvement for this approach was achieved by the findings of the Knochel 
group, showing that the addition of stoichomeric amounts of LiCl, deaggregates the amide 
bases to create bimetallic species with the general formula R2NMgCl·LiCl.
36 These reagents 
and especially TMPMgCl·LiCl (5) show high solubility in THF, increased reactivity and 
additionally, offer long term stability under inert atmosophere at room temperature. An 
explanation for this behaviour was proposed by studies from Mulvey in which 
TMPMgCl·LiCl (5) was crystalized as a monomeric species (Scheme 10).37 Although the 
reacting structure may be different from the crystal and the structure in solution.38 
 
  
 
 
 
Scheme 10: Preparation and crystal structure of TMPMgCl·LiCl (5). 
 
                                                     
32 L. Meunier, C. R. Hebd. Seances Acad. Sci. 1903, 136, 758. 
33 a) C. R. Hauser, H. G. Walker, J. Am. Chem. Soc. 1947, 69, 295. b) C. R. Hauser, F. C. Frostick, J. Am. Chem. 
Soc. 1949, 71, 1350. 
34 a) P. E. Eaton, C. H. Lee, Y. Xiong, J. Am. Chem. Soc. 1989, 111, 8016. b) W. Schlecker, A. Huth, E. Ottow, 
J. Mulzer, J. Org. Chem. 1995, 60, 8414. 
35 W. Schlecker, A. Huth, E. Ottow, J. Mulzer, J. Org. Chem. 1995, 60, 8414. 
36 A. Krasovskiy, V. Krasovskaya, P. Knochel, Angew. Chem. Int. Ed. 2006, 45, 2958. 
37 P. García-Álvarez, D. V. Graham, E. Hevia, A. R. Kennedy, J. Klett, R. E. Mulvey, C. T. O'Hara, S. 
Weatherstone, Angew. Chem. Int. Ed. 2008, 47, 8079.  
38 R. Neufeld, D. Stalke, Chem. Eur. J. 2016, 22, DOI: 10.1002/chem.201601494. 
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The excellent kinetic basicity and broad functional group tolerance makes TMPMgCl·LiCl 
(5) suitable for deprotonation of various activated aromatics, heterocyclic and aliphatic 
coumpounds in a highly regio- and chemoselective manner (Scheme 11).39 
 
 
Scheme 11: Magnesiation of various aromatic and hetero-aromatic substrates by using 
TMPMgCl·LiCl (5). 
 
The concept was expanded by the development of magnesium bis amide bases, such as 
TMP2Mg·2LiCl (6) in order to deprotonate moderately activated aromatic and heteroaromatic 
compounds (Scheme 12).40  
 
Scheme 12: Magnesiation of various aromatic, hetero-aromatic and non-aromatic substrates by using 
TMP2Mg·2LiCl (6). 
 
Despite the excellent reactivity of these magnesium bases and their high tolerance toward 
nitriles, esters, and aryl ketones, there are still numerous functional groups, that are not 
compatible with TMPMgCl·LiCl (5) or TMP2Mg·2LiCl (6).  
                                                     
39 For a review see: T. Klatt, J. T. Markiewicz, C. Sämann, P. Knochel, J. Org. Chem. 2014, 79, 4253. 
40 a) G. C. Clososki, C. J. Rohbogner, P. Knochel, Angew. Chem. Int. Ed. 2007, 46, 7681. b) C. J. Rohbogner, G. 
C. Clososki, P. Knochel, Angew. Chem. Int. Ed. 2008, 47, 1503. c) C. J. Rohbogner, A. J. Wagner, G. C. 
Clososki, P. Knochel, Org. Synth. 2009, 86, 374. 
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For example, molecules bearing an aldehyde or nitro group, as well as very electron poor 
heterocycles do not undergo directed magnesiations due to degradation. By transmetalation of 
TMPLi (4) or TMPMgCl·LiCl (5) with ZnCl2, the milder zinc amides TMPZnCl·LiCl
41 (7) 
and TMP2Zn·2MgCl2·2LiCl
42 (8), respectively, can be readily prepared. These bases can be 
used for the mild zincation of a variety of sensitive substrates (Scheme 13, Scheme 14). 
 
 
Scheme 13: Zincation of various functionalized aromatic compounds using TMPZnCl·LiCl (7). 
 
 
Scheme 14: Zincation of various sensitive heterocycles using TMP2Zn·2MgCl2·2LiCl (8). 
  
                                                     
41 a) L. Klier, T. Bresser, T. A. Nigst, K. Karaghiosoff, P. Knochel, J. Am. Chem. Soc. 2012, 134, 13584. b) T. 
Bresser, P. Knochel, Angew. Chem. Int. Ed. 2011, 50, 1914. c) M. Mosrin, P. Knochel, Org. Lett. 2009, 11, 
1837. d) D. Haas, M. Mosrin, P. Knochel, Org. Lett. 2013, 15, 6162. 
42 a) S. H. Wunderlich, P. Knochel, Angew. Chem. Int. Ed. 2007, 46, 7685. b) S. H. Wunderlich, P. Knochel, 
Org. Lett. 2008, 10, 4705. b) M. Mosrin, P. Knochel, Chem. Eur. J. 2009, 15, 1468. c) M. Kienle, C. Dunst, P. 
Knochel, Org. Lett. 2009, 11, 5158. d) A. Unsinn, P. Knochel, Chem. Commun. 2012, 48, 2680. 
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1.2. Objectives 
 
The aim of the first project was the development of a regioselective metalation of uracil, 
uridine and cytidine in positions C(5) and C(6) by Mg- and Zn-organometallics. The addition 
of Lewis acids as additives should trigger either kinetic or thermodynamic deprotonation. 
Subsequent quenching with various electrophiles and removal of the attached protecting 
groups should enable the acces to several functionalized heterocycles (Scheme 15). 
 
Scheme 15: Regioselective functionalization of uridine and cytidine. 
 
In a second project, the synthetic method for the preparation of functionalized highly 
diversified indoles as well as azaindoles43 developed by Frischmuth and Knochel, will be 
applied for the preparation of pyrrolo[2,3-d]pyrimidines in order to create a novel synthetic 
route to the marine alkaloid rigidin A.44 Starting from functionalized iodo-ynamides an 
iodine-magnesium exchange reaction is proposed to be carried out, followed by a copper-
mediated ring closing reaction. Subsequent allylation or acylation reactions will allow to 
explore the scope of the methodology affording highly functionalized 
pyrrolo[2,3-d]pyrimidines and provide a fast access to the desired natural product (Scheme 
16).  
                                                     
43 A. Frischmuth, P. Knochel, Angew. Chem. Int. Ed. 2013, 52, 10084. 
44 a) R. Scott, A. Kornienko, ChemMedChem 2014, 9, 1428. b) R. A. Davis, L. V. Christensen, A. D. 
Richardson, R. M. da Rocha, C. M. Ireland, Mar. Drugs 2003, 1, 27. c) M. Tsuda, K. Nozawa, K. Shimbo, J. 
Kobayashi, J. Nat. Prod. 2003, 66, 292. 
A. INTRODUCTION 
 
 
 
14 
 
Scheme 16: Preparation pyrrolo[2,3-d]pyrimidines via copper-mediated carbomagnesiation of 
ynamides leads to natural product rigidin A. 
 
Furthermore, a new synthetic protocol for regioselective metalations of fluorobenzenes that 
bear sterically hindered, but removable silyl groups was developed to furnish unusual 
para-substituted aromatic compounds. Subsequent desilylation and regioselective 
functionalization with common organometallics should afford various tetrasubstituted 
fuorobenzene derivatives (Scheme 17). 
 
Scheme 17: Metalation of fluorobenzenes in para-position and further desilylation and 
functionalization. 
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1. METALATION AND DEPROTECTION OF URACILS, URIDINES 
AND CYTIDINES 
1.1. General Introduction 
1.1.1.  DNA Bases and Natural Products 
 
Deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) are two of the most crucial 
molecules in nature and occurs in every cell of the human body and as well as almost all other 
organisms.45 DNA carries the genetic information and is essential for the growth, 
development, functioning and reproduction of cells. DNA is structured in two strands called 
polynucleotides, each consisting of a chain of simpler units (nucleotides). Each nucleotide is 
composed of a nucleoside and a phosphate moiety. A nucleoside simply consists of a 
nucleobase and a five-carbon sugar (either ribose or deoxyribose). Some pyrimidine 
nucleobases that are relevant for this current work (uracil (9), thymine (10), cytosine (11)) and 
the corresponding nucleosides (uridine (12), thymidine (13b), cytidine (14b)) are displayed in 
Scheme 18. 
 
 
Scheme 18: Pyrimidine nucleobases uracil, thymine, cytosine and their nucleosides uridine, 
desoxythymidine, desoxycytidine and cytidine. 
 
                                                     
45 L. Stryer in Biochemie, (Eds.: J. M. Berg, J. L. Tymoczko, L. Stryer), Springer Spektrum, Berlin, Heidelberg, 
2013, p. 110. 
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Furthermore, the pyrimidine scaffold can be found in numerous natural products.46 The 
uracilylalanine willardiine is an example of a non-proteogenic amino acid and was first 
isolated from seeds of Acacia willardiana by Gmelin in 1959 (Scheme 19).47 
In recent years, several pathways for the synthesis of analogues of emivirine were developed. 
It belongs to the non-nucleoside reverse transcriptase inhibitors (NNRTIs)48 and targets the 
retrovirus HIV-1. The xanthine oxidase inhibitor oxypurinol49 is an active metabolite of the 
drug allopurinol and can be used for the treatment of hyperuricemia and gout. Moreover, the 
scaffold is present in larger biomolecules such as the peptide family penilumamide,50 isolated 
from Penicillum in 2010. 
 
 
 
 
 
 R1 R2 
penilumamide: C2H4SOMe OMe 
penilumamide B: C2H4SMe OMe 
penilumamide C: C2H4SO2Me OMe 
penilumamide D: Me NH2 
Scheme 19: Natural products containing the uracil scaffold. 
 
Moreover, pyrimidine nucleobases represent important molecules in pharmaceutical 
applications51 as they display antibiotic, antifungal, anticancer and antiviral activity.52 To 
briefly mention, 5-fluorocytosine (flucytosine) has antimycotic activity, while 5-fluorouracil 
(adrucil) and 5-fluorodesoxyuridine (floxuridine) are clinically established anticancer drugs 
(Scheme 20).  
                                                     
46 I. M. Lagoja, Chem. Biodiversity 2005, 2, 1. 
47 a) I. Virtanen, R. Gmelin, Acta. Chem. Scand. 1959, 13, 1244. b) T. S. Ashworth, E. G. Brown, F. M. Roberts, 
Biochem. J. 1972, 129, 897. 
48 a) H. Tanaka, H. Takashima, M. Ubasawa, K. Sekiya, N. Inouye, M. Baba, S. Shigeta, R. T. Walker, E. De 
Clercq, T. Miyasaka, J. Med. Chem. 1995, 38, 2860. b) O. S. Pedersen, E. B. Pedersen, Antiviral Chem. 
Chemother. 1999, 10, 2860. 
49 T. Nagamatsu, T. Fujita, K. Endo, J. Chem. Soc., Perkin Trans. 1. 2000, 33.  
50 a) S. W. Meyer, T. F. Mordhorst, C. Lee, P. R. Jensen, W. Fenical, M. Köck, Org. Biomol. Chem. 2010, 8, 
2158. b) M. Chen, C. L. Shao, X. M. Fu, C. J. Kong, Z. G. She, C. Y. Wang. J. Nat. Prod. 2014, 77, 1601. 
51 Science of Synthesis, Six-Membered Hetarenes with Two Identical Heteroatoms (Ed. Y. Yammamoto), Georg 
Thieme Verlag, 2004, p. 379. 
52 Heterocyclic Chemistry, Vol. 5 (Eds.: J. A. Joule, K. Mills), John Wiley & Sons, West Sussex, 2010, p. 645.  
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Furthermore, various antiviral agents are based on functionalized nucleosides including both 
modifications at the sugar moiety or heterocyclic system. For example, idoxuridine displays 
activity against hepatitis or zidovudine (AZT) acts as an anti-HIV protease inhibitor.52 
 
Scheme 20: Functionalized uracils and uridines with pharmaceutical application. 
 
1.1.2. Current State of the Art for the Metalation of Uracils and Uridines 
 
As uridine derivatives are an important pharmaceutical core structure, the functionalization of 
their heterocyclic system is of essential synthetic interest and has been studied thoroughly in 
the literature.53 
Direct metalation of uridine 12 using lithium bases was developed at the C(5)- and 
C(6)-positions by the group of Miyasaka (Scheme 21).54,55 The regioselectivity of the direct 
lithiation was proposed to be depending on the coordination effect of the hydroxylgroup at 
position C´(5) of the sugar moiety. The free hydroxyl group was able to direct the metalation 
to position C(6) by coordination of the LDA base. In contrast, introduction of a bulky silyl 
protecting group suppressed the coordination and the metalation occured at the more activated 
C(5)-position. As a result, uridine was metalated in a very selective manner. However, the use 
of highly reactive lithium bases allowed only a limited choice of electrophiles and lead to 
moderate product yields. Furthermore, functionalization of protected uridine was achieved by 
halogen-metal exchange56 or zinc insertion57 and subsequent reactions with electrophiles, but 
the products were obtained only in poor or mediocre yields. 
                                                     
53 Comprehensive Heterocyclic Chemistry III, Pyridazines and their Benzo Derivatives (Eds.: R. K. Alan, A. R. 
Christopher, F. V. S. Eric, J. K. T. Richard), Elsevier, Oxford, 2008, p. 1.  
54 a) H. Tanaka, I. Nasu, T. Miyasaka, Tetrahedron Lett. 1979, 20, 4755. b) H. Tanaka, H. Hayakawa, T. 
Hiyasaka, Tetrahedron 1982, 38, 2635. c) M. Shimizu, H. Tanaka, H. Hayakawa, T. Miyasaka, Tetrahedron 
Lett. 1990, 31, 1295. 
55 a) H. Hayakawa, H. Tanaka, K. Obi, M. Itoh, T. Miyasaka. Tetrahedron Lett. 1987, 28, 87. b) M. Shimizu, H. 
Tanaka, H. Hayakawa, T. Miyasaka, Tetrahedron Lett. 1990, 31, 1295. 
56 T. L. V. Ulbricht, Tetrahedron 1959, 6, 225.  
57 a) T. M. Stevenson, B. A. S. Prasad, J. R. Citineni, P. Knochel, Tetrahedron Lett. 1996, 37, 8375. b) B. A. S. 
Prasad, T. M. Stevenson, J. R. Citineni, V. Nyzam, P. Knochel, Tetrahedron 1997, 53, 7237. 
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Scheme 21: Reported examples of the metalation of uridine. 
 
1.1.3. General Concept: Metalation in the Presence of Two Directing Groups 
 
The group of Knochel developed a new procedure for the regioselective metalation of 
chromones (Scheme 22).41a This scaffold containes two different directing groups, the vinyl-
ethereal oxygen and the carbonyl oxygen, which are next to two acidic protons in C(2)- and 
C(3)-position, respectively. 
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Scheme 22: Regioselective metalation of chromone in position C(2) or C(3) depending on the 
presence of the Lewis acid MgCl2. 
 
The carbonyl group served as the stronger directing group, lead to the coordination of the 
TMPZnCl·LiCl base (7) at the carbonyl oxygen and directed the metalation in position C(3) 
to furnish the kinetic product. However, in the presence of a stronger Lewis acid such as 
MgCl2 the carbonyl coordination side was occupied and the metalation with the 
TMP2Zn·2MgCl2·2LiCl base (8) was directed at the more acidic position C(2), which 
provided the thermodynamic product. Analogously, the concept could be applied for the 
metalation of the nucleobase uracil and the nucleosides uridine and cytidine.  
 
1.2. Regioselective Metalation of Uracil 
1.2.1. Optimized Metalation Conditions for Uracil 
 
As it was anticipated, the concept of the metalation of chromones could be extended to uracil. 
First of all, the two lactam groups of the scaffold were protected at the nitrogen atoms. 
Hereby, methyl was choosen as a protecting group due to its small steric demand and the 
absence of additional coordination effects. Second of all, the optimized metalation conditions 
were developed by Klier and furnished the regioselectively functionalized C(5)- or C(6)-
products (16a, 18a) by quenching with iodine (Scheme 23).58  
                                                     
58 Project was developed in cooperation with L. M. Klier (see: L. M. Klier, Dissertation, LMU-München, 2015).  
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Scheme 23: Optimized metalation conditions for uracil. 
 
1.2.2. Uracil Reaction Scope 
 
With the metalation conditions in hand, the scope of the reaction with different electrophiles 
was explored. Thus, methyl protected uracil 9 reacted with TMPMgCl·LiCl (5), lead to a 
regiospecific metalation at position C(5). Quenching with different electrophiles provided 
products 16a-j in moderate to good yields (Table 1). Reaction of 15 with dimethyl disulfide 
afforded the thioether 16b in 56% yield (entry 2), whereas reaction with ethyl chloroformate 
furnished the ester 16c in 66% yield (entry 3).  
 
Table 1: Metalation of 1,3-dimethyluracil in position C(5) and subsequent reactions with 
electrophiles.  
 
Entry Electrophile Product/Yield[a]  Entry Electrophile Product/Yield[a] 
1 I2 
 
 
6 
 
 
  16a: 72%    16f: 66%[b] 
2 S2Me2 
 
 
7 
 
 
  16b: 56%    16g: 48%[c,d] 
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3 ClCO2Et 
 
 
8  
 
  16c: 66%    16h: 79%[c,d] 
4 
 
 
 
9 
 
 
  16d: 83%[b]    16i: 54%[b] 
5 
 
 
 
10 
 
 
  16e: 71%[b]    16j: 74%[b] 
[a] Isolated yield of analytically pure products. [b] CuCN·2LiCl was added. [c] ZnCl2 was added. [d] Obtained 
by a palladium-catalyzed cross-coupling with Pd(dba)2 (2 mol%) and P(2-furyl)3 (4 mol%). 
 
Transmetalation of 15 with CuCN·2LiCl and subsequent acylations with various acid 
chlorides provided aliphatic or hetero aromatic ketones 16d-f in 66-83% yield (entries 4-6). 
Transmetalation of 15 with ZnCl2 and subsequent Pd-catalyzed Negishi
59 cross-couplings 
(2 mol% Pd(dba)2, 4 mol% P(2-furyl)3) with heteroaromatic or alkenyl halides gave the 
cross-coupling products 16g-h (48-79%, entries 7-8). Additionally, Cu-catalyzed 
alkynylation60 of 15 with CuCN·2LiCl and iodoacetylene derivatives afforded the highly 
functionalized acetylenes 16i-j in 54-74% yield (entries 9-10). 
The reaction of methyl protected uracil 9 with TMP2Zn·2MgCl2·2LiCl (8) at –30 °C provided 
the bis heterocyclic zinc reagent 17 allowing the direct functionalization at position C(6) 
(Table 2). Iodolysis of the zinc reagent 17 provided 6-iodouracil (18a) in 81% yield (entry 1). 
Similarly, copper-mediated acylation with benzoyl chloride afforded the C(6)-functionalized 
uracil derivative 18b (84%, entry 2). Moreover, Pd-catalyzed Negishi cross-coupling 
(2 mol% Pd(dba)2, 4 mol% P(2-furyl)3) with 1-iodooct-1-ene or 4-iodoanisole or furnished 
the expected C(6)-substituted uracils 18c (74%, entry 3) and 18d (84%, entry 4).  
 
 
                                                     
59 a) E. Negishi, L. F. Valente, M. Kobayashi, J. Am. Chem. Soc. 1980, 102, 3298. b) E. Negishi, Acc. Chem. 
Res. 1982, 15, 340. 
60 a) P. Knochel, N. Millot, A. L. Rodriguez, Org. React. 2001, 58, 417. b) Organozinc Reagents 
(Eds.: P. Knochel, P. Jones), Oxford University Press, New York, 1999, p. 1. c) M. C. P. Yeh, S. C. Berk, J. 
Talbert, P. Knochel, J. Org. Chem. 1988, 53, 2390. 
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Table 2: Metalation of 1,3-dimethyluracil in position C(6) and subsequent reactions with 
electrophiles. 
 
Entry Electrophile Product/Yield[a]  Entry Electrophile Product/Yield[a] 
1 I2 
 
 
3  
 
  18a: 81%    18c: 74%[c] 
2 
 
 
 
4 
 
 
  18b: 84%[b]    18d: 84%[c] 
[a] Isolated yield of analytically pure products. [b] CuCN·2LiCl was added. [c] Obtained by a palladium-
catalyzed cross-coupling with Pd(dba)2 (2 mol%) and P(2-furyl)3 (4 mol%). 
 
1.2.3. Preparation of 5,6-Disubstituted Uracil Derivatives 
 
We further examined the prospect of a second metalation of a C(5)-substituted uracil 
derivative in order to prepare 5,6-disubstituted coumpounds. Metalation of halogen 
substituted or arylated uracils (16a, 16g) using various TMP-bases and reaction temperatures 
gave limited results in terms of metalated species, as observed by TLC or 1H-NMR of 
reaction aliquots quenched with iodine. However, it was observed that metalation was 
successful when the substituent at C(5) had a strong directing effect, for example the uracil 
16d containing a keto-group. The metalation of uracil 16d with TMPMgCl·LiCl (5, -30 °C, 
12 h) and subsequent iodolysis provided the disubstituted uracil 19 in moderate 52% yield 
(Scheme 24). Using this substrate two straight forward ring-closing reactions were performed 
when 19 was treated with hydrazine or hydroxylamine for 1 h at 80 °C in DMF to provide the 
pyrazole 20 and the isoxazole 21 in very good 94-96% yield. 
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Scheme 24: Preparation of pyrazole and isoxazole derivatives 20 and 21. 
 
1.3. Regioselective Metalation of Uridine and Cytidine 
1.3.1. Protection of Uridine and Cytidine 
 
First, the sugar moieties of the nucleosides uridine (12) and cytidine (14b) were protected in 
two straight forward steps. At the C’(3)- and C’(4)-hydroxy group an acetal moiety was 
introduced. Subsequent protection at the C’(5)-hydroxy group with a bulky TBDMS 
(tert-butyldimethylsilyl) group furnished the sugar protected uridine 22 or cytidine 25 in 
92-96% yield (Scheme 25, Scheme 26).  
 
Scheme 25: Full protection of uridine (12). 
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Second, the pyrimidine scaffold of uridine was protected with two different groups, furnishing 
the MOM(methoxymethyl)-protected uridine (23) or the PMB(4-methoxybenzyl ether)-
protected uridine (24) in excellent yields (87-90%). Additionally, the amine function of the 
cytidine (25) was treated with an excess of di-tert-butyl dicarbonate (Boc2O), providing the 
fully protected cytidine derivative (26, Scheme 26).61 
 
 
Scheme 26: Full protection of cytidine (14b). 
 
1.3.2. Optimization of the Reaction Conditions for Uridine Metalation 
 
Analogous to the metalation of uracil, the concept was transfered for the functionalization of 
the uridine scaffold (23, 24) in a regiospecific manner. Metalation of 23 with TMPMgCl·LiCl 
(5) yielded the C(5)-magnesiated intermediate 27 almost exclusively after 24 h, as confirmed 
by 1H-NMR of the iodolysis product 28a (Scheme 27). 
 
Scheme 27: Optimized metalation conditions for uridine (23). 
                                                     
61 S. He, H. Zhao, X. Guo, G. Xin, B. Huang, L. Ma, X. Zhou, R. Zhang, D. Du, X. Wu, Z. Xing, W. Huang, Q. 
Chen, Y. He, Tetrahedron 2013, 69, 9245. 
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Metalation of 23 with TMP2Zn·2LiCl·2MgCl2 (8) provided the C(6) zincated uridine 29 after 
72 h. The regioselectivity of the metalation product was confirmed by 1H-NMR of the 
iodolysis product 30a. 
 
1.3.3. Functionalization of Protected Uridines  
 
With the optimized metalation conditions in hand, various products of C(5)- and 
C(6)-functionalized uridines were prepared. Reaction of the C(5)-magnesiated uridine 27 with 
different electrophiles lead to products 28a-d (Table 3).  
 
Table 3: Metalation of MOM-protected uridine in position C(5) and subsequent reactions with 
electrophiles. 
 
Entry Electrophile Product/Yield[a] 
1 I2 
 
  28a: 70% 
2 ClCO2Et 
 
  28b: 44% 
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3 
 
 
  28c: 71%[b] 
4 
 
 
  28d: 81%[c,d] 
[a] Isolated yield of analytically pure products. [b] CuCN·2LiCl was added. [c] ZnCl2 was added. [d] Obtained 
by a palladium-catalyzed cross-coupling with Pd(dba)2 (2 mol%) and P(2-furyl)3 (4 mol%). 
 
Thus, quenching with iodine or chloroformate furnished the C(5)-iodo derivative 28a (70%, 
entry 1) and the ester 28b (44%, entry 2), respectively. Moreover, copper-mediated acylation 
with cyclopropanecarbonyl chloride afforded the C(5)-functionalized uridine derivative 28c in 
71% yield (entry 3). Additionally, after transmetalation of 27 to zinc, Pd-catalyzed Negishi 
cross-coupling (2 mol% Pd(dba)2, 4 mol% P(2-furyl)3) with 4-iodoanisole provided the 
product 28d (81%, entry 4).  
The metalation with TMP2Zn·2MgCl2·2LiCl (8) provided the C(6)-zincated uridine 29, which 
was reacted with iodine to provide the C(6)-iodo derivative 30a in 95% yield (Table 4, 
entry 1). Furthermore, Pd-catalyzed Negishi cross-coupling reactions (2 mol% Pd(dba)2, 
4 mol% P(2-furyl)3) with 1-chloro-4-iodobenzene or 4-iodobenzonitrile afforded the products 
30b-c in 69-84% yield (entries 2-3). 
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Table 4: Metalation of MOM-protected uridine in position C(6) and subsequent reactions with 
electrophiles.  
 
Entry Electrophile Product/Yield[a] 
1 I2 
 
  30a: 95% 
2 
 
 
  30b: 84%[b] 
3 
 
 
  30c: 69%[b] 
[a] Isolated yield of analytically pure products. [b] Obtained by a palladium-catalyzed cross-coupling with 
Pd(dba)2 (2 mol%) and P(2-furyl)3 (4 mol%). 
 
Similarly, a metalation method for the PMB-protected uridine 24 was developed and 
regioselective C(5)-magnesation provided the metalated species 31 at -30 °C in 36 h. 
Subsequent quenching with iodine afforded the C(5)-iodo derivative 32a in 66% yield (Table 
5, entry1). Compared to the MOM-protected iodo uridine 28a, the reaction displayed similar 
yield, but extended reaction time for the metalation. Copper-mediated allylation with allyl 
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bromide afforded the C(5)-functionalized uridine derivative 32b in 79% yield (entry 2) and 
transmetalation to the zinc species, followed by Pd-catalyzed cross-coupling reaction (2 mol% 
Pd(dba)2, 4 mol% P(2-furyl)3) with iodobenzene afforded the product 32c in 72% yield 
(entry 3).  
 
Table 5: Metalation of PMB-protected uridine in position C(5) and subsequent reactions with 
electrophiles. 
 
Entry Electrophile Product/Yield[a] 
1 I2 
 
  32a: 66% 
2  
 
  32b: 79%[b] 
3 
 
 
  32c: 72%[c,d] 
[a] Isolated yield of analytically pure products. [b] CuCN·2LiCl was added. [c] ZnCl2 was added. [d] Obtained 
by a palladium-catalyzed cross-coupling with Pd(dba)2 (2 mol%) and P(2-furyl)3 (4 mol%). 
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1.3.4. Deprotection of Uridine 
 
In order to prepare compounds with potential biological interest, we investigated the removal 
of all protecting groups of the functionalized uridines of type 28 and 30. Cleavage of the 
acetal group and the silyl ether has been accomplished under weakly acidic conditions.62 
However, the deprotection of N-MOM-protected amides could be only performed by using 
strong acids.63  
Thus, different deprotecting conditions were tested on the unsubstituted uridine 23 (Table 6). 
First of all, a number of acidic conditions were examinated (entries 1-5) and showed, that the 
protecting groups on the sugar moiety were selectively cleaved to furnish uridine 33.  
 
Table 6: Screening of deprotection conditions for MOM-protected uridine. 
 
Entry Reagent (equiv) Reaction conditions 
Isolated yield 
of 33[a] 
Isolated yield 
of 34[a] 
1 2.0 M HCl (excess) 25 °C, 16 h 87% - 
2 conc. HCl (excess) 25 °C, 16 h 88% - 
3 conc. HCl (excess) 60 °C, 16 h 40% 25% 
4 70% aq. TFA (excess) 25 °C, 16 h 74% - 
5 p-TolSO2Na (2.0) 
2.0 M HCl (2.5) 
MeCN, 25 °C, 27 h 
 
62% - 
6 ZrCl4 (0.5) iPrOH, 80 °C, 24 h - - 
7 BBr3 CH2Cl2, -78 to 25 °C, 24 h - - 
[a] Isolated yield of analytically pure products.   
 
                                                     
62 Y.-C. Shih, Y.-Y. Yang, C.-C. Lin, T.-C. Chien, J. Org. Chem, 2013, 78, 4027. 
63 a) A. Madin, C. J. O’Donnell, T. Oh, D. W. Old, L. E. Overman, M. J. Sharp, Angew. Chem., Int. Ed. 1999, 
38, 2934. b) S. Yokoshima, H. Tokuyama, T. Fukuyama, Angew. Chem., Int. Ed. 2000, 39, 4073. c) D. M. 
Barnes, J. Barkalow, D. J. Plata, Org. Lett. 2009, 11, 273. d) P. S. Baran, C. A. Guerrero, B. D. 
Hafensteiner, N. B. Ambhaikar, Angew. Chem., Int. Ed. 2005, 44, 3892. 
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The best result was obtained working with concentrated HCl as a solvent at 25 °C (88% yield 
of 33, entry 2). However, the cleavage of the MOM-group was only partly achieved under 
harsh acidic conditions at 60 °C with concentrated HCl (25% yield of 34, entry 3) in 
combination with decomposition of the uridine scaffold. Moreover, the use of Lewis acid 
conditions by treatment with ZrCl4
64 or BBr3
65
 provided no desired product (entries 6-7). 
With the optimized conditions for the sugar moiety, we readily performed a selective 
deprotection to afford the MOM-protected nucleosides 33a-d in 72-82% yield (Scheme 28). 
 
Scheme 28: Deprotection of substituted uridines leading to nucleosides 33a-d. 
 
1.4. Metalation of Cytidine  
1.4.1. Metalation Conditions for Cytidine 
 
The metalation procedure was extended to the bis-Boc protected cytidine (26) and treatment 
with TMP2Zn·2MgCl2·2LiCl (8) at –30 °C in THF for 4 h provided the C(6)-zincated species 
34 as single regioisomer (Scheme 29). Subsequent quenching with iodine furnished iodo 
product 15a in 61% yield. Moreover, a palladium-catalyzed cross-coupling of the metalated 
spezies 34 with Pd(dba)2 (2 mol%), P(2-furyl)3 (4 mol%) and iodobenzene furnished the 
C(6)-arylated product 15b in 43% yield. 
                                                     
64 G. V. M. Sharma, K. L. Reddy, P. S. Lakshmi, P. Radha Krishna, Tetrahedron 2004, 45, 9229. 
65 E. Sotelo, A. Coelho, E. Ravina, Tetrahedron Lett. 2001, 42, 8633. 
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Scheme 29: Metalation of bis-Boc-protected cytidine in position C(6) and subsequent reaction with 
electrophiles. [a] Isolated yield of analytically pure products. [b] Obtained by a palladium-catalyzed 
cross-coupling with Pd(dba)2 (2 mol%) and P(2-furyl)3 (4 mol%). 
 
1.4.2. Deprotection of Cytidine 
 
A full deprotection method for cytidine derivative 35b was employed under acidic conditions 
(CF3COOH, 70% in H2O) at 25 °C and resulting in the formation of the arylated cytidine 36 
in 85% yield (Scheme 30). 
 
Scheme 30: Deprotection of the substituted cytidine 35b leading to the nucleosides derivative 36. 
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2. PREPARATION OF FUNCTIONALIZED PYRROLO[2,3-
D]PYRIMIDINES VIA AN INTRAMOLECULAR COPPER-
MEDIATED CARBOMAGNESIATION OF YNAMIDES 
2.1. Introduction 
2.1.1. Natural Products  
 
Heterocyclic fused-pyrimidines are key structures in various natural alkaloids, which displays 
a multitude of biological activities. One of the most abundant and important heterocycles 
from this class are pyrrolopyrimidines, where a pyrimidine scaffold is fused to a pyrrole ring. 
This introduction is focused on the pyrrolo[2,3-d]pyrimidine isomer and its occurrence in 
numerous biologically-relevant molecules or phamaceuticals.66 An example of a moleculs 
containing this core structure is Pemetrexed67, a chemotherapy drug manufactured by Eli Lilly 
(Scheme 31). Moreover, Tofacitinib an inhibitor of Janus kinase 1 (JAK1) and Janus kinase 3 
(JAK3) can be used for treatment of rheumatoid arthritis.68 Additionally, Ruxolitinib is a drug 
for the treatment of intermediate or high-risk myelofibrosis, a type of bone marrow 
cancer.69,70 
 
Scheme 31: Selected pharmaceutical relevant pyrrolopyrimidines. 
 
Furthermore, a number of nucleoside modifications in the RNA are based on the 
pyrrolopyrimidne scaffold. Two of these modifications, Queuosine and Archaeosine, are 
                                                     
66 For a general review, see: a) L. M. De Coen, T. S. A. Heugebaert, D. Garcia, C. V. Stevens, Chem. Rev. 2016, 
116, 80. b) F. Seela, X. Peng, S. Budow, Curr. Org. Chem. 2007, 11, 427. c) E. Altmann, L. Widler, M. 
Missbach, Mini Rev. Med. Chem. 2002, 2, 201. 
67 E. C. Taylor, B. Liu, J. Org. Chem. 2003, 68, 9938. 
68 Tofacitinib. Drugs R. D. 2010, 10, 271. 
69 R.A. Mesa, U. Yasothan, P. Kirkpatrick, Nat. Rev. Drug Discov. 2012, 11, 103. 
70 Alan R. Katritzky in Comprehensive heterocyclic chemistry, (Ed: Alan R. Katritzky), Elsevier Books, 2008, 
p.1. 
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present in the transfer-RNA of both bacteria and eukaryotes (Scheme 32).71 Another natural 
nucleoside, Xylocydine, is a nanomolar CDK (cyclin-dependant kinase) inhibitor.72 
 
Scheme 32: RNA nucleosides Quenosine, Archaeosine and Xylocydine.  
 
Moreover, the marine alkaloids rigidin A, B, C, D and E (37a-e) represent another important 
class of moleculs based on pyrrolopyrimidines (Scheme 33). The family of alkaloids was first 
isolated in 1990 from the tunicate Eudistoma cf. rigida found near Okinawa and New 
Guinea.73 These compounds were shown to exhibit cytotoxicity against murine leukemia 
L1210 cells, while rigidin A was also found to possess anticalmodulin activity.74 As a result 
of miniscule isolation yields of these natural products (0.0015% for A, 0.00031% for B, 
0.00008% for C, 0.00004% for D, and 0.018% for E based on dry weight) synthetic routes for 
rigidins are highly desirable.  
Before 2012, the synthetic accomplishments in the rigidin area included three total syntheses 
of rigidin A75,76,77 and one of rigidin E.77,78 However, all of these approaches involved long 
multistep synthetic routes with low overall yields.  
 
                                                     
71 a) D. Iwata-Reuyl, Bioorg.Chem. 2003, 31, 24. b) M. Watanabe, M. Matsuo, S. Tanaka , H. Akimoto, S. 
Asahil, S. Nishimural, J. R. Katze, T. Hashizume, P. F. Crain, J. A. McCloske, N. Okada, J. Bio. Chem. 1997, 
272, 20146. 
72 S. J. Cho, S. S. Lee, Y. J. Kim, B. D. Park, J. S. Choi, L. Liu, Y. M. Ham, K. B. Moon, S. K. Lee, Cancer Lett. 
2010, 287,196. 
73 J. Kabayashi, J. Cheng, Y. Kikuchi, M. Ishibashi, S. Yamamura, Y. Ohizumi, T. Ohta, S. Nozoe, Tetrahedron 
Lett. 1990, 31, 4617. 
74 a) M. Tsuda, K. Nozawa, K. Shimbo, J. Kobayashi, J. Nat. Prod., 2003, 66, 292. b) R. A. Davis, L. V. 
Christensen, A. D. Richardson, R. M. da Rocha, C. M. Ireland, Mar. Drugs, 2003, 1, 27. c) R. Scott, A. 
Kornienko, ChemMedChem, 2014, 9, 1428. 
75 E. D. Edstrom, Y. Wei, J. Org. Chem. 1993, 58, 403. 
76 a) T. Sakamoto, Y. Kondo, S. Sato, H. Yamanaka, J. Chem. Soc. Perkin Trans. 1996, 1, 459. b) T. Sakamoto, 
Y. Kondo, S. Sato, H. Yamanaka, Tetrahedron Lett. 1994, 35, 2919. 
77 J. T. Gupton, E. J. Banner, A. B. Scharf, B. K. Norwood, R. P. F. Kanters, R. N. Dominey, J. E. Hempel, A. 
Kharlamova, I. Bluhn-Chertudi, C. Hickenboth, Tetrahedron 2006, 62, 8243. 
78 B. Cao, H. Ding, R. Yang, X. Wang, Q. Xiao, Mar. Drugs 2012, 10, 1412. 
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 R1 R2 R3 
37a: rigidin A H H H 
37b: rigidin B H OMe H 
37c: rigidin C H H OMe 
37d: rigidin D H OMe OMe 
37e: rigidin E Me H H 
Scheme 33: Structure of rigidin A-E (37a-e). 
 
A more efficient approach was developed by Magedov in one-pot multicomponent reations to 
rapidly access the rigidins A-D and various structural variants of this heterocyclic scaffold.79 
 
2.1.2. Carbocupration Development 
 
Carbocuprations80 are powerful addition reactions for the construction of complex 
stereodefined organic molecules81 and their intramolecular version is very attractive for 
constructing heterocyclic organometallics.82 Recently, Kunz and Knochel described a general 
preparation of functionalized benzo[b]thiophenes and benzo[b]thieno[2,3-d]thiophenes via an 
intramolecular catalytic carbocupration reaction.83 Based on this work, a preparation of 
functionalized indoles and azaindoles of type 38 by copper-mediated carbomagnesation was 
developed by Fischmuth and Knochel (Scheme 34).43 
                                                     
79 a) L. V. Frolova, N. M. Evdokimov, K. Hayden, I. Malik, S. Rogelj, A. Kornienko, I. V. Magedov, Org. Lett. 
2011, 13, 1118. b) L. V. Frolova, I. V. Magedov, A. E. Romero, M. Karki, I. Otero, K. Hayden, N. M. 
Evdokimov, L. M. Y. Banuls, S. K. Rastogi, W. R. Smith, L. Shi-Long, R. Kiss, C. B. Shuster, E. Hamel, T. 
Betancourt, S. Rogelj, A. Kornienko J. Med. Chem. 2013, 56, 6886. 
80 a) J. P. Das, H. Chechik, I. Marek, Nat. Chem. 2009, 1, 128. b) A. Abramovitch, I. Marek, Eur. J. Org. Chem. 
2008, 4924. c) Y. Minko, M. Pasco, H. Chechik, I. Marek, Beilstein J. Org. Chem. 2013, 9, 526. For reviews on 
carbocupration reactions see also: d) J. F. Normant, A. Alexakis, Synthesis 1981, 841. e) A. Basheer, I. Marek, 
Beilstein J. Org. Chem. 2010, 6, No. 77. f) N. Chinkov, D. Tene, I. Marek in Metal-Catalyzed Cross-Coupling 
Reactions (Ed.: F. Diederich, A. de Meijere), Wiley-VCH, Weinheim, 2004, p. 1. g) N. Krause in Modern 
Organocopper Chemistry (Ed.: N. Krause), Wiley-VCH, Weinheim, 2002, p. 1. 
81 a) C. Germon, A. Alexakis, J. F. Normant, Synthesis 1984, 40. b) E. Nakamura, S. Mori, Angew. Chem. Int. 
Ed. 2000, 39, 3750. c) A. Alexakis, J. E. Bäckvall, N. Krause, O. Pàmies, M. Diéguez, Chem. Rev. 2008, 108, 
2796. d) Y. Minko, M. Pasco, L. Lercher, I. Marek, Nat. Protoc., 2013, 8, 749. e) L. Ackermann, Angew. Chem. 
Int. Ed. 2011, 50, 3842. f) R. Jeyachandran, H. K. Potukuchi, L. Ackermann, Beilstein J. Org. Chem. 2012, 8, 
1771. g) F. Monnier, M. Taillefer, Angew. Chem. Int. Ed. 2009, 48, 6954. h) G. Lefevre, G. Franc, A. Tlili, C. 
Adamo, M. Taillefer, I. Ciofini, A. Jutand, Organometallics 2012, 31, 7694. A. Tlili, F. Monnier, M. Taillefer, 
Chem. Commun. 2012, 48, 6408. i) G. Danoun, A. Tlili, F. Monnier, M. Taillefer, Angew. Chem. Int. Ed. 2012, 
51, 12815. 
82 a) Z. Shen, X. Lu, Adv. Synth. Catal. 2009, 351, 3107. b) V. Kavala, D. Janreddy, M. J. Raihan, C.-W. Kuo, C. 
Ramesh, C.-F. Yao, Adv. Synth. Catal. 2012, 354, 2229. 
83 T. Kunz, P. Knochel, Angew. Chem. Int. Ed. 2012, 51, 1958. 
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The latter method offered a mild and general one-pot preparation of highly functionalized 
heterocycles via a five-endo-dig84 intramolecular carbocupration starting from 
bromine-magnesium exchange with iPrMgCl·LiCl (1) of the corresponding bromo-ynamide 
(39)85 to furnished the magnesium species 40. Subsequent transmetalation with CuCN·2LiCl 
lead to cuprated heterocylic intermediates of type 41 and quenching with various electrophiles 
gave access to substituted indoles and azaindoles in good yields. 
 
Scheme 34: Preparation of indoles, 4-, 5-, 6-, and 7-azaindoles and selected examples via copper-
mediated carbomagnesiation of ynamides of type 39. 
 
 
 
                                                     
84 a) I. L. Kruse, J. E. Baldwin, J. C. S. Chem. Commun. 1976, 18, 734. b) R. C. Thomas, I. L. Kruse, L. 
Silberman, E. J. Baldwin, J. Org. Chem. 1977, 42, 3846. 
85 Review: a) G. Evano, A. Coste, K. Jouvin, Angew. Chem. Int. Ed. 2010, 49, 2840. b) K. A. DeKorver, H. Li, 
A.G. Lohse, R. Hayashi, Z. Lu, Y. Zhan, R. P. Hsung, Chem. Rev. 2010, 110, 5064. c) A. Coste, G. Karthikeyan, 
F. Couty, G. Evano, Angew. Chem. Int. Ed. 2009, 48, 4381. d) K. Jouvin, J. Heimburger, G. Evano, Chem. Sci. 
2012, 3, 756. e) J.Y. Kim, S.H. Kim, S. Chang, Tetrahedron Lett. 2008, 49, 1745. f) F. Nissen, V. Richard, C. 
Alayrac, B. Witulski, Chem. Commun. 2011, 47, 6656. g) S. Balieu, K. Toutah, L. Carro, L.-M. Chamoreau, H. 
Rousselière, C. Courillon, Tetrahedron Lett. 2011, 52, 2876. 
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2.2. Preparation of Pyrrolo[2,3-d]pyrimidines 
2.2.1. Preparation of Functionalized Ynamides 
 
We applied this mild, intramolecular copper-mediated carbomagnesiation procedure for the 
synthesis of functionalized pyrrolo[2,3-d]pyrimidines and have further investigated the 
preparation of a relevant natural product, the marine alkaloid rigidin A. 
Firstly, we prepared the N-sulfonyl ynamide 42 derived from 2,4-dimethoxypyrimidine (43) 
by consecutive magnesation-iodolysis sequences86 using TMPMgCl·LiCl (5) and iodine 
afforded 5,6-diiodo-dimethoxypyrimidine (44) in 65% overall yield (Scheme 35). Copper-
catalyzed amination87 with p-toluenesulfonamide in the presence of Cs2CO3 in MeCN 
provided pyrimidyl N-sulfonylamide (45) in 68% yield. After deprotonation with KHMDS 
(KHMDS = potassium hexamethyldisilazane), treatment with 
phenyl((trimethylsilyl)ethynyl)iodonium triflate88 afforded the 6-substituted pyrimidyl 
N-sulfonyl ynamide (42) in 67% yield. 
 
 
Scheme 35: Preparation of TMS-substituted ynamides of type 42. 
 
 
 
                                                     
86 M. Mosrin, N. Boudet, P. Knochel, Org. Biomol. Chem. 2008, 6, 3237. 
87 Y.-C. Teo, F.-F. Yong, Synlett 2011, 837. 
88 a) P. Murch, B. L. Williamson, P. J. Stang, Synthesis 1994, 1255. b) B. Witulski, T. Stengel, Angew. Chem. 
Int. Ed. 1998, 37, 489. c) K. Tanaka, K. Takeishi, Synthesis 2007, 2920. 
B. RESULTS AND DISCUSSION 
 
 
 
 
39 
2.2.2. Preparation of Functionalized Pyrrolo[2,3-d]pyrimidines 
 
Compound 42 was then submitted to an iodine-magnesium exchange using iPrMgCl·LiCl (1, 
THF, -40 °C, 2 h) (Scheme 35). The intermediate magnesium reagent of type 40 was 
transmetalated to the corresponding copper species using CuCN·2LiCl. Then a smooth 
trans-carbocupration proceeded at 25 °C within 16 h lead to a heterocyclic intermediate of 
type 41. After hydrolysis, the pyrrolo[2,3-d]pyrimidine (46a) was obtained in 67% isolated 
yield (Table 7, entry 1). Allylation of the copper intermediate of type 41 with allyl bromide or 
2-cyclohexenyl bromide provided the allylated products (46b-c) in 57-81% yield (entries 2-3). 
Moreover, acylation with benzoyl chloride furnished the substituted benzoylated 
N-heterocycle (46d) in 67% yield (entry 4). Furthermore, quenching with various substituted 
aromatic acid chlorides provided the corresponding 2-acylated pyrrolo[2,3-d]pyrimidines 
46e-g in 53-77% yield (entries 5-7). 
 
Table 7: Functionalized pyrrolo[2,3-d]pyrimidines of type 46 obtained by copper-mediated 
carbomagnesiation of ynamide 42 and subsequent reactions with various electrophiles (E-X).  
 
Entry Electrophile Product/Yield[a] 
1 H2O 
 
  46a: 67% 
2  
 
  46b: 81% 
3 
 
 
  46c: 57% 
B. RESULTS AND DISCUSSION 
 
 
 
 
40 
4 
 
 
  46d: 67% 
5 
 
 
  46e: 71% 
6 
 
 
  46f: 77% 
7 
 
 
  46g: 53% 
[a] Isolated yield of analytically pure products.  
 
2.2.3. Further Functionalizations 
 
We have further shown that the 3-TMS-substituted pyrrolo[2,3-d]pyrimidine (46b) can be 
readily converted into the corresponding iodide (47) by using ICl89 in CH2Cl2 (0 °C, 10 min) 
in 74% yield. The iodoindole 47 undergoes Negishi cross-couplings with various freshly 
prepared arylzinc reagents using PEPPSI-IPr90 (3 mol%) furnished meta- and 
para-substituted, arylated products (48a-c) as highly functionalized N-heterocycles in 
52-63% yield (Scheme 36).  
                                                     
89 Z. Bo, A. D. Schlüter, J. Org. Chem. 2002, 67, 5327. 
90 a) C. J. O’Brien, E. A. B. Kantchev, C. Valente, N. Hadei, G. A. Chass, A. Lough, A. C. Hopkinson, M. G. 
Organ, Chem. Eur. J. 2006, 12, 4743. b) M. G. Organ, S. Avola, I. Dubovyk, N. Hadei, E. A. B. Kantchev, C. J. 
O’Brien, C. Valente, Eur. J. Chem. 2006, 12, 4749. c) L. C. McCann, M. G. Organ, Angew. Chem. Int. Ed. 2014, 
53, 4386. 
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Scheme 36: Transformation of the TMS-substituted indole 46b to the iodine 47 and subsequent 
Negishi cross-couplings. 
 
2.3. Synthesis of Rigidin A 
 
With these results in hand, we applied the methodology to a synthesis of the marine natural 
product rigidin A (37a; Scheme 37). Thus, iodolysis of 46e with ICl furnished the 3-iodo-
derivative (49) in 89% yield.  
 
Scheme 37: Synthesis of rigidin A (37a). 
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Removal of the sulfonamide group with KOH in a mixture of MeOH:THF provided the 
pyrrolo[2,3-d]pyrimidine (50) in 61% yield. The N-heterocycle 50 was further converted to 
rigidin A (37a) according to the procedure of Sakamoto76a in two steps. Thus, a Suzuki-
reaction91 with 4-anisylboronic acid catalyzed by Pd(PPh3)4 (2 mol%) afforded the fully 
substituted heterocycle 51 (57% yield), followed by a deprotection of all four methoxy-
substituents with an excess of BBr3
92 lead to rigidin A (37a) in five steps starting from the 
N-sulfonyl ynamide (42) in ca. 8% overall yield. 
 
 
 
 
 
  
                                                     
91 N. Miyaura, A. Suzuki, Chem. Rev. 1995, 95, 2457. 
92 a) F. L. Benton, T. E. Dillon, J. Am. Chem. Soc. 1942, 64, 1128. b) J. F. W. McOmie, M. L. Watts, D. E. West, 
Tetrahedron 1968, 24, 2289. c) C. Sousa, P. J. Silva, Eur. J. Org. Chem. 2013, 5195. 
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3. REGIOSELECTIVE PREPARATION OF TETRASUBSTITUTED 
FLUOROBENZENES 
3.1. Overview of Remote meta- or para-selective Functionalizations 
 
Achieving site selectivity in carbon-hydrogen (C-H) functionalization reactions is a 
significant challenge in organic chemistry, especially when the target C-H bond is distant 
from existing functional groups. The usual approach is to use the electronic and/or 
coordinative characteristics of a directing group, which lead to ortho-selectivity through the 
formation of conformationally rigid six- or seven-membered cyclic transition states. However, 
meta-selective C-H functionalizations still remain a big challenge.  
The group of Yu reported a class of easily removable nitrile-containing templates that directed 
the activation of meta-C-H bonds (Scheme 38). These templates are conformationally locked 
by their substituents and enabled cyclopalladation reactions to selective functionalize certain 
arenes,93 aromatic amines94 and aromatic amides.95 
 
 
Scheme 38: Selected examples of remote meta-C-H bond activation using nitrile containing templates. 
 
 
 
 
                                                     
93 a) G. Yang, P. Lindovska, D. Zhu, J. Kim, P. Wang, R.-Y. Tang, M. Movassaghi, J.-Q. Yu, J. Am. Chem. Soc. 
2014, 136, 10807. b) L. Wan, N. Dastbaravardeh, G. Li, J.-Q. Yu, J. Am. Chem. Soc. 2013, 135, 18056. c) S. 
Lee, H. Lee, K. L. Tan, J. Am. Chem. Soc. 2013, 135, 18778. d) D. Leow1, G. Li, T.-S. Mei, J.-Q. Yu, Nature 
2012, 486, 518. 
94 R.-Y. Tang, G. Li, J.-Q. Yu, Nature 2014, 507, 215. 
95 X.-C. Wang, W. Gong, L.-Z. Fang, R.-Y. Zhu, S. Li, K. M. Engle, J.-Q. Yu, Nature 2015, 519, 334. 
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Moreover, Hartwig reported a one-pot method for sterically controlled meta-selective 
functionalizations of arenes through Ir-catalyzed C-H borylations, followed by Pd- or Ni-
catalyzed cross-couplings of the resulting arylboronate esters with alkyl, allyl and benzoyl 
electrophiles (Scheme 39).96  
 
 
Scheme 39: Selective examples of meta-functionalization through sterical demanding Ir-catalyzed 
C-H borylation. 
 
Furthermore, a few examples of remote metalation methods are reported in the literature. The 
group of Mulvey developed a protocol by which the metalating agent, a sodium-magnesium 
mixed TMP-base, enabled ortho-meta′ or meta-meta′ dimetalation, depending on the nature of 
the directing group (Scheme 40).97 Moreover, several of these complexe bimetalic reagents 
were developed and enabled unconventional metalation pattern.98 
 
 
Scheme 40: Site-selective metalation using mixed TMP-bases. 
 
                                                     
96 a) D. W. Robbins, J. F. Hartwig, Angew. Chem. Int. Ed. 2013, 52, 933. b) Y.-N. Wang, X.-Q. Guo, X.-H. Zhu, 
R. Zhong, L.-H. Cai, X.-F. Hou, Chem. Commun. 2012, 48, 10437. 
97 A. J. Martínez-Martínez, A. R. Kennedy, R. E. Mulvey, C. T. O’Hara, Science 2014, 346, 834. 
98 a) R. E. Mulvey, Acc. Chem. Res. 2009, 42, 743. b) D. R. Armstrong, W. Clegg, S. H. Dale, E. Hevia, L. M. 
Hogg, G. W. Honeyman, R. E. Mulvey, Angew. Chem. Int. Ed. 2006, 45, 3775. 
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However, remote selectivity can be also influenced by the sterical demand of functional 
groups suppressing common metalation sites on the aromatic scaffold. In fundamental work 
from Schlosser on metalation of haloarenes99 a few examples of meta-selective metalation 
patterns were reported (Scheme 41).100 The selectivity of the metalation of substituted 
2,6-dihaloarenes depended on the sterical demand of the three substituents. Especially, 
introduction of the bulky triethylsilyl group directed the metalation to the less basic 
meta-position due to a so called “buttressing effect”.101 
 
 
Scheme 41: Examples of meta-selective metalations of haloarenes. 
 
 
3.2. Preparation of Bis Silylbenzene Derivatives 
 
Taking aforementioned strategies into account, we envisioned a new protocol for the 
para-metalation of 2,6-bis silyl fluoroarenes. At first, we prepared the starting material by 
performing a bromine-lithium exchange with t-BuLi on 2-bromofluorobenzene (52) and 
trapping with triisopropylsilyl chloride (TIPSCl) afforded the silyl compound 53 in 62% yield 
(Scheme 42).  
                                                     
99 a) C. Heiss, T. Rausis, M. Schlosser, Synthesis 2005, 617. c) T. Rausis, M. Schlosser, Eur. J. Org. Chem. 
2002, 3351. d) C. Heiss, E. Marzi, F. Mongin, M. Schlosser, Eur. J. Org. Chem. 2007, 669. 
100 a) M. Schlosser, C. Heiss, Eur. J. Org. Chem. 2003, 4618. b) C. Heiss, E. Marzi, M. Schlosser, Eur. J. Org. 
Chem. 2003, 4625. c) C. Heiss, F. Leroux, M. Schlosser, Eur. J. Org. Chem. 2005, 5242. d) M. Schlosser, C. 
Heiss, E. Marzi, R. Scopelliti, Eur. J. Org. Chem. 2006, 4398. 
101 J. Gorecka, C. Heiss, R. Scopelliti, M. Schlosser, Org. Lett. 2004, 6, 4591. 
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Subsequent metalation with TMPLi (4) at the activated position ortho to fluorine and 
quenching with different silyl chlorides provided the bis silyl derivatives 54 and 55 in 
74-86% yield. 
 
 
Scheme 42: Preparation of bis silyl arenes bearing various trialkylsilyl groups. 
 
Furthermore, two symmetric silyl groups were introduced on fluorobenzene (56) in a one-pot 
procedure. The addition of TMPLi (4, 2.2 equiv) in the presence of triethylsilyl chloride 
(TESCl, 2.5 equiv)102 afforded the bis silyl arene 57 in 89% yield (Scheme 43). Additionally, 
double bromine-lithium exchange of dibromobenzene 58 with n-BuLi (59) was trapped in situ 
with TESCl (2.5 equiv) and furnished the bis silyl arene 60 in 93% yield. 
 
Scheme 43: Preparation of bis silyl arenes with equal trialkylsilyl groups. 
 
3.3. Optimization of Reaction Conditions for para-selective Metalation 
 
A new metalation protocol that enables meta-selective functionalization of fluoroarenes was 
investigated. In the preliminary experiments, we treated bis silyl arene 55 with n-BuLi (59) in 
THF at -78 °C for 24 h, but no conversion was observed (Table 8, entry 1). Also the addition 
of stoichiometric amount of potassium tert-butoxide (KOtBu), to generate a kinetic enhanced 
and so called “superbase” did not increase the conversion rate (entry 2).103 To our delight, 
                                                     
102 S. Lulinski, J. Serwatowski, J. Org. Chem. 2003, 68, 9384. 
103 F. Mongin, R. Maggi, M. Schlosser, Chimia 1996, 50, 650. 
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switching to s-BuLi (2) furnished the desired product with low 10% conversion (entry 3). 
Moreover, moderate conversions (28-45%, entries 4-6) were achieved by the addition of 
coordinative nitrogen ligands, which break up the aggregates of the lithium base and enhance 
their reactivity.104 Especially the mixture of s-BuLi (2), KOtBu and PMDTA (N,N,N′,N′′,N′′-
pentamethyldiethylenetriamine) proofed to be capable for deprotonation in position C(4) of 
the bis silyl arene 55 (entry 6). Decreasing the steric demand of the silyl group to the 
trimethysilyl (TMS) derivative 54 resulted in a regioselectivity switched metalation in 
position C(3) (entry 7). However, performing the reaction on TES-derivative (57), metalation 
occured selectively in the desired meta-position with 47% conversion (entry 8).  
 
Table 8: Optimization of reaction conditions: screening of base, additives and size of the alkyl silyl 
group.  
 
Entry Silyl arene Base (equiv) Additives (equiv) Conversion[a,b] 
1 
 
n-BuLi (1.5) - - 
 55    
2 55 n-BuLi (1.5) KOtBu (1.5) traces 
3 55 s-BuLi (1.5) KOtBu (1.5) 10% 
4 55 s-BuLi (1.5) KOtBu (1.5), NEt3 (1.5) 28% 
5 55 s-BuLi (1.5) KOtBu (1.5), TMEDA (1.5) 34% 
6 55 s-BuLi (1.5) KOtBu (1.5), PMDTA (1.5) 45%[b] 
7 
 
s-BuLi (1.5) KOtBu (1.5), PMDTA (1.5) 
65%[b] 
(ortho product) 
 54    
8 
 
s-BuLi (1.5) KOtBu (1.5), PMDTA (1.5) 47%[b] 
 57    
[a] GC yield after quenching with S2Me2 (3.0 equiv). [b] Regioselectivity was checked by 1H-NMR. 
                                                     
104 F. Faigl, E. Marzi, M. Schlosser, Chem. Eur. J. 2000, 6, 771. 
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To further improve the conversion, we evaluated the role of the solvent (Table 9, 
entries 1-4).105 The metalation of bis triethylsilyl arene 57 was performed in different ethereal 
solvents or ihexane and the highest conversion was observed in diethyl ether (56%, entry 1). 
Moreover, performing the reaction at a temperature of -65 °C led to 76% conversion (entry 5). 
At -50 °C the conversion dropped significantly due to deprotonation of the solvent (entry 6). 
Finally, we observed an optimum of 2.5 equivalents of base and additives (entries 6-8) and 
examinated an optimal reaction time of 20 h to afford the metalated species 61 (entries 9-11). 
 
Table 9: Optimization of reaction conditions: Screening of solvent, temperature, time and equivalent 
of base and additives. 
 
Entry Base (equiv) Additives [a] Solvent 
Temp. 
(°C) 
time 
(h) 
Conversion[b] 
1 s-BuLi (1.5) KotBu, PMDTA Et2O -78 24 56% 
2 s-BuLi (1.5) KOtBu, PMDTA MTBE -78 24 41% 
3 s-BuLi (1.5) KOtBu, PMDTA Bu2O -78 24 18% 
4 s-BuLi (1.5) KOtBu, PMDTA ihexane -78 24 traces 
5 s-BuLi (1.5) KOtBu, PMDTA Et2O -65 24 76% 
6 s-BuLi (1.5) KOtBu, PMDTA Et2O -50 24 39% 
7 s-BuLi (2.5) KOtBu, PMDTA Et2O -65 24 86% 
8 s-BuLi (4.0) KOtBu, PMDTA Et2O -65 24 85% 
9 s-BuLi (2.5) KOtBu, PMDTA Et2O -65 36 74% 
10 s-BuLi (2.5) KOtBu, PMDTA Et2O -65 20 
88% (71%[c] isolated 
yield) 
11 s-BuLi (2.5) KOtBu, PMDTA Et2O -65 16 82% 
[a] Additives were used with the same equivalents as the base. [b] GC yield after quenching with S2Me2 
(3.0 equiv). [c] Regioselectivity was checked by 1H-NMR. 
 
 
 
                                                     
105 A. J. Bridges, W. C. Patt, T. M. Stickney, J. Org. Chem. 1990, 55, 773. 
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3.4. Functionalization in para-Position 
 
With the optimized conditions in hand, we metalated fluoroarene 57 with a mixture of s-BuLi 
(2), KOtBu and PMDTA in Et2O at -65 °C in 20 h and subsequently reacted it with numerous 
electrophiles providing remote para-substituted arenes of type 62 (Table 10). Thus, metalated 
species 61 was quenched with deuterium oxide lead to the deuterated product 62a in 
78% yield (entry 1). 
 
Table 10: Metalation of bis silyl fluoroarene 57 in para-position C(4) and subsequent reactions with 
electrophiles. 
 
Entry Electrophile Product/Yield[a]  Entry Electrophile Product/Yield[a] 
1 D2O 
 
 
5 Br2  
 
  62a, 78%    62e, 61% 
2 S2Me2 
 
 
6 I2  
 
  62b, 71%    62f, 64% 
3 
 
 
 
7 
 
 
  62c, 50%    62g, 50% 
4 
 
 
 
8 Me-I 
 
  62d, 55%    62h, 68% 
[a] Isolated yield of analytically pure products. 
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Also reaction with dimethyl disulfide provided the thioether 62b in 71% yield (entry 2). 
Furthermore, several halogens were introduced (entries 3-6). Thus, reaction of the metalated 
species 61 with N-fluorobenzenesulfonimide (NFSI)106 furnished the difluoro derivative 62c 
in 50% yield. Additionally, treatment with hexachloroacetone, bromine or iodine afforded the 
para-halogenated compounds 62d-f in 55-64% yields. Moreover, the use of 
dimethylmalononitrile107 resulted in formation of benzonitrile 62g in 50% yield (entry 7). 
Finally, quenching with methyl iodide furnished the alkylated product 62h in 68% yield 
(entry 8).  
 
Table 11: Metalation of bis silyl arene 60 in meta-position C(5) and subsequent reactions with 
electrophiles. 
 
Entry Electrophile Product/Yield[a]  Entry Electrophile Product/Yield[a] 
1 S2Me2 
 
 
3 
 
 
  64a, 57%    64c, 40% 
2 I2 
 
 
4 ClCO2Et 
 
  64b, 46%    64d, 35% 
[a] Isolated yield of analytically pure products. 
 
Similary, this concept was extended to functionalize selectively the unactivated 1,3-bis silyl 
arene 60 in remote meta-position under the same reaction conditions. Thus, the metalated 
species 63 was converted to 1,3,5-substituted arens of type 64 in 35-57% yield (Table 11). 
The metalated species 63 reacted under standard metalation conditions with dimethyl 
disulfide to provide the thioether 64a in 57% yield (entry 1).  
                                                     
106 F. A. Davis, P.V. N. Kasu, Tetrahedron Lett. 1998, 39, 6135. 
107 J. T. Reeves, C. A. Malapit, F. G. Buono, K. P. Sidhu, M. A. Marsini, C. A. Sader, K. R. Fandrick, C. A. 
Busacca, C. H. Senanayake, J. Am. Chem. Soc. 2015, 137, 9481. 
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Iodolysis produced the expected halogenated product 64b in 46% yield (entry 2). Moreover, 
quenching with phenylisocyanate or ethyl chloroformate lead to the desired amide 64c and 
ester 64d in 35-40% yield (entries 3-4). 
However, only a few electrophiles furnished the para-substituted arenes of type 62 in good 
yields (Table 10). Thus, we performed bromine-lithium exchange with n-BuLi (59) at -78 °C 
of bromoarene 62e to generate the metalated species 65 without the addition of KOtBu or 
PMDTA. Subsequent reaction with various electrophiles afforded C(4)-substituted derivatives 
of type 66 in 56-92% yield (Table 12).  
 
Table 12: Bromine-lithium exchange of bromoarene 62e in position C(4) and subsequent reactions 
with electrophiles.  
 
Entry Electrophile Product/Yield[a]  Entry Electrophile Product/Yield[a] 
1 TMS-Cl 
 
 
 
 
 
  
66a, 92%  7 
8 
R = 4-SMe 
R = 3-Cl 
66g, 69% 
66h, 74% 
2 iPrO-Bpin 
 
 
9 
 
 
  66b, 88%    66i, 76%[b] 
3 
B(OMe)3 
NaOH, H2O2 
 
 
 
 
 
  
66c, 80%  10 
11 
R = tBu 
R = SMe 
66j, 72%[b] 
66k, 56%[b] 
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4 
CO2 
(excess) 
 
 
12  
 
  66d, 71%    66l, 77%[b] 
5 ClCONEt2 
 
 
13 
 
 
  66e, 85%    66m, 85%[c,d] 
6 
 
 
 
14 
 
 
  66f, 65%    66n, 74%[c,d] 
[a] Isolated yield of analytically pure products. [b] CuCN·2LiCl (1.2 equiv) was added. [c] ZnCl2 was added. 
[d] Obtained by a palladium-catalyzed cross-coupling with Pd(dba)2 (3 mol%) and P(2-furyl)3 (6 mol%). 
 
Therefore the lithiated arene 65 reacted with trimethylsilyl chloride to afford trisilyl 
compound 66a in 92% yield (entry 1). Moreover, reaction with boronic esters furnished the 
pinacol ester 66b (88%, entry 2) and provided after basic workup with hydrogen peroxide the 
free alcohol 66c (80%, entry 3). Also treatment with several carbonyl electrophiles were 
performed and the metalated species 65 reacted with dry ice, carbamoyl chloride or 
morpholine-carbaldehyde to afford the carboxylic acid, the amide or the aldehyde (66d-f, 
65-85%, entries 4-6). Similary, 65 reacted with various aromatic aldehydes to give the 
corresponding alcohols (66g-h, 69-74% yield, entries 7-8). Transmetalation of 65 with 
CuCN·2LiCl and subsequent acylation with various acid chlorides provided aliphatic or 
aromatic ketones 66i-k in 56-76% yield (entries 9-11).  
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Furthermore, copper-mediated allylation with allyl bromide afforded the arene 66l in 77% 
yield (entry 12). In addition, transmetalation of 65 with ZnCl2 and subsequent Pd-catalyzed 
Negishi108 cross-couplings (3 mol% Pd(dba)2, 6 mol% P(2-furyl)3) with 4-bromobenzonitrile 
or 2-bromopyridine lead to the cross-coupling products (66m-n, 74-85% yield, entries 13-14).  
 
3.5. Functionalization in ortho-Position 
 
In addition, we have shown, that 4-bromoarene (62e) can be selectively converted into the 
corresponding mono iodide (67) by using ICl (1.1 equiv) in CH2Cl2 (25 °C, 20 h) in 
86% yield (Scheme 44).  
 
Scheme 44: Mono-iodination of 62e. 
 
The 2-iodo-arene 67 enabled a selective iodine-magnesium exchange with iPrMgCl·LiCl (1) 
at 0 °C in 1 h and subsequent reactions of the magnesium species 68 with various 
electrophiles provided ortho-functionalized products of type 69a-m (Table 13). Thus, 
trapping the magnesium species 68 with ethyl chloroformate furnished the ester 69a in 74% 
yield (entry 1) and reaction with dimethylmalononitrile gave the benzonitrile 69b in 79% 
yield (entry 2). Moreover, treatment with 4-formylmorpholine resulted in the formation of the 
aldehyde 69c in 58% yield (entry 3). Quenching the magnesium species 68 with several 
aromatic or heteroaromatic aldehydes afforded alcohols 69d-g in moderate yields (entries 4-7, 
20-64%). After transmetalation with CuCN·2LiCl and subsequent acylation or allylation the 
keton 69h (entry 8, 87% yield) or the acrylate 69i (entry 9, 81% yield) were produced. 
Finally, palladium-catalyzed Negishi cross-couplings (after transmetalation with ZnCl2) with 
various aromatic bromides, heteroaromatic bromides and vinyl iodides were readily 
performed and provided the ortho-substituted products 69j-m in 65-85% yield (entries 10-13). 
 
 
                                                     
108 a) E. Negishi, L. F. Valente, M. Kobayashi, J. Am. Chem. Soc. 1980, 102, 3298. b) E. Negishi, Acc. Chem. 
Res. 1982, 15, 340. 
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Table 13: Selective iodine-magnesium exchange of arene 67 in ortho-position C(2) and subsequent 
reactions with electrophiles.  
 
Entry Electrophile Product/Yield[a]  Entry Electrophile Product/Yield[a] 
1 ClCO2Et 
 
 
8 
 
 
  69a, 74%    69h, 87%[b] 
2 
 
 
 
9 
 
 
  69b, 79%    69i, 81%[b] 
3 
 
 
 
 
 
 
  
69c, 58%  10 
11 
R = 4-OMe 
R = 3-OTBS 
69j, 71%[c,d] 
69k, 78%[c,d] 
 
 
 
 
12 
 
 
4 
5 
6 
R = Cl 
R = OMe 
R = CN 
69d, 40% 
69e, 44% 
69f, 64% 
 
  
69l, 65%[c,d] 
7 
 
 
 
13 
 
 
  69g, 20%    69m, 85%[c,d] 
[a] Isolated yield of analytically pure products. [b] CuCN·2LiCl (1.2 equiv) was added. [c] ZnCl2 was added. [d] 
Obtained by a palladium-catalyzed cross-coupling with Pd(dba)2 (3 mol%) and P(2-furyl)3 (6 mol%). 
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3.6. Desilylation Reactions 
 
We already have shown, that triethylsilyl arenes of type 62 or 66 can be versatile starting 
materials for ortho-functionalized products after cleavage of the silyl group with ICl to form 
the corresponding iodide. We were able to extend these studies to other ipso-desilylation 
procedures (Table 14).  
 
Table 14: Various ispo-desilylation reactions. 
Entry Educt 
Reagent (equiv) 
Conditions 
Product/Yield[a] 
1 
 
TBAF (1.2) 
THF, 0 °C, 2 h 
 
 69h  70, 91% 
2 69h 
Cl6C2 (2.0) 
CsF (2.0) 
DMF, 25 °C, 3 h  
   71, 88% 
3 69h 
Cl4Br2C2 (2.0) 
CsF (2.0) 
DMF, 60 °C, 16 h  
   72, 83% 
4 69h 
ICl (1.1) 
CH2Cl2, 25 °C, 20 h 
 
   73, 88% 
5 
 
PhI(OCOCF3)2 (1.5) 
Pd(OAc)2 (5 mol%) 
AcOH, 80 °C, 20 h  
 64b  74, 65% 
[a] Isolated yield of analytically pure products. 
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Primarily, we deprotected the silyl arene 69h with tetra-n-butylammonium fluoride (TBAF) in 
THF under mild conditions to furnish the trisubstituted arene 70 in 91% yield (entry 1). No 
desilylation of arene 69h was provided though reactions with bromine, pyridinium bromide 
perbromide (PyHBr3),
109 N-bromosuccinimide (NBS) or N-chlorosuccinimide (NCS)110 were 
tested. However, using a dry fluoride-source in combination with halogen electrophiles was 
the method of choice.111 The TES-group was removed by using CsF in DMF in the presence 
of C2Cl6 or C2F4Br2 and furnished the chloride 71 (entry 2, 88% yield) and the bromide 72 
(entry 3, 83% yield), respectively. Additionally, a smooth ipso-desilylation with ICl was 
performed to generate the iodide 73 in 88% yield (entry 4). Moreover, desilylative 
acetoxylation with PhI(OCOCF3)2 (1.5 equiv) was proceeded in the presence of catalytic 
amount of Pd(OAc)2 and afforded the 1,3,5-trisubstituted arene 74 in 65% yield (entry 5).
112 
However, substituents in ortho-position to the TES-group inhibited the acetoxylation reaction. 
 
3.7. Preparation of Tetrasubstituted Fluorobenzenes 
 
To demonstrate the superiority of these organometallic methods, we prepared selectively three 
different tetrasubstituted 1,4-difluorobenzene derivatives by relying on the same toolbox of 
organometallic procedures, that had already proven successfully in previous chapters. Starting 
from difluoro compound 62c, we have made three substitution patterns 75, 76 and 77 showing 
the flexibility of these methods by introducing different electrophiles to the 1,4-difluoro core 
structure (Scheme 45). Thus, bis silyl compound 62c was fully desilylated by ICl (3.0 equiv) 
at 25 °C furnished the diiodo derivative 78 in 87% yield. Iodine-magnesium exchange 
reaction with iPrMgCl·LiCl (1) at 0 °C and subsequent copper-mediated acylation with 
benzoyl chloride afforded ketone 79 in 69% yield. A second iodine-magnesium exchange 
reaction with iPrMgCl·LiCl (1) at 0 °C and trapping with 3-bromobenzaldehyde provided the 
2,6-substituted 1,4-difluorobenzene 75 in 65% yield.  
The two other desired compounds were prepared starting with a mono deprotection of arene 
62c with ICl (1.0 equiv) to afford the mono iodinated compound 80 in 86% yield. 
Deprotonation with TMPMgCl·LiCl (5) at -20 °C in 4 h and further reaction with ethyl 
cyanoformate provided the highly functionalized ester 81 in 55% yield. Full desilylation was 
                                                     
109 K. Groom, S. M. S. Hussain, J. Morin, C. Nilewski, T. Rantanen, V. Snieckus, Org. Lett. 2014, 16, 2378. 
110 Z. Zhao, V. Snieckus, Org. Lett. 2005, 7, 2523. 
111 C. L. Fraser, N. R. Anastasi, J. J. S. Lamba, J. Org. Chem. 1997, 62, 9314. 
112 K. Gondo, J. Oyamada, T. Kitamura, Org. Lett. 2015, 17, 4778. 
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achieved with TBAF in THF to provide the tetrasubstituted benzene 82 in 90% yield. 
Subsequent iodine-magnesium exchange with iPrMgCl·LiCl (1) and transmetalation with 
ZnCl2 enabled a palladium catalyzed Negishi cross-coupling with 4-iodoanisole to furnish the 
2,3-substituted 1,4-difluorobenzene 76 in 68% yield. 
 
 
Scheme 45: Preparation of different tetrasubstituted 1,4-difluorobenzene derivatives. [a] ICl (3.0 
equiv), CH2Cl2, 25 °C, 20 h; [b] iPrMgCl·LiCl (1, 1.1 equiv), THF, 0 °C, 1 h; [c] CuCN·2LiCl 
(1.2 equiv); [d] PhCOCl (1.2 equiv), 25 °C, 6 h; [e] 3-BrPhCHO (1.2 equiv), 25 °C, 12 h; [f] ICl (1.0 
equiv), CH2Cl2, 25 °C, 20 h; [g] TMPMgCl·LiCl (5, 1.2 equiv), THF, -20 °C, 4 h; [h] NCCO2Et 
(1.2 equiv), 25 °C, 2 h; [i] TBAF (1.2 equiv), THF, 0 °C, 2 h; [j] ZnCl2 (1.2 equiv); [k] Pd(dba)2 
(3 mol%), P(2-furyl)3 (6 mol%), 4-iodoanisole (1.2 equiv), 25 °C, 4 h; [l] sat. aq. NH4Cl; [m] allyl 
bromide (1.2 equiv), 25 °C, 6 h. 
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Finally, the synthesis of the third desired compound was accomplished by deiodination of 81 
using iPrMgCl·LiCl (1) followed by a sequent quench with aq. NH4Cl solution to provide the 
tetrasubstituted benzene 83 in 92% yield. A subsequent desilylation with ICl (1.0 equiv) 
afforded the iodo compound 84 in 85% yield. Additional iodine-magnesium exchange with 
iPrMgCl·LiCl (1) and copper-mediated allylaltion with allyl bromide furnished the 
2,5-substituted 1,4-difluorobenzene 77 in 84% yield. 
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4. SUMMARY 
4.1. Metalation and Deprotection of Uracils, Uridines and Cytidine 
 
In summary, we have shown that the Lewis acid MgCl2 allowed control of the metalation 
regioselectivity of uridines and subsequent reactions with various electrophiles provided easy 
access to functionalized nucleosides (Scheme 46). In the absence of a Lewis acid, metalation 
of uridine derivatives with TMPMgCl·LiCl occured at the position C(5). In the presence of 
MgCl2, zincation using TMP2Zn·2LiCl·2MgCl2 occured at the position C(6). Further 
deprotection with HCl afforded various MOM-protected uridines. 
 
Scheme 46: Regioselective functionalization of uridine. 
 
Additionally, using TMP2Zn·2LiCl·2MgCl2 also allowed to functionalize cytidine derivatives 
at the position C(6) and deprotection with TFA furnished the fully deprotected cytidine 
derivative (Scheme 47). 
 
Scheme 47: Regioselective functionalization and deprotection of cytidine. 
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4.2. Preparation of Functionalized Pyrrolo[2,3-d]pyrimidines via an 
Intramolecular Copper-mediated Carbomagnesiation of Ynamides  
 
A mild and general intramolecular copper-mediated carbomagnesiation procedure for the 
synthesis of higly functionalized pyrrolo[2,3-d]pyrimidines starting from the readily available 
ynamide was performed (Scheme 48).  
 
Scheme 48: Preparation of pyrrolo[2,3-d]pyrimidines by a copper-mediated cyclization reaction 
starting from iodo-ynamides. 
 
Further functionalization of these N-heterocycles gave access to a synthetic route of the 
marine alkaloid rigidin A (Scheme 49). 
 
Scheme 49: Synthesis of rigidin A. 
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4.3. Regioselective Preparation of Tetrasubstituted Fluorobenzenes 
 
Furthermore, a new synthetic protocol for a regioselective remote metalation of benzenes was 
developed (Scheme 50). The presence of two sterical demanding triethylsilyl groups forced 
the lithiation in meta- or para-position. Subsequent trapping with electrophiles provided 
rather unusual substitution pattern. Further desilylation reactions and regioselective 
functionalization with via halogen-magnesium exchange with iPrMgCl·LiCl afforded various 
2,6-tetrasubstituted 1,4-dihalobenzene derivatives. 
 
 
Scheme 50: Regioselective functionalization in remote meta- or para-position and preparation of 
2,6-tetrasubstituted 1,4-dihalobenzene derivatives. 
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Moreover, we selectively prepared the additional two other tetrasubstituted 
1,4-difluorobenzene derivatives with different substitution patterns starting with a metalation 
using TMPMgCl·LiCl. Following desilylation or exchange reactions allowed a short access to 
the 2,3-substituted or 2,5-substituted 1,4-difluorobenzene derivatives within a few steps 
(Scheme 51). 
 
 
Scheme 51: Regioselective preparation of 2,3-tetrasubstituted and 2,5-tetrasubstituted 
1,4-difluorobenzene derivatives. 
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1. GENERAL CONSIDERATIONS 
 
All reactions are carried out under argon atmosphere in flame-dried glassware. Syringes which are 
used to transfer anhydrous solvents or reagents are purged with argon prior to use. THF was 
continuously refluxed and freshly distilled from sodium benzophenone ketyl under nitrogen. Yields 
refere to isolated yields of compounds estimated to be pure as determined by 1H-NMR (25 °C) and 
capillary GC. The products are prepared corresponding to known literature procedures. The analytical 
data for known compounds match the literature data.  
 
1.1. Solvents 
 
Solvents were dried according to standard procedures by distillation over drying agents and stored 
under argon. 
CH2Cl2 was predried over CaCl2 and distilled from CaH2. 
1,4-Dioxane was predried over CaCl2 and distilled from Na. 
DMF was heated to reflux for 14 h over CaH2 and distilled from CaH2.  
Et2O was predried over CaCl2 and dried with the solvent purification system SPS-400-2 from 
INNOVATIVE TECHNOLOGIES INC. 
MeOH was treated with phthalic anhydride (25 g/L) and sodium, heated to reflux for 6 h and 
distilled. 
PMDTA (N,N,N′,N′′,N′′-pentamethyldiethylenetriamine) was dried over KOH and distilled. 
Pyridine was dried over KOH and distilled. 
THF (tetrahydrofuran) was continuously refluxed and freshly distilled from Na/benzophenone ketyl 
under nitrogen and stored over 4 Å molecular sieve under an argon atmosphere. 
Toluene was predried over CaCl2, distilled from CaH2 and stored over 4 Å molecular sieve under an 
argon atmosphere. 
Triethylamine was dried over KOH and distilled. 
Solvents for reaction workup and for column chromatography were distilled prior to use. 
 
1.2. Preparation of Reagents 
 
Commercially available reagents were used without further purification unless otherwise stated. 
Liquid aldehydes and acid chlorides were distilled prior to use.  
TMPH was distilled under argon prior to use.  
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Preparation of CuCN·2LiCl solution: 
CuCN·2LiCl solution (1.0 M in THF) was prepared by drying CuCN (7.17 g, 80 mmol) and LiCl 
(6.77 g, 160 mmol) in a Schlenk-tube under vacuum at 140 °C for 5 h. After cooling, dry THF (80 mL) 
was added and stirring was continued until all salts were dissolved. 
Preparation of ZnCl2 solution: 
ZnCl2 solution (1.0 M in THF) was prepared by drying ZnCl2 (136.3 g, 100 mmol) in a Schlenk-flask 
under vacuum at 140 °C for 5 h. After cooling, dry THF (100 mL) was added and stirring was 
continued until all salts were dissolved. 
Preparation of TMPMgCl·LiCl (7): 
In a dry and argon-flushed Schlenk-flask TMPH (2,2,6,6-tetramethylpiperidine, 14.8 g, 105 mmol) 
was added to iPrMgCl·LiCl (6) (71.4 mL, 1.40 M in THF, 100 mmol) at 23 °C and the mixture was 
stirred for 3 days at 23 °C. The freshly prepared TMPMgCl·LiCl (7) was titrated prior to use at 0 °C 
with benzoic acid using 4-(phenylazo)diphenylamine as indicator. 
Preparation of TMP2MgCl·LiCl (8): 
TMP2Mg·2LiCl solution (0.6 M in THF) was prepared by the slow addition of n-BuLi (4.26 mL, 
2.35 M in hexane, 10 mmol) to a solution of TMPH (1.41 g, 10 mmol) in THF (10 mL) at -40 °C. 
After stirring for 30 min the mixture was warmed up to 0 °C and TMPMgCl·LiCl (7) (8.3 mL, 1.2 M 
in THF, 10 mmol) was added dropwise. The resulting mixture was stirred for 30 min, warmed up to 
23 °C and the solvent was evaporated under vacuum (10-3 mbar). THF was then added slowly under 
vigorous stirring until the salts were completely dissolved. 
Preparation of TMPLi (4): 
TMPLi solution (0.63 M in THF) was prepared by slow addition of n-BuLi (2.17 mL, 5.0 mmol, 2.3 M 
in hexane) to a solution of TMPH (706 mg, 0.85 mL, 5.0 mmol) in THF (5 mL) at -40 °C and stirred 
for 30 min at -40 °C. 
iPrMgCl·LiCl (1) was purchased as a solution in THF from Rockwood Lithium GmbH. 
n-BuLi was purchased as a solution in hexane from Rockwood Lithium GmbH. 
s-BuLi was purchased as a solution in hexane from Rockwood Lithium GmbH. 
t-BuLi was purchased as a solution in hexane from Rockwood Lithium GmbH. 
 
Content determination of organometallic reagent: 
n-BuLi was titrated using iPrOH and 1,10-phenanthroline as indicator in THF. 113 
Organomagnesium reagents were titrated using I2 in THF.  
TMP2Mg·2LiCl and TMPMgCl·LiCl were titrated with benzoic acid and 
4-(phenylazo)diphenylamine as indicator in THF at -40 °C.  
TMPLi was titrated using N-benzylbenzamide in THF.114 
                                                     
113 H.-S. Lin, A Paquette, Synth. Commun. 1994, 24, 2503. 
114 A.F. Burchat, J.M. Chong, N. Nielsen, J. Organomet. Chem. 1997, 542, 281. 
C. EXPERIMENTAL SECTION 
 
67 
1.3. Analytical Data 
 
Gas chromatography was performed with machines of type Hewlett-Packard 6890 or 5890 series II, 
using a column of type HP 5 (Hewlett-Packard, 5% phenylmethylpolysiloxane; length: 15 m, 
diameter: 0.25 mm; film thickness: 0.25 µm). The detection was accomplished by using a flame 
ionization detector. The carrier gas was nitrogen. Alkanes like dodecane or tetradecane were used as 
internal standards. 
Infrared spectra were recorded from 4000-400 cm-1 on a Perkin 281 IR spectrometer. Samples were 
measured neat (ATR, Smiths Detection DuraSample IR II Diamond ATR). The absorption bonds are 
reported in wave numbers (cm-1). 
Mass spectra were recorded on Finnigan MAT 95Q or Finnigan MAT 90 instrument for electron 
impact ionization (EI). High resolution mass spectra (HRMS) were recorded on the same instrument.  
Melting points are uncorrected and were measured on a Büchi B.540 apparatus. 
NMR spectra were recorded on Varian Mercury 200, Bruker AC 300, WH 400, or AMX 600 
instruments. Chemical shifts are reported as δ-values in ppm relative to the solvent peak, i.e. 
chloroform-d (δ 7.26 ppm for 1H-NMR and δ 77.0 ppm for 13C-NMR), DMSO-d6 (δ 2.50 ppm for 1H-
NMR and δ 39.5 ppm for 13C-NMR). For the characterization of the observed signal multiplicities the 
following abbreviations were used: s (singlet), d (doublet), t (triplet), m (multiplet), q (quartet), quint 
(quintet), sxt (sextet), oct (octet), as well as br (broad). 
 
1.4. Chromatography 
 
Thin layer chromatography (TLC) was performed using aluminum plates coated with SiO2 (Merck 60, 
F-254). The spots were visualized by UV-light or by staining of the TLC plate with the solution below 
followed by heating if necessary: 
- Phosphomolybdic acid (5.0 g), Ce(SO4)2 (2.0 g) and conc. H2SO4 (12.0 mL) in water 
(230 mL). 
- Iodine absorbed on silica gel. 
- KMnO4 (0.3 g), K2CO3 (20 g) and KOH (0.3 g) in water (300 mL). 
Flash column chromatography was performed using SiO2 60 (0.04-0.063 mm, 230-400 mesh) from 
Merck. 
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2. URACIL, URIDINE, CYTIDINE 
2.1. Typical Procedures 
 
Typical Procedure for the Metalation of Uracil in C(5) Position using TMPMg·LiCl (5) (TP1): 
A dry and argon flushed Schlenk-flask, equipped with a magnetic stirrer and a septum was charged 
with 1,3-dimethyluracil (1.0 equiv) in dry THF (0.5 M solution). TMPMgCl·LiCl was added at -40 °C 
and stirred at this temperature for 4 h (the completion of the reaction was checked by GC analysis of 
reaction aliquots quenched with iodine in THF). 
 
Typical Procedure for Allylation or Acylation Reactions (TP2): 
To the freshly prepared magnesium or zinc reagent was added CuCN·2LiCl (1.1 equiv, 1.0 M in THF) 
and the reaction mixture was stirred for 15 min at the indicated temperature The respective allyl 
bromide or acyl chloride was added and the reaction mixture was stirred for the indicated time and 
temperature. The reaction mixture was quenched with concentrated aqueous NH4Cl:NH3-solution 
(19:1), extracted three times with EtOAc. The organic layers were dried (MgSO4) and concentrated in 
vacuo. The crude residue was purified by flash column chromatography on silica gel. 
 
Typical Procedure for Cross-Coupling Reactions (TP3): 
To the freshly prepared magnesium reagent was added ZnCl2 (1.1 equiv, 1.0 M in THF) and the 
reaction mixture was stirred for 15 min at 0 °C. The catalytic system and the aryl or vinyl halide (1.0 
equiv) were added and the reaction mixture was warmed to 25 °C. After stirring for the indicated time, 
the reaction mixture was quenched with saturated aqueous NH4Cl-solution, extracted three times with 
EtOAc, the organic layers dried (MgSO4) and concentrated in vacuo. The crude residue was purified 
by flash column chromatography on silica gel. 
 
Typical Procedure for the Metalation of Uracil in C(6) Position using TMP2Zn·2MgCl2·2LiCl (8) 
(TP4): 
A dry and argon flushed Schlenk-flask, equipped with a magnetic stirring bar and a septum was 
charged with 1,3-dimethyluracil (1.0 equiv) in dry THF (0.5 M solution). TMP2Zn·2MgCl2·2LiCl was 
added at -30 °C and stirred at this temperature for 48 h (the completion of the reaction was checked by 
GC analysis of reaction aliquots quenched with iodine in THF). 
 
Typical Procedure for the Metalation of Uridine in C(5) Position using TMPMg·LiCl (5) (TP5): 
A dry and argon flushed Schlenk-flask, equipped with a magnetic stirring bar and a septum was 
charged with 5'-O-tert-butyldimethylsilyl-4-(4-methoxybenzyl)-2',3'-O-isopropylidene uridine 
(1.0 equiv) in dry THF (0.5 M solution). TMPMgCl·LiCl was added at -40 °C and stirred at this 
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temperature for 24 h (the completion of the reaction was checked by GC analysis of reaction aliquots 
quenched with iodine in THF). 
 
Typical Procedure for the Metalation of uridine in C(6) position using TMP2Zn·2MgCl2·2LiCl 
(8) (TP6): 
A dry and argon flushed Schlenk-flask, equipped with a magnetic stirring bar and a septum was 
charged with 5'-O-tert-butyldimethylsilyl-4-(4-methoxybenzyl)-2',3'-O-isopropylidene uridine 
(1.0 equiv) in dry THF (0.5 M solution). TMP2Zn·2MgCl2·2LiCl was added at -30 °C and stirred at 
this temperature for 72 h (the completion of the reaction was checked by GC analysis of reaction 
aliquots quenched with iodine in THF). 
 
2.2. Synthesis of 1,3-Dimethyluracil Derivatives 
 
5-Iodo-1,3-dimethyluracil (16a) 
 
According to TP1 1,3-dimethyluracile (9, 140 mg, 1.0 mmol, 1.0 equiv) was dissolved in dry THF and 
TMPMgCl·LiCl (1.0 ml, 1.1 mmol, 1.10 M, 1.1 equiv) was added dropwise at -40 °C and the reaction 
mixture was stirred for 4 h at this temperature. After the completion of the metalation iodine (280 mg, 
1.1 mmol, 1.1 equiv) was added dropwise at -40 °C and allowed to warm up to room temperature 
within 6 h. The mixture was quenched with sat. aq. Na2S2O3 (5 mL), extracted with CH2Cl2 (3 x 
5 mL), dried over MgSO4, filtered and concentrated in vacuo. Purification by flash chromatography on 
silica gel (ihexane:EtOAc:NEt3, 8:2:0.05) afforded 16a (192 mg, 72%) as a colorless solid. 
 
m.p.: 227 - 229 °C. 
1H-NMR (600 MHz, CDCl3): δ / ppm = 8.23 (s, 1H), 3.28 (s, 3H), 3.19 (s, 3H). 
13C-NMR (150 MHz, CDCl3): δ / ppm = 160.7, 151.6, 149.4, 66.7, 36.9, 29.2. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3068, 3050, 2955, 1688, 1634, 1616, 1509, 1475, 1441, 1425, 
1391, 1352, 1340, 1262, 1222, 1143, 1070, 1011, 957, 944, 814, 752. 
MS (EI, 70 eV): m/z (%) = 266 (100), 208 (13), 167 (19). 
HRMS (C6H7IN2O2): calc.: 265.9552; found: 265.9548 (M+). 
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5-(Methylthio)-1,3-dimethyluracil (16b) 
 
According to TP1 1,3-dimethyluracile (9, 140 mg, 1.0 mmol, 1.0 equiv) was dissolved in dry THF and 
TMPMgCl·LiCl (1.0 ml, 1.1 mmol, 1.10 M, 1.1 equiv) was added dropwise at -40 °C and the reaction 
mixture was stirred for 4 h at this temperature. After the completion of the metalation dimethyl 
disulfide (103 mg, 1.1 mmol, 1.1 equiv) was added dropwise at -40 °C and allowed to warm up to 
room temperature within 6 h. The mixture was quenched with sat. aq. NH4Cl (5 mL), extracted with 
CH2Cl2 (3 x 5 mL), dried over MgSO4, filtered and concentrated in vacuo. Purification by flash 
chromatography on silica gel (ihexane:EtOAc:NEt3, 7:3:0.05) afforded 16b (104 mg, 56%) as a 
colorless solid. 
 
m.p.: 187 - 189 °C. 
1H-NMR (600 MHz, CDCl3): δ / ppm = 7.42 (s, 1H), 3.41 (s, 3H), 3.38 (s, 3H), 2.33 (s, 3H). 
13C-NMR (150 MHz, CDCl3): δ / ppm = 161.7, 153.0, 144.7, 66.7, 39.8, 31.4, 17.9. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3070, 3049, 2940, 1672, 1633, 1616, 1510, 1458, 1418, 1386, 
1270, 1220, 1196, 1144, 1092, 1004, 968, 858, 786, 742, 668. 
MS (EI, 70 eV): m/z (%) = 186 (100), 171 (25), 140 (36), 83 (12), 42 (74). 
HRMS (C7H10N2O2S): calc.: 186.0463; found: 186.0474 (M+). 
 
5-Carboxylic acid ethyl ester-1,3-dimethyluracil (16c) 
 
According to TP1 1,3-dimethyluracile (9, 140 mg, 1.0 mmol, 1.0 equiv) was dissolved in dry THF and 
TMPMgCl·LiCl (1.0 ml, 1.1 mmol, 1.10 M, 1.1 equiv) was added dropwise at -40 °C and the reaction 
mixture was stirred for 4 h at this temperature. After the completion of the metalation ethyl 
chloroformate (120 mg, 1.1 mmol, 1.1 equiv) was added dropwise at -40 °C and allowed to warm up 
to room temperature within 6 h. The mixture was quenched with sat. aq. NH4Cl (5 mL), extracted with 
CH2Cl2 (3 x 5 mL), dried over MgSO4, filtered and concentrated in vacuo. Purification by flash 
chromatography on silica gel (ihexane:EtOAc:NEt3, 7:3:0.05) afforded 16c (140 mg, 66%) as a 
colorless solid. 
 
m.p.: 113.1 - 114.8 °C. 
1H-NMR (600 MHz, CDCl3): δ / ppm = 8.18 (d, J = 1.6 Hz, 1H), 4.37 – 4.30 (m, 2H), 3.49 (d, J = 1.5 
Hz, 3H), 3.36 (d, J = 1.4 Hz, 3H), 1.39 – 1.32 (m, 3H). 
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13C-NMR (150 MHz, CDCl3): δ / ppm = 163.2, 159.2, 151.1, 149.9, 104.4, 61.3, 37.8, 28.2, 14.3. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3066, 2986, 2956, 2920, 1738, 1696, 1656, 1616, 1522, 1444, 
1372, 1330, 1300, 1252, 1210, 1130, 1076, 1036, 966, 906, 872, 792, 762, 694. 
MS (EI, 70 eV): m/z (%) = 212 (25), 167 (85), 140 (100), 110 (9), 97 (11), 83 (17), 71 (11), 57 (16), 
53 (9), 42 (61). 
HRMS (C9H12N2O4): calc.: 212.0797; found: 212.0800 (M+). 
 
5-(Pivaloyl)-1,3-dimethyluracil (16d) 
 
According to TP1 1,3-dimethyluracile (9, 140 mg, 1.0 mmol, 1.0 equiv) was dissolved in dry THF and 
TMPMgCl·LiCl (1.0 ml, 1.1 mmol, 1.10 M, 1.1 equiv) was added dropwise at -40 °C and the reaction 
mixture was stirred for 4 h at this temperature. Subsequently, the acylation reaction was accomplished 
according to TP2 with CuCN·2LiCl (1.2 mL, 1.2 mmol, 1.0 M in THF, 1.2 equiv) and pivaloyl 
chloride (54 mg, 1.2 mmol, 1.2 equiv) and allowed to warm to 25 °C in 16 h. The mixture was 
quenched with sat. aq. NH4Cl (5 mL), extracted with CH2Cl2 (3 x 5 mL), dried over MgSO4, filtered 
and concentrated in vacuo. Purification by flash chromatography on silica gel (ihexane:EtOAc:NEt3, 
9:1:0.05) afforded 16d (186 mg, 83%) as a colorless solid. 
 
m.p.: 103 - 105 °C. 
1H-NMR (600 MHz, CDCl3): δ / ppm = 7.95 (s, 1H), 3.33 (s, 3H), 3.17 (s, 3H), 1.17 (s, 9H). 
13C-NMR (150 MHz, CDCl3): δ / ppm = 206.1, 160.8, 151.3, 146.3, 114.0, 44.5, 37.2, 28.1, 26.7. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3067, 2963, 2926, 2872, 1777, 1705, 1651, 1609, 1520, 1478, 
1443, 1390, 1356, 1342, 1284, 1221, 1179, 1049, 1026, 986, 967, 941, 934, 846, 794, 785, 760, 738, 
663. 
MS (EI, 70 eV): m/z (%): 224 (28), 167 (100), 140 (34), 57 (13), 42 (66), 40 (16).  
HRMS (C11H16N2O3): calc.: 224.2563; found: 224.1157 (M+). 
 
5-(Cyclopropanecarbonyl)-1,3-dimethyluracil (16e) 
 
According to TP1 1,3-dimethyluracile (9, 140 mg, 1.0 mmol, 1.0 equiv) was dissolved in dry THF and 
TMPMgCl·LiCl (1.0 ml, 1.1 mmol, 1.10 M, 1.1 equiv) was added dropwise at -40 °C and the reaction 
mixture was stirred for 4 h at this temperature. Subsequently, the acylation reaction was accomplished 
according to TP2 with CuCN·2LiCl (1.2 mL, 1.2 mmol, 1.0 M in THF, 1.2 equiv) and 
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cyclopropanecarbonyl chloride (125 mg, 1.2 mmol, 1.2 equiv) and allowed to warm to 25 °C in 16 h. 
The mixture was quenched with sat. aq. NH4Cl (5 mL), extracted with CH2Cl2 (3 x 5 mL), dried over 
MgSO4, filtered and concentrated in vacuo. Purification by flash chromatography on silica gel 
(ihexane:EtOAc:NEt3, 9:1:0.05) afforded 16e (148 mg, 71%) as a colorless solid. 
 
m.p.: 154 - 156 °C. 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.25 (s, 1H), 3.52 (s, 3H), 3.43 – 3.30 (m, 1H), 3.27 (s, 3H), 
1.00 – 0.94 (m, 2H), 0.93 – 0.88 (m, 2H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 196.1, 161.4, 149.8, 149.7, 110.8, 36.9, 27.2, 18.4, 11.1. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3103, 3057, 3006, 2958, 1704, 1659, 1644, 1594, 1516, 1476, 
1442, 1424, 1417, 1391, 1351, 1338, 1197, 1186, 1119, 1086, 1071, 1064, 1047, 1030, 996, 987, 972, 
887, 778, 758, 693, 665. 
HRMS (ESI) (C10H12N2O3): calc.: 208.2139; found: 208.2139 (M+). 
 
5-(Furan-2-carbonyl)-1,3-dimethyluracil (16f) 
 
According to TP1 1,3-dimethyluracile (9, 140 mg, 1.0 mmol, 1.0 equiv) was dissolved in dry THF and 
TMPMgCl·LiCl (1.0 ml, 1.1 mmol, 1.10 M, 1.1 equiv) was added dropwise at -40 °C and the reaction 
mixture was stirred for 4 h at this temperature. Subsequently, the acylation reaction was accomplished 
according to TP2 with CuCN·2LiCl (1.2 mL, 1.2 mmol, 1.0 M in THF, 1.2 equiv) and 2-furoyl 
chloride (157 mg, 1.2 mmol, 1.2 equiv) and allowed to warm to 25 °C in 16 h. The mixture was 
quenched with sat. aq. NH4Cl (5 mL), extracted with CH2Cl2 (3 x 5 mL), dried over MgSO4, filtered 
and concentrated in vacuo. Purification by flash chromatography on silica gel (ihexane:EtOAc:NEt3, 
8:2:0.05) afforded 16f (154 mg, 66%) as a colorless solid. 
 
m.p.: 139 - 140 °C. 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.28 (s, 1H), 8.01 (dd, J = 1.75, 0.78 Hz, 1 H), 7.38 (dd, J = 
3.70, 0.78 Hz, 1 H), 6.71 (dd, J = 3.61, 1.66 Hz, 1 H), 3.37 (s, 3H), 3.17 (s, 3H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 177.0, 160.4, 152.0, 151.3, 149.1, 148.6, 121.4, 113.0, 
111.3, 37.4, 28.1. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3142, 3129, 3097, 2952, 1706, 1695, 1658, 1647, 1600, 1554, 
1520, 1470, 1458, 1437, 1401, 1390, 1364, 1297, 1243, 1208, 1167, 1121, 1097, 1041, 998, 940, 923, 
893, 881, 863, 818, 787, 773, 753, 697, 683.  
HRMS (ESI) (C11H10N2O4): calc.: 234.2110; found: 234.0623 (M+). 
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5-(Pyridin-2-yl)-1,3-dimethyluracil (16g) 
 
According to TP1 1,3-dimethyluracile (9, 140 mg, 1.0 mmol, 1.0 equiv) was dissolved in dry THF and 
TMPMgCl·LiCl (1.0 ml, 1.1 mmol, 1.10 M, 1.1 equiv) was added dropwise at -40 °C and the reaction 
mixture was stirred for 4 h at this temperature. Subsequently, the cross-coupling was accomplished 
according to TP3 with ZnCl2 (1.2 mL, 1.0 M in THF, 1.2 mmol, 1.2 equiv), Pd(dba)2 (11 mg, 2 mol%) 
and P(2-furyl)3 (9 mg, 4 mol%) and 2-bromopyridine (190 mg, 1.2 mmol, 1.2 equiv) at 25 °C in 16 h. 
The mixture was quenched with sat. aq. NaCl (5 mL), extracted with CH2Cl2 (3 x 5 mL), dried over 
MgSO4, filtered and concentrated in vacuo. Purification by flash chromatography on silica gel 
(ihexane:EtOAc:NEt3, 8:2:0.05) afforded 16g (104 mg, 48%) as a colorless solid. 
 
m.p.: 205 - 207 °C. 
1H-NMR (300 MHz, CDCl3): δ / ppm = 8.68 – 8.64 (m, 1H), 8.58 (dd, J = 4.8, 1.6 Hz, 1H), 7.97 
(ddd, J = 8.0, 2.3, 1.7 Hz, 1H), 7.38 (s, 1H), 7.34 (ddd, J = 8.0, 4.8, 0.9 Hz, 1H), 3.52 (s, 3H), 3.45 (s, 
3H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 162.1, 151.3, 149.0, 148.4, 140.6, 136.2, 129.0, 123.1, 111.1, 
37.3, 28.3. 
IR (Diamond-ATR, neat): ~  / cm-1 = 1688, 1646, 1632, 1565, 1508, 1480, 1456, 1432, 1408, 1367, 
1349, 1293, 1210, 1126, 1044, 1005, 970, 910, 817, 780, 771, 753, 717, 669. 
MS (EI, 70 eV): m/z (%) = 218 (9), 217 (100), 160 (10), 159 (80), 119 (17), 104 (9), 91 (11), 73 (9), 
44 (20), 42 (32). 
HRMS (C11H11N3O2): calc.: 217.2239; found: 217.0841 (M+). 
 
5-(E)-(Oct-1-en-1-yl)-1,3-dimethyluracil (16h) 
 
According to TP1 1,3-dimethyluracile (9, 140 mg, 1.0 mmol, 1.0 equiv) was dissolved in dry THF and 
TMPMgCl·LiCl (1.0 ml, 1.1 mmol, 1.10 M, 1.1 equiv) was added dropwise at -40 °C and the reaction 
mixture was stirred for 4 h at this temperature. Subsequently, the cross-coupling was accomplished 
according to TP3 with ZnCl2 (1.2 mL, 1.0 M in THF, 1.2 mmol, 1.2 equiv), Pd(dba)2 (11 mg, 2 mol%) 
and P(2-furyl)3 (9 mg, 4 mol%) and (E)-1-iodooct-1-ene (286 mg, 1.2 mol, 1.2 equiv) at 25 °C in 6 h. 
The mixture was quenched with sat. aq. NaCl (5 mL), extracted with CH2Cl2 (3 x 5 mL), dried over 
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MgSO4, filtered and concentrated in vacuo. Purification by flash chromatography on silica gel 
(ihexane:EtOAc:NEt3, 9:1:0.05) afforded 16h (198 mg, 79%) as a colorless solid. 
 
m.p.: 182.4 - 183.1 °C 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.07 (s, 1H), 6.28 (dt, J = 15.8, 6.9 Hz, 1H), 6.13 – 6.00 (m, 
1H), 3.35 (s, 3H), 3.30 (s, 3H), 2.08 (qd, J = 7.1, 1.5 Hz, 2H), 1.35 (m, 2H), 1.23 (m, 6H), 0.85 – 0.76 
(m, 3H). 
13C-NMR (150 MHz, CDCl3): δ / ppm = 162.5, 151.2, 137.9, 132.5, 120.7, 111.9, 37.0, 33.4, 31.7, 
29.2, 28.9, 28.0, 22.6, 14.1. 
IR (Diamond-ATR, neat): ~  / cm-1 = 2926, 2856, 1698, 1658, 1454, 1368, 1290, 1260, 1172, 1088, 
968, 928, 840, 758, 690, 658. 
MS (EI, 70 eV): m/z (%) = 250 (51), 221 (11), 207 (13), 193 (42), 179 (86), 166 (13), 153 (100), 122 
(31), 94 (21), 81 (13), 67 (13), 55 (20), 53 (11), 43 (51), 42 (43). 
HRMS (C14H22N2O2): calc.: 250.1681; found: 250.1675 (M+). 
 
5-(Phenylethynyl) -1,3-dimethyluracil (16i) 
 
According to TP1 1,3-dimethyluracile (9, 140 mg, 1.0 mmol, 1.0 equiv) was dissolved in dry THF and 
TMPMgCl·LiCl (1.0 ml, 1.1 mmol, 1.10 M, 1.1 equiv) was added dropwise at -40 °C and the reaction 
mixture was stirred for 4 h at this temperature. Subsequently, ZnCl2 (1.2 mL, 1.0 M in THF, 1.2 mmol, 
1.2 equiv) was added and stirred for 1 h at -20 °C. CuCN·LiCl (1.2 ml, 1.2 mmol, 1.0 M, 1.2 equiv) 
and (iodoethynyl)benzene (274 mg, 1.2 mol, 1.2 equiv) were added was stirred at 25 °C for 16 h. The 
mixture was quenched with sat. aq. NaCl (5 mL), extracted with CH2Cl2 (3 x 5 mL), dried over 
MgSO4, filtered and concentrated in vacuo. Purification by flash chromatography on silica gel 
(ihexane:EtOAc:NEt3, 9:1:0.05) afforded 16i (130 mg, 54%) as a colorless solid. 
 
m.p.: 166.5 - 167.8 °C. 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.50 (s, 1H), 7.49 – 7.46 (m, 2H), 7.32 – 7.28 (m, 3H), 3.43 
(s, 3H), 3.38 (s, 3H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 161.6, 150.9, 145.1, 131.6, 128.5, 128.3, 122.7, 99.2, 93.3, 
80.5, 37.3, 28.4. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3068, 2950, 2854, 1700, 1648, 1446, 1370, 1346, 1306, 1216, 
1152, 1082, 1042, 992, 952, 906, 860, 836, 792, 750, 688. 
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MS (EI, 70 eV): m/z (%) = 240 (100), 211 (2), 182 (15), 153 (5), 140 (6), 126 (14), 114 (37), 91 (2), 
86 (2), 74 (2), 63 (5), 42 (25). 
HRMS (C14H12N2O2): calc.: 240.0899; found: 240.0889 (M+). 
 
5-((Trimethylsilyl)ethynyl)-1,3-dimethyluracil (16j) 
 
According to TP1 1,3-dimethyluracile (9, 140 mg, 1.0 mmol, 1.0 equiv) was dissolved in dry THF and 
TMPMgCl·LiCl (1.0 ml, 1.1 mmol, 1.10 M, 1.1 equiv) was added dropwise at -40 °C and the reaction 
mixture was stirred for 4 h at this temperature. Subsequently, ZnCl2 (1.2 mL, 1.0 M in THF, 1.2 mmol, 
1.2 equiv) was added and stirred for 1 h at -20 °C. CuCN·LiCl (1.2 ml, 1.2 mmol, 1.0 M, 1.2 equiv) 
and (iodoethynyl)trimethylsilane (269 mg, 1.2 mol, 1.2 equiv) were added was stirred at 25 °C for 16 
h. The mixture was quenched with sat. aq. NaCl (5 mL), extracted with CH2Cl2 (3 x 5 mL), dried over 
MgSO4, filtered and concentrated in vacuo. Purification by flash chromatography on silica gel 
(ihexane:EtOAc:NEt3, 9:1:0.05) afforded 16j (130 mg, 74%) as a colorless solid. 
 
m.p.: 172.8 - 174.5 °C. 
1H-NMR (400 MHz, CDCl3): δ / ppm = δ 7.45 (s, 1H), 3.39 (s, 3H), 3.34 (s, 3H), 0.20 (s, 9H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 161.6, 150.9, 146.0, 99.2, 99.1, 95.6, 37.3, 28.3, -0.2. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3060, 2954, 2902, 2148, 1704, 1646, 1454, 1392, 1348, 1248, 
1182, 1094, 1048, 984, 958, 922, 842, 766, 702, 666. 
MS (EI, 70 eV): m/z (%) = 236 (25), 221 (100), 207 (4), 193 (6), 164 (10), 123 (33), 107 (12), 93 (9), 
79 (8). 
HRMS (C11H16N2O2Si): calc.: 236.0981; found: 236.1054 (M+). 
 
6-Iodo-1,3-dimethyluracil (18a) 
 
According to TP4 1,3-dimethyluracile (9, 140 mg, 1.0 mmol, 1.0 equiv) was dissolved in dry THF and 
TMP2Zn·2MgCl2·2LiCl (0.84 ml, 0.6 mmol, 0.71 M, 0.6 equiv) was added dropwise at -30 °C and the 
reaction mixture was stirred for 48 h at this temperature. After the completion of the metalation iodine 
(307 mg, 1.2 mmol, 1.2 equiv) was added dropwise at -30 °C and allowed to warm to to 25 °C within 
6 h. The mixture was quenched with sat. aq. Na2S2O3 (5 mL), extracted with CH2Cl2 (3 x 5 mL), dried 
over MgSO4, filtered and concentrated in vacuo. Purification by flash chromatography on silica gel 
(ihexane:EtOAc:NEt3, 9:1:0.05) afforded 18a (216 mg, 81%) as a colorless solid. 
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m.p.: 183 - 184 °C. 
1H-NMR (600 MHz, CDCl3): δ / ppm = 6.41 (s, 1H), 3.52 (s, 3H), 3.10 (s, 3H). 
13C-NMR (150 MHz, CDCl3): δ / ppm = 161.2, 150.0, 117.0, 113.0, 41.7, 28.2. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3068, 3050, 2955, 1688, 1634, 1616, 1509, 1475, 1441, 1425, 
1391, 1352, 1340, 1262, 1222, 1143, 1070, 1011, 957, 944, 814, 752. 
MS (EI, 70 eV): m/z (%) = 267 (6), 266 (95), 83 (4), 82 (100), 57 (6), 54 (8), 52 (6).  
HRMS (C6H7IN2O2): calc.: 265.9552; found: 265.9536 (M+). 
 
6-Benzoyl-1,3-dimethyluracil (18b) 
 
According to TP4 1,3-dimethyluracile (9, 140 mg, 1.0 mmol, 1.0 equiv) was dissolved in dry THF and 
TMP2Zn·2MgCl2·2LiCl (0.84 ml, 0.6 mmol, 0.71 M, 0.6 equiv) was added dropwise at -30 °C and the 
reaction mixture was stirred for 48 h at this temperature. Subsequently, the acylation reaction was 
accomplished according to TP2 with CuCN·2LiCl (1.2 mL, 1.2 mmol, 1.0 M in THF, 1.2 equiv) and 
benzoyl chloride (169 mg, 1.2 mmol, 1.2 equiv) and allowed to warm to 25 °C in 16 h. The mixture 
was quenched with sat. aq. NH4Cl (5 mL), extracted with CH2Cl2 (3 x 5 mL), dried over MgSO4, 
filtered and concentrated in vacuo. Purification by flash chromatography on silica gel 
(ihexane:EtOAc:NEt3, 8:2:0.05) afforded 18b (204 mg, 84%) as a colorless oil. 
 
1H-NMR (600 MHz, CDCl3): δ / ppm = 8.13 – 7.92 (m, 2H), 7.89 – 7.70 (m, 1H), 7.70 – 7.46 (m, 
2H), 5.85 (s, 1H), 3.21 (s, 3H), 3.09 (s, 3H). 
13C-NMR (150 MHz, CDCl3): δ / ppm = 189.5, 162.1, 151.9, 150.3, 136.0, 134.3, 130.7, 129.8, 
100.9, 33.7, 28.1. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3706, 3086, 3064, 2954, 1705, 1651, 1594, 1580, 1519, 1476, 
1446, 1432, 1399, 1364, 1312, 1252, 1210, 1180, 1159, 1073, 1053, 1024, 994, 914, 844, 827, 805, 
758, 726, 699, 687, 668. 
MS (EI, 70 eV): m/z (%) = 244 (62), 216 (37), 215 (42), 159 (19), 158 (21), 105 (100), 82 (81), 77 
(63).  
HRMS (C13H12N2O3): calc.: 244.0848; found: 244.0845 (M+). 
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6-(E)-(Oct-1-en-1-yl)-1,3-dimethyluracil (18c) 
 
According to TP4 1,3-dimethyluracile (9, 140 mg, 1.0 mmol, 1.0 equiv) was dissolved in dry THF and 
TMP2Zn·2MgCl2·2LiCl (0.84 ml, 0.6 mmol, 0.71 M, 0.6 equiv) was added dropwise at -30 °C and the 
reaction mixture was stirred for 48 h at this temperature. Subsequently, the cross-coupling was 
accomplished according to TP3 with ZnCl2 (1.2 mL, 1.0 M in THF, 1.2 mmol, 1.2 equiv), Pd(dba)2 
(11 mg, 2 mol%) and P(2-furyl)3 (9 mg, 4 mol%) and (E)-1-iodooct-1-ene (286 mg, 1.2 mol, 
1.2 equiv) at 25 °C in 6 h. The mixture was quenched with sat. aq. NaCl (5 mL), extracted with 
CH2Cl2 (3 x 5 mL), dried over MgSO4, filtered and concentrated in vacuo. Purification by flash 
chromatography on silica gel (ihexane:EtOAc:NEt3, 9:1:0.05) afforded 18c (185 mg, 74%) as a 
colorless solid. 
 
m.p.: 67 - 68 °C. 
1H-NMR (600 MHz, CDCl3): δ / ppm = 6.33 (m, 1H), 6.13 (m, 1H), 5.74 (m, 1H), 3.37 (s, 3H), 3.32 
(s, 3H), 2.21 – 2.16 (m, 2H), 1.57 – 1.18 (m, 8H), 0.96 – 0.76 (m, 3H). 
13C-NMR (150 MHz, CDCl3): δ / ppm = 162.69, 152.35, 152.07, 142.13, 121.29, 98.42, 32.92, 32.25, 
31.48, 28.69, 28.33, 27.84, 22.47, 14.09. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3063, 3019, 2919, 2864, 2864, 2854, 2834, 1692, 1657, 1637, 
1572, 1509, 1452, 1428, 1372, 1341, 1308, 1296, 1288, 1248, 1235, 1221, 1189, 1173, 1154, 1132, 
1089, 1058, 1026, 999, 975, 948, 931, 918, 893, 883, 862, 853, 821, 785, 767, 752, 738, 726, 674.  
MS (EI, 70 eV): m/z (%) = 250 (60), 207 (12), 194 (13), 193 (100), 180 (11), 167 (30). 
HRMS (C14H22N2O2): calc.: 250.1681; found: 250.1683 (M+). 
 
6-(4-Methoxyphenyl)-1,3-dimethyluracil (18d) 
 
According to TP4 1,3-dimethyluracile (9, 140 mg, 1.0 mmol, 1.0 equiv) was dissolved in dry THF and 
TMP2Zn·2MgCl2·2LiCl (0.84 ml, 0.6 mmol, 0.71 M, 0.6 equiv) was added dropwise at -30 °C and the 
reaction mixture was stirred for 48 h at this temperature. Subsequently, the cross-coupling was 
accomplished according to TP3 with ZnCl2 (1.2 mL, 1.0 M in THF, 1.2 mmol, 1.2 equiv), Pd(dba)2 
(11 mg, 2 mol%) and P(2-furyl)3 (9 mg, 4 mol%) and 4-iodoanisole (281 mg, 1.2 mmol, 1.2 equiv) at 
25 °C in 16 h. The mixture was quenched with sat. aq. NaCl (5 mL), extracted with CH2Cl2 
(3 x 5 mL), dried over MgSO4, filtered and concentrated in vacuo. Purification by flash 
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chromatography on silica gel (ihexane:EtOAc:NEt3, 8:2:0.05) afforded 18d (207 mg, 84%) as a 
colorless solid. 
 
m.p.: 88 - 89 °C. 
1H-NMR (600 MHz, CDCl3): δ / ppm = 7.34 (d, J = 8.80 Hz, 2H), 7.01 (d, J = 8.80 Hz, 2H), 5.59 
(s, 1H), 3.82 (s, 3H), 3.29 (s, 3H), 3.19 (s, 3H). 
13C-NMR (150 MHz, CDCl3): δ / ppm = 163.2, 161.2, 155.8, 152.6, 129.3, 125.3, 113.9, 101.0, 
54.59, 33.84, 27.0. 
IR (Diamond-ATR, neat): ~  / cm-1 = 2954, 2923, 2869, 2846, 1699, 1687, 1645, 1603, 1570, 
1514, 1443, 1429, 1414, 1391, 1368, 1299, 1254, 1226, 1206, 1178, 1164, 1151, 1119, 1027, 
1015, 1010, 1001, 846, 839, 813, 791, 761, 738, 716, 704, 699, 688, 659. 
HRMS (ESI) (C13H14N2O3): calc.: 246.1004; found: 246.0996 (M+). 
 
6-Iodo-1,3-dimethyl-5-pivaloyl uracil (19) 
 
A dry and argon flushed Schlenk-flask, equipped with a magnetic stirrer and a septum was charged 
with 5-pivaloyl-1,3-dimethyl-uracil (16d, 123 mg, 0.54 mmol, 1.0 equiv) in dry THF (0.5 mL). 
TMPMgCl·LiCl was added at -30 °C and stirred at this temperature for 12 h. After the completion of 
the metalation iodine (207 mg, 0.81 mmol, 1.5 equiv) was added dropwise at -30 °C and allowed to 
warm to room temperature. The mixture was quenched with sat. aq. Na2S2O3 (5 mL), extracted with 
CH2Cl2 (3 x 5 mL), dried over MgSO4, filtered and concentrated in vacuo. Purification by flash 
chromatography on silica gel (ihexane:EtOAc:NEt3, 9:1:0.05) afforded 19 (98 mg, 52%) as a colorless 
solid. 
 
m.p.: 151 - 153 °C. 
1H-NMR (200 MHz, CDCl3): δ / ppm = 3.73 (s, 3H), 3.33 (s, 3H), 1.34 (s, 9H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 207.3, 165.2, 149.0, 124.2, 112.7, 45.1, 34.7, 28.0, 27.4.  
IR (Diamond-ATR, neat): ~  / cm-1 = 3048, 2957, 1694, 1638, 1618, 1507, 1455, 1440, 1426, 1377, 
1352, 1320, 1252, 1220, 1143, 1048, 1011, 950, 814, 756. 
HRMS (ESI) (C11H15IN2O): calc.: 350.0128; found: 350.0140 (M+). 
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3-(tert-Butyl)-5,7-dimethyl-1H-pyrazolo[3,4-d]pyrimidine-4,6(5H,7H)-dione (20) 
 
To a solution of 6-iodo-1,3-dimethyl-5-pivaloyl uracil (19, 35 mg, 0.10 mmol, 1.0 equiv) in dry DMF 
(1 mL) was N2H4 (1 M in THF, 0.15 mL, 0.15 mmol, 1.5 equiv) added. The reaction mixture was 
stirred for 1 h at 60 °C. Upon completion, the reaction was quenched with sat. aq. NaCl (10 mL), 
extracted with CH2Cl2 (3 x 20 mL), dried over MgSO4 and concentrated in vacuo. Purification by flash 
chromatography on silica gel (ihexane:EtOAc:NEt3, 3:1:0.05) afforded 20 (23 mg, 0.096 mmol, 96%) 
as a colorless solid. 
 
m.p.: 255 - 257 °C. 
1H-NMR (200 MHz, CDCl3): δ / ppm = 10.21 (s, 1H), 3.52 (s, 3H), 3.40 (s, 3H), 1.53(s, 9H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 158.9, 155.4, 152.5, 152.0, 97.3, 32.7, 29.7, 28.1, 27.9. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3222, 3165, 3129, 3073, 3042, 2988, 2965, 2919, 2876, 2854, 
1706, 1661, 1596, 1522, 1492, 1436, 1426, 1417, 1405, 1367, 1351, 1307, 1294, 1241, 1010, 981, 
925, 786, 774, 743, 708. 
MS (EI, 70 eV): m/z (%) = 237 (13), 236 (81), 235 (23), 222 (16), 221 (100), 137 (13). 
HRMS (C11H16N4O2): calc.: 236.1273; found: 236.1216 (M+). 
 
3-(tert-Butyl)-5,7-dimethylisoxazolo[5,4-d]pyrimidine-4,6(5H,7H)-dione (21) 
 
To a solution of 6-iodo-1,3-dimethyl-5-pivaloyl uracil (19, 35 mg, 0.10 mmol, 1.0 equiv) in dry DMF 
(1 mL) was NH2OH·HCl (11 mg, 0.15 mmol, 1.5 equiv) added. The reaction mixture was stirred for 1 
h at 60 °C. Upon completion, the reaction was quenched with sat. aq. NaCl (10 mL), extracted with 
CH2Cl2 (3 x 20 mL), dried over MgSO4 and concentrated in vacuo. Purification by flash 
chromatography on silica gel (ihexane:EtOAc:NEt3, 4:1:0.05) afforded 21 (22 mg, 0.094 mmol, 94%) 
as a colorless solid. 
 
m.p.: 230 - 232 °C. 
1H-NMR (200 MHz, CDCl3): δ / ppm = 3.49 (s, 3H), 3.37 (s, 3H), 1.52(s, 9H).  
13C-NMR (75 MHz, CDCl3): δ / ppm = 185.8, 158.8, 155.0, 151.0, 98.0, 35.4, 30.3, 28.3, 27.1.  
IR (Diamond-ATR, neat): ~  / cm-1 = 2976, 2930, 2874, 2857, 2361, 2340, 1724, 1673, 1613, 1551, 
1497, 1424, 1372, 1362, 1302, 1272, 1250, 1182, 1012, 786, 742. 
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MS (EI, 70 eV): m/z (%) = 237 (40), 222 (79), 196 (12), 195 (33), 182 (23), 181 (50), 126 (12), 125 
(14), 124 (42), 67 (812), 58 (34), 57 (90), 56 (16), 55 (14), 53 (14), 43 (36).  
HRMS (C11H15N3O3): calc.: 237.1113; found: 236.1066 (M+). 
 
2.3. Protection of Uridine and Cytidine 
 
5'-O-tert-Butyldimethylsilyl-2',3'-O-isopropylidene uridine (22) 
 
A stirred suspension of uridine (12, 10 g, 41 mmol, 1.0 equiv) in dry acetone (200 mL) was treated 
with conc. H2SO4 (0.5 mL) dropwise at 25 °C and the resulting mixture was stirred further for 1 h and 
neutralized with Et3N. Evaporation of the solvent and washing one time with acetone gave 2',3'-O-
isopropyliden uridine as a crude white solid.  
A dry and argon flushed Schlenk-flask, equipped with a magnetic stirrer and a septum was charged 
with the cruede 2',3'-O-isopropyliden uridine in dry CH2Cl2 (250 mL) and was treated with imidazole 
(5.6 g, 82 mmol, 2.0 equiv) and TBDMSCl (6.79 g, 45.1 mmol, 1.1 equiv) at 0 °C. The reaction 
mixture was brought to 25 °C and stirred for 1 h. The solvent was evaporated under vacuum and the 
solid taken into ethyl acetate (30 mL), washed with water (15 mL), sat. NaCl-solution (15 mL), dried 
over MgSO4, filtered and concentrated in vacuo. Purification by flash chromatography on silica gel 
(CHCl3:MeOH, 20:1:) afforded 22 (15.7 g, 96%) as a colorless foam. 
 
m.p.: 137.1 - 138.8 °C. 
1H-NMR (600 MHz, CDCl3): δ / ppm = 8.43 – 8.35 (m, 1H), 7.69 (d, J = 8.1 Hz, 1H), 5.97 (d, J = 2.8 
Hz, 1H), 5.67 (dd, J = 8.1, 2.3 Hz, 1H), 4.80 – 4.72 (m, 1H), 4.67 (dd, J = 6.2, 2.8 Hz, 1H), 4.31 (q, J 
= 2.7 Hz, 1H), 3.91 (dd, J = 11.5, 2.4 Hz, 1H), 3.79 (dd, J = 11.5, 2.9 Hz, 1H), 1.58 (d, J = 0.8 Hz, 
3H), 1.35 (d, J = 0.9 Hz, 3H), 0.89 (s, 9H), 0.08 (s, 3H), 0.08 (s, 3H). 
13C-NMR (150 MHz, CDCl3): δ / ppm = 162.72, 149.87, 140.46, 114.12, 102.13, 91.90, 86.62, 85.38, 
80.26, 63.33, 27.27, 25.83, 25.34, 18.33, -5.45, -5.56. 
IR (Diamond-ATR, neat): ~  / cm-1 = 2950, 2856, 2804, 1778, 1690, 1462, 1398, 1368, 1332, 1298, 
1268, 1210, 1126, 1090, 1062, 998, 968, 862, 830, 776, 732, 688, 658. 
HRMS (ESI) (C17H27N2O6Si): calc. 383.1683; found 383.1647 (M+-Me). 
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5'-O-tert-Butyldimethylsilyl-4-(methoxymethyl)-2',3'-O-isopropylidene uridine (23) 
 
To a solution of 22 (1.92 g, 5.00 mmol, 1.0 equiv) and NaH (240 mg, 60% in paraffin oil, 
6.0 mmol, 1.2 equiv) in 10 mL dry DMF methoxymethyl chloride (604 mg, 7.5 mmol, 1.5 equiv) 
was added. After 17 h of stirring at 25 °C the solvent was removed in vacuo. Purification by flash 
chromatography on silica gel (ihexane:EtOAc, 4:1) afforded 23 (1.92 g, 87%) as a colorless oil. 
 
1H-NMR (600 MHz, DMSO-d6): δ / ppm = 7.67 (d, J = 8.2 Hz, 1H), 5.94 (d, J = 2.6 Hz, 1H), 5.72 (d, 
J = 8.2 Hz, 1H), 5.39 – 5.32 (m, 2H), 4.73 (dd, J = 6.1, 2.7 Hz, 1H), 4.69 (dd, J = 6.1, 2.6 Hz, 1H), 
4.35 (q, J = 2.7 Hz, 1H), 3.91 (dd, J = 11.5, 2.3 Hz, 1H), 3.78 (dd, J = 11.6, 3.0 Hz, 1H), 3.43 (s, 3H), 
1.58 (s, 3H), 1.35 (d, J = 0.9 Hz, 3H), 0.88 (s, 9H), 0.07 (d, J = 3.9 Hz, 6H). 
13C-NMR (150 MHz, DMSO-d6): δ / ppm = 162.66, 151.00, 139.10, 113.92, 101.58, 93.13, 86.96, 
85.73, 80.42, 71.80, 63.40, 57.86, 27.25, 25.81, 25.32, 18.29, -5.59. 
IR (Diamond-ATR, neat): ~  / cm-1 = 2988, 2953, 2932, 2899, 2886, 2858, 1718, 1666, 1453, 1409, 
1361, 1254, 1211, 1157, 1126, 1082, 1005, 968, 939, 914, 832, 806, 774, 717, 682. 
HRMS (ESI) (C19H31N2O7Si): calc.: 427.1901; found: 427.1900 (M+-Me). 
 
5'-O-tert-Butyldimethylsilyl-4-(4-methoxybenzyl)-2',3'-O-isopropylidene uridine (24) 
 
To a solution of 22 (1.92 g, 5.00 mmol, 1.0 equiv) and 1,8-diazabicycloundec-7-ene (1.56 g, 
10.0 mmol, 2.0 equiv) in 20 mL dry DMF 4-methoxybenzyl chloride (1.14 g, 7.5 mmol, 
1.5 equiv) was added. After 17 h of stirring at 25 °C the solvent was removed in vacuo. 
Purification by flash chromatography on silica gel (ihexane:EtOAc, 4:1) afforded 24 (2.27 g, 90%) as 
a colorless oil. 
 
1H-NMR (600 MHz, CDCl3): δ / ppm = 7.62 (d, J = 8.1 Hz, 1H), 7.46 – 7.42 (m, 2H), 6.82 – 6.78 (m, 
2H), 5.93 (d, J = 2.6 Hz, 1H), 5.70 (d, J = 8.1 Hz, 1H), 5.07 (d, J = 13.6 Hz, 1H), 4.98 (d, J = 13.6 Hz, 
1H), 4.73 (dd, J = 6.2, 2.8 Hz, 1H), 4.66 (dd, J = 6.2, 2.6 Hz, 1H), 4.32 (q, J = 2.7 Hz, 1H), 3.89 (dd, J 
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= 11.5, 2.4 Hz, 1H), 3.77 – 3.74 (m, 4H), 1.57 (d, J = 0.8 Hz, 3H), 1.35 (d, J = 0.8 Hz, 3H), 0.86 (s, 
9H), 0.05 (d, J = 4.5 Hz, 6H). 
13C-NMR (150 MHz, CDCl3): δ / ppm = 162.63, 159.04, 150.84, 138.14, 130.78, 128.98, 113.91, 
113.63, 101.64, 93.06, 86.93, 85.81, 80.35, 63.31, 55.20, 43.48, 27.25, 25.78, 25.34, 18.25, -5.49. 
IR (Diamond-ATR, neat): ~  / cm-1 = 2988, 2954, 2931, 2858, 1710, 1663, 1613, 1585, 1512, 1453, 
1384, 1344, 1298, 1246, 1212, 1177, 1157, 1128, 1078, 1035, 1005, 967, 907, 832, 806, 775, 729. 
HRMS (ESI) (C25H35N2O7Si): calc.: 503.2214; found: 503.2216 (M+-Me). 
 
5'-O-tert-Butyldimethylsilyl-2',3'-O-isopropylidene cytidine (25) 
 
A stirred suspension of cytidine (14b, 10 g, 41 mmol, 1.0 equiv) in dry acetone (200 mL) was treated 
with conc. H2SO4 (0.5 mL) dropwise at 25 °C and the resulting mixture was stirred further for 1 h and 
neutralized with Et3N. Evaporation of the solvent and washing one time with acetone gave 2',3'-O-
isopropyliden cytidine as a cruede white solid.  
A dry and argon flushed Schlenk-flask, equipped with a magnetic stirrer and a septum was charged 
with the cruede 2',3'-O-isopropyliden cytidine in dry CH2Cl2 (250 mL) and was treated with imidazole 
(5.6 g, 82 mmol, 2.0 equiv) and TBDMSCl (6.79 g, 45.1 mmol, 1.1 equiv) at 0 °C. The reaction 
mixture was brought to 25 °C and stirred for 1 h. The solvent was evaporated under vacuum and the 
solid was dissolved in ethyl acetate (30 mL), washed with water (15 mL), sat. NaCl-solution (15 mL), 
dried over MgSO4, filtered and concentrated in vacuo. Purification by flash chromatography on silica 
gel (CHCl3:MeOH, 15:1:) afforded 25 (15.0 g, 92%) as a colorless solid. 
 
m.p.: 110.7 - 112.9 °C. 
1H-NMR (400 MHz, DMSO-d6): δ / ppm = 7.57 (d, J = 7.4 Hz, 1H), 7.15 (br, 2H), 5.69 (d, J = 2.0 
Hz, 1H), 5.61 (d, J = 7.4 Hz, 1H), 4.74 (dd, J = 6.3, 2.0 Hz, 1H), 4.62 (dd, J = 6.3, 3.7 Hz, 1H), 3.99 
(dt, J = 4.9, 3.9 Hz, 1H), 3.73 (dd, J = 11.2, 4.1 Hz, 1H), 3.65 (dd, J = 11.2, 5.1 Hz, 1H), 1.38 (s, 3H), 
1.19 (s, 3H), 0.77 (s, 9H), -0.05 (d, J = 1.2 Hz, 6H). 
13C-NMR (101 MHz, DMSO-d6): δ / ppm = 166.34, 155.29, 143.11, 113.05, 94.40, 93.16, 87.30, 
81.01, 63.73, 55.36, 27.53, 26.23, 25.66, 18.43, -4.99. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3332, 3126, 2930, 2858, 2740, 2644, 1640, 1488, 1374, 1254, 
1212, 1122, 1078, 968, 926, 834, 778, 720, 680. 
HRMS (ESI) (C18H32N3O5Si): calc. 398.2106; found 398.2108 (M+H+). 
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5'-O-tert-Butyldimethylsilyl-4-(bis(tert-butoxycarbonylamino))-2',3'-O-isopropylidene cytidine 
(26) 
 
Boc2O (1.78 g, 8.16 mmol, 6.0 eq.) was added to a solution of 25 (540 mg, 1.36 mmol, 1.0 equiv), 4-
(dimethylamino)-pyridine (75 mg, 0.55 mmol, 0.4 equiv) and NEt3 (275 mg, 2.72 mmol, 2.0 equiv) in 
2 mL dry THF. The reaction mixture was stirred at 25 °C for 4 h. The mixture was quenched with 
sat. aq. NaCl (50 mL), extracted with EtOAc (3 x 100 mL), dried over Na2SO4, filtered and 
concentrated in vacuo. Purification by flash chromatography on silica gel (ihexane:EtOAc, 6:1) 
afforded 26 (706 mg, 87%) as a colorless liquid. 
 
1H-NMR (300 MHz, CDCl3): δ / ppm = 7.92 (d, J = 7.5 Hz, 1H), 6.92 (d, J = 7.5 Hz, 1H), 5.83 (d, J 
= 1.9 Hz, 1H), 4.70 (dd, J = 6.1, 1.9 Hz, 1H), 4.65 (dd, J = 6.1, 3.3 Hz, 1H), 4.31 – 4.24 (m, 1H), 3.86 
(dd, J = 11.5, 2.7 Hz, 1H), 3.72 (dd, J = 11.5, 3.8 Hz, 1H), 1.50 (s, 3H), 1.47 (s, 18H), 1.26 (s, 3H), 
0.80 (s, 9H), -0.01 (d, J = 1.2 Hz, 6H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 162.50, 154.07, 149.52, 144.29, 113.70, 95.66, 94.23, 88.03, 
86.03, 84.85, 80.19, 63.33, 27.69, 27.24, 25.88, 25.32, 18.33, -5.37, -5.48. 
IR (Diamond-ATR, neat): ~  / cm-1 = 2981, 2932, 1778, 1744, 1680, 1626, 1525, 1455, 1370, 1319, 
1256, 1211, 1156, 1117, 1081, 10005, 960, 925, 835, 810, 781, 736, 682, 662. 
HRMS (ESI) (C24H38N3O9Si): calc.: 540.2377; found: 540.2463 (M+-tBu). 
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2.4. Functionalization of Uridine 
 
Preparation of Uridine Derivative (28a) 
 
According to TP5 5'-O-tert-butyldimethylsilyl-4-(methoxymethyl)-2',3'-O-isopropylidene uridine (23, 
111 mg, 0.25 mmol, 1.0 equiv) was dissolved in dry THF and TMPMgCl·LiCl (5, 0.27 mL, 1.1 M in 
THF, 0.3 mmol, 1.2 equiv) was added dropwise at -40 °C and the reaction mixture was stirred for 24 h 
at this temperature. The mixture was quenched with iodine (77 mg, 0.3 mmol, 1.2 equiv) and warmed 
up to 25 °C within 2 h. The mixture was quenched with sat. aq. Na2S2O3 (10 mL), extracted with 
EtOAc (3 x 20 mL), dried over Na2SO4, filtered and concentrated in vacuo. Purification by flash 
chromatography on silica gel (EtOAc:ihexane/NEt3 2:8:0.05) afforded 28a (99 mg, 70%) as a yellow 
liquid.  
 
1H-NMR (300 MHz, CDCl3) δ / ppm = 7.97 (s, 1 H), 5.83 (d, J = 1.94 Hz, 1 H), 5.47 - 5.38 (m, 2 H), 
4.75 - 4.69 (m, 2 H), 4.45 - 4.41 (m, 1 H), 3.95 - 3.89 (m, 1 H), 3.82 - 3.76 (m, 1 H), 3.43 (s, 3 H), 
1.58 (s, 3 H), 1.36 (s, 3 H), 0.91 - 0.89 (m, 9 H), 0.11 (d, J=0.83 Hz, 6 H). 
 13C-NMR (75 MHz, CDCl3) δ / ppm = 159.8, 150.6, 143.6, 113.8, 94.4, 87.2, 85.9, 80.9, 73.5, 67.8, 
63.5, 58.2, 27.2, 26.0, 25.2, 18.4, -5.1, -5.4. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3459, 2953, 2929, 2856, 2228, 1713, 1661, 1608, 1503, 1459, 
1408, 1382, 1373, 1361, 1254, 1212, 1157, 1126, 1083, 1068, 1018, 969, 939, 916, 833, 815, 778, 
730, 686, 675, 665. 
MS (70 eV, EI): m/z (%) = 553 (8), 511 (100), 451 (20) 339 (84), 309 (20), 307 (20), 277 (44), 229 
(42), 171 (65), 143 (34), 129 (75). 
HRMS (C19H30IN2O7Si): calc.: 553.0867; found: 553.0869 (M+-Me). 
 
Preparation of Uridine Derivative (28b) 
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According to TP5 5'-O-tert-butyldimethylsilyl-4-(methoxymethyl)-2',3'-O-isopropylidene uridine (23, 
111 mg, 0.25 mmol, 1.0 equiv) was dissolved in dry THF and TMPMgCl·LiCl (5, 0.27 mL, 1.1 M in 
THF, 0.3 mmol, 1.2 equiv) was added dropwise at -40 °C and the reaction mixture was stirred for 24 h 
at this temperature. The mixture was quenched with ethyl choroformate (33 mg, 0.3 mmol, 1.2 equiv) 
and warmed up to -10 °C within 4 h. The mixture was quenched with sat. aq. NH4Cl (10 mL), 
extracted with EtOAc (3 x 20 mL), dried over Na2SO4, filtered and concentrated in vacuo. Purification 
by flash chromatography on silica gel (EtOAc:ihexane/NEt3 2:8:0.05) afforded 28b (57 mg, 44%) as a 
yellow liquid.  
 
1H-NMR (300 MHz, CDCl3) δ / ppm = 8.49 (s, 1 H), 5.72 (d, J = 1.94 Hz, 1 H), 5.37 (q, J = 9.40 Hz, 
2 H), 4.84 (dd, J = 5.81, 2.21 Hz, 1 H), 4.71 (d, J = 6.08 Hz, 1 H), 4.55 (s, 1 H), 4.39 - 4.19 (m, 2 H), 
3.96 - 3.87 (m, 1 H), 3.84 - 3.73 (m, 1 H), 3.43 (s, 3 H), 1.57 (s, 3 H), 1.36 (s, 3 H), 1.34 (t, J = 7.19. 3 
H), 0.80 (s, 9 H), 0.03 (s, 3 H), 0.02 (s, 3 H). 
 13C-NMR (75 MHz, CDCl3) δ / ppm = 163.0, 158.8, 150.4, 146.7, 133.5, 103.9, 96.6, 88.5, 86.4, 81.6, 
72.1, 63.9, 61.2, 58.1, 27.0, 25.7, 25.0, 18.2, 14.3, -5.6, -5.8. 
IR (Diamond-ATR, neat): ~  / cm-1 = 2986, 2966, 2949, 2934, 2857, 1752, 1735, 1728, 1709, 1675, 
1624, 1532, 1454, 1373, 1365, 1355, 1266, 1227, 1217, 1188, 1158, 1123, 1091, 1029, 970, 918, 861, 
835, 797, 778. 
HRMS (ESI, C23H39N2O9Si): calc.: 515.2347; found: 515.2424 (M+). 
 
Preparation of Uridine Derivative (28c) 
 
According to TP5 5'-O-tert-butyldimethylsilyl-4-(methoxymethyl)-2',3'-O-isopropylidene uridine (23, 
111 mg, 0.25 mmol, 1.0 equiv) was dissolved in dry THF and TMPMgCl·LiCl (5, 0.27 mL, 1.1 M in 
THF, 0.3 mmol, 1.2 equiv) was added dropwise at -40 °C and the reaction mixture was stirred for 24 h 
at this temperature. Subsequently, the acylation reaction was accomplished according to TP2 with 
CuCN·2LiCl (0.3 mL, 0.3 mmol, 1.0 M in THF, 1.2 equiv) and cyclopropanecarbonyl chloride 
(32 mg, 0.3 mmol, 1.2 equiv) and allowed to warm to 25 °C in 16 h. The mixture was quenched with 
sat. aq. NH4Cl (5 mL), extracted with CH2Cl2 (3 x 5 mL), dried over MgSO4, filtered and concentrated 
in vacuo. Purification by flash chromatography on silica gel (ihexane:EtOAc:NEt3, 9:1:0.05) afforded 
28c (91 mg, 71%) as a colorless oil. 
 
C. EXPERIMENTAL SECTION 
 
86 
1H-NMR (300 MHz, CDCl3) δ / ppm = 8.45 (s, 1 H), 5.75 (d, J = 2.49 Hz, 1 H), 5.42 (q, J = 9.40 Hz, 
2 H), 4.83 (dd, J = 5.94, 2.35 Hz, 1 H), 4.71 (dd, J = 5.94, 1.52 Hz, 1 H), 4.59 - 4.48 (m, 1 H),3.87 
(dd, J = 11.61, 3.04 Hz, 1 H), 3.77 (dd, J = 11.61, 3.04 Hz, 1 H), 3.46 (s, 3 H), 3.29 (tt, J = 7.84, 4.60 
Hz, 1 H), 1.58 (s, 3 H),1.36 (s, 3 H), 1.18 - 1.14 (m, 2 H), 1.03 - 0.97 (m, 2 H), 0.80 (s, 9H), 0.04 (s, 3 
H), 0.02 (s, 3 H). 
13C-NMR (75 MHz, CDCl3) δ / ppm = 196.8, 161.1, 150.5, 145.6, 113.4, 111.5, 96.5, 88.4, 86.4, 81.6, 
72.2, 63.8, 58.0, 27.0, 25.8, 25.1, 19.4, 18.2, 12.7, -5.6, -5.8.  
IR (Diamond-ATR, neat): ~  / cm-1 = 2987, 2951, 2931, 2856, 1720, 1678, 1659, 1594, 1453, 1410, 
1384, 1362, 1351, 1321, 1288, 1272, 1252, 1212, 1158, 1122, 1090, 1053, 1021, 990, 969, 919, 872, 
860, 833, 814, 780. 
MS (70 eV, EI): m/z (%) = 511 (2), 454 (26), 453 (100), 395 (11), 282 (12), 281 (57), 251 (12), 249 
(15), 229 (12), 249 (15), 229 (12), 219 (21), 171 (33), 143 (16), 129 (25), 117 (13). 
HRMS (C24H40N2O8Si): calc.: 511.2470; found: 510.2464 (M+H+). 
 
Preparation of Uridine Derivative (28d) 
 
According to TP5 5'-O-tert-butyldimethylsilyl-4-(methoxymethyl)-2',3'-O-isopropylidene uridine (23, 
111 mg, 0.25 mmol, 1.0 equiv) was dissolved in dry THF and TMPMgCl·LiCl (5, 0.27 mL, 1.1 M in 
THF, 0.3 mmol, 1.2 equiv) was added dropwise at -40 °C and the reaction mixture was stirred for 24 h 
at this temperature. Subsequently, the cross-coupling was accomplished according to TP3 with ZnCl2 
(0.3 mL, 1.0 M in THF, 0.3 mmol, 1.2 equiv), Pd(dba)2 (2.7 mg, 2 mol%) and P(2-furyl)3 (2.2 mg, 
4 mol%) and 4-iodoanisole (72 mg, 0.3 mol, 1.2 equiv) at 25 °C in 6 h. The mixture was quenched 
with sat. aq. NH4Cl (5 mL), extracted with CH2Cl2 (3 x 5 mL), dried over MgSO4, filtered and 
concentrated in vacuo. Purification by flash chromatography on silica gel (ihexane:EtOAc:NEt3, 
9:1:0.05) afforded 28d (111 mg, 81%) as a colorless solid. 
 
m.p.: 112 - 113 °C. 
1H-NMR (400 MHz, CDCl3) δ / ppm = 7.56 (s, 1 H), 6.88 (m, 2 H), 7.38 (m, 2 H), 5.88 (d, J = 2.73 
Hz, 1 H), 5.43 (q, J = 9.55 Hz, 2 H), 4.83 (dd, J = 6.24, 2.73 Hz, 1 H), 4.73 (dd, J = 6.24, 2.73 Hz, 1 
H), 4.35 (q, J = 2.73 Hz, 1 H), 3.79 (s, 3 H), 3.75 - 3.89 (m, 2 H), 3.45 (s, 3 H), 1.58 (s, 3 H), 1.35 (s, 3 
H), 0.76 (s, 9 H), -0.04 (s, 3 H), -0.11 (s, 3 H). 
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13C-NMR (101 MHz, CDCl3) δ / ppm = 162.1, 159.4, 150.6, 135.9, 126.7, 125.2, 114.2, 113.9, 113.8, 
94.2, 87.1, 85.4, 80.8, 72.3, 63.5, 58.0, 55.3, 27.2, 25.8, 25.3, 18.3, -5.5, -5.64. 
IR (Diamond-ATR, neat): ~  / cm-1 = 2987, 2952, 2930, 2856, 1712, 1658, 1609, 1576, 1514, 1453, 
1413, 1382, 1373, 1290, 1247, 1212, 1179, 1157, 1126, 1080, 1032, 1005, 970, 918, 831, 812, 795, 
779, 760, 733, 701, 679, 666. 
MS (70 eV, EI): m/z (%) = 548 (27), 492 (29), 491 (96), 319 (95), 287 (28), 257 (21), 230 (30). 
HRMS (C27H40N2O8Si): calc.: 548.2554; found: 548.2553 (M+). 
 
Preparation of Uridine Derivative (30a) 
 
According to TP6 5'-O-tert-butyldimethylsilyl-4-(methoxymethyl)-2',3'-O-isopropylidene uridine (23, 
111 mg, 0.25 mmol, 1.0 equiv) was dissolved in dry THF and TMP2Zn·2MgCl2·2LiCl (0.21 ml, 
0.15 mmol, 0.71 M, 0.6 equiv) was added dropwise at -30 °C and the reaction mixture was stirred for 
72 h at this temperature. The mixture was quenched with iodine (77 mg, 0.3 mmol, 1.2 equiv) and 
warmed up to 25 °C within 2 h. The mixture was quenched with sat. aq. Na2S2O3 (10 mL), extracted 
with EtOAc (3 x 20 mL), dried over Na2SO4, filtered and concentrated in vacuo. Purification by flash 
chromatography on silica gel (ihexane:EtOAc:NEt3, 9:1:0.05) afforded 30c (94 mg, 69%) as a 
colorless oil. 
 
1H-NMR (300 MHz, CDCl3) δ / ppm = 6.51 (s, 1 H), 6.09 (d, J = 1.11 Hz, 1 H), 5.28 (s, 2 H), 5.20 
(dd, J = 6.50, 1.24 Hz, 1 H), 4.86 (dd, J = 6.36, 4.42 Hz, 1 H), 4.21 - 4.14 (m, 1 H), 3.82 - 3.77 
(m, 2 H), 3.42 (s, 3 H), 1.56 (s, 3 H), 1.34 (s, 3 H), 0.89 (s, 9 H), 0.05 (s, 3 H), 0.04 (s, 3 H). 
13C-NMR (75 MHz, CDCl3) δ / ppm = 160.5, 148.0, 116.4, 113.8, 112.3, 102.6, 89.8, 84.4, 82.0, 72.3, 
64.0, 58.0, 27.2, 25.9, 25.4, 18.5, -5.3, -5.4. 
IR (Diamond-ATR, neat): ~  / cm-1 = 2986, 2952, 2929, 2884, 2855, 1719, 1665, 1584, 1435, 
1424, 1372, 1363, 1347, 1332, 1252, 1207, 1196, 1156, 1131, 1082, 1064, 1005, 948, 917, 876, 
833, 816, 770, 673, 662. 
HRMS (ESI) (C19H30IN2O7Si): calc.: 553.0867; found: 553.0868 (M+-Me). 
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Preparation of Uridine Derivative (30b) 
 
According to TP6 5'-O-tert-butyldimethylsilyl-4-(methoxymethyl)-2',3'-O-isopropylidene uridine (23, 
111 mg, 0.25 mmol, 1.0 equiv) was dissolved in dry THF and TMP2Zn·2MgCl2·2LiCl (0.21 ml, 
0.15 mmol, 0.71 M, 0.6 equiv) was added dropwise at -30 °C and the reaction mixture was stirred for 
72 h at this temperature. Subsequently, the cross-coupling was accomplished according to TP3 
Pd(dba)2 (2.7 mg, 2 mol%) and P(2-furyl)3 (2.2 mg, 4 mol%) and 1-chloro-4-iodobenzene (71 mg, 0.3 
mol, 1.2 equiv) at 25 °C in 6 h. The mixture was quenched with sat. aq. NH4Cl (5 mL), extracted with 
CH2Cl2 (3 x 5 mL), dried over MgSO4, filtered and concentrated in vacuo. Purification by flash 
chromatography on silica gel (ihexane:EtOAc:NEt3, 9:1:0.05) afforded 30b (116 mg, 84%) as a 
colorless oil. 
 
1H-NMR (300 MHz, CDCl3) δ / ppm = 7.51 - 7.40 (m, 4 H), 5.66 (s, 1 H), 5.43 (d, J = 1.38 Hz, 1 H), 
5.37 (s, 2 H), 5.21 (dd, J = 6.50, 1.52 Hz, 1 H), 4.84 (dd, J = 6.36, 4.42 Hz, 1 H), 4.08 – 4.02 (m, 1 H), 
3.86 - 3.82 (m, 2 H), 3.47 (s, 3 H), 1.39 (s, 3 H), 1.29 (s, 3 H), 0.90 (s, 9 H), 0.06 (s, 6 H). 
13C-NMR (75 MHz, CDCl3) δ / ppm = 16.6, 154.0, 151.1, 167.0, 130.9, 129.6, 129.4, 113.6, 103.9, 
93.6, 89.3, 84.1, 82.1, 71.9, 64.1, 58.0, 27.1, 25.9, 25.4, 18.4, -5.2, -5.3. 
IR (Diamond-ATR, neat): ~  / cm-1 = 2987, 2952, 2929, 2884, 2855, 1717, 1671, 1621, 1493, 1471, 
1440, 1405, 1383, 1372, 1357, 1252, 1208, 1159, 1140, 1088, 1067, 1015, 969, 954, 901, 868, 834, 
774, 729, 681, 667, 663.  
HRMS (ESI) (C26H37ClN2O7Si): calc.: 553.2059; found: 553.2152 (M+). 
 
Preparation of Uridine Derivative (30c) 
 
According to TP6 5'-O-tert-Butyldimethylsilyl-4-(methoxymethyl)-2',3'-O-isopropylidene uridine (23, 
111 mg, 0.25 mmol, 1.0 equiv) was dissolved in dry THF and TMP2Zn·2MgCl2·2LiCl (0.21 ml, 
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0.15 mmol, 0.71 M, 0.6 equiv) was added dropwise at -30 °C and the reaction mixture was stirred for 
72 h at this temperature. Subsequently, the cross-coupling was accomplished according to TP3 
Pd(dba)2 (2.7 mg, 2 mol%) and P(2-furyl)3 (2.2 mg, 4 mol%) and 4-iodobenzenonitrile (70 mg, 
0.3 mol, 1.2 equiv) at 25 °C in 6 h. The mixture was quenched with sat. aq. NH4Cl (5 mL), extracted 
with CH2Cl2 (3 x 5 mL), dried over MgSO4, filtered and concentrated in vacuo. Purification by flash 
chromatography on silica gel (ihexane:EtOAc:NEt3, 9:1:0.05) afforded 30c (94 mg, 69%) as a 
colorless oil. 
 
1H-NMR (400 MHz, CDCl3) δ / ppm = 7.81 - 7.78 (m, 2 H), 7.61 (s, 2 H), 5.66 (s, 1 H), 5.35 (s, 2 H), 
5.27 (d, J = 1.56 Hz, 1 H), 5.20 (dd, J = 6.43, 1.36 Hz, 1 H), 4.82 (dd, J = 6.43, 4.48 Hz, 1 H), 4.05 - 
4.00 (m, 1 H), 3.82 - 3.80 (m, 2 H), 3.46 (s, 3 H), 1.36 (s, 3 H), 1.27 (s, 3 H), 0.88 (s, 9 H), 0.04 (s, 6 
H). 
13C-NMR (101 MHz, CDCl3) δ / ppm = 161.3, 153.0, 150.9, 136.7, 132.8, 129.0, 117.7, 114.7, 113.7, 
104.3, 93.8, 89.4, 83.9, 81.9, 72.0, 64.0, 58.1, 27.0, 25.9, 25.3, 18.4, -5.2, -5.3. 
IR (Diamond-ATR, neat): ~  / cm-1 = 2952, 2931, 2856, 1718, 1671, 1624, 1605, 1504, 1471, 1441, 
1406, 1387, 1384, 1373, 1356, 1270, 1253, 1207, 1159, 1140, 1084, 1067, 1021, 1006, 970, 952, 939, 
916, 901, 868, 833, 816, 775, 731, 684, 664. 
HRMS (ESI) (C27H36N3O7Si): calc.: 542.2323; found: 542.2325 (M+-H). 
 
Preparation of Uridine Derivative (32a) 
 
According to TP5 5'-O-tert-butyldimethylsilyl-4-(4-methoxybenzyl)-2',3'-O-isopropylidene uridine 
(24, 111 mg, 0.25 mmol, 1.0 equiv) was dissolved in dry THF and TMPMgCl·LiCl (5, 0.27 mL, 1.1 M 
in THF, 0.3 mmol, 1.2 equiv) was added dropwise at -30 °C and the reaction mixture was stirred for 
36 h at this temperature. The mixture was quenched with iodine (77 mg, 0.3 mmol, 1.2 equiv) and 
warmed up to 25 °C within 2 h. The mixture was quenched with sat. aq. Na2S2O3 (10 mL), extracted 
with EtOAc (3 x 20 mL), dried over Na2SO4, filtered and concentrated in vacuo. Purification by flash 
chromatography on silica gel (EtOAc:ihexane/NEt3 2:8:0.05) afforded 32a (106 mg, 66%) as a yellow 
liquid.  
 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.90 (s, 1H), 7.49 – 7.44 (m, 2H), 6.82 – 6.76 (m, 2H), 5.85 – 
5.76 (m, 1H), 5.15 – 5.00 (m, 2H), 4.72 – 4.67 (m, 2H), 4.39 (tt, J = 2.6, 1.3 Hz, 1H), 3.88 (dd, J = 
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11.7, 2.2 Hz, 1H), 3.78 – 3.76 (m, 1H), 3.75 (s, 3H), 1.58 (d, J = 0.8 Hz, 3H), 1.35 (d, J = 0.7 Hz, 3H), 
0.84 (s, 9H), 0.07 (d, J = 2.5 Hz, 6H). 
 13C-NMR (100 MHz, CDCl3): δ / ppm = 159.68, 159.22, 150.53, 142.65, 131.16, 128.47, 113.82, 
113.66, 94.35, 87.20, 85.96, 80.80, 68.03, 63.41, 55.20, 45.24, 27.16, 25.93, 25.22, 18.30, -5.11, -5.46. 
IR (Diamond-ATR, neat): ~  / cm-1 = 2958, 2933, 2860, 2224, 1710, 1668, 1608, 1503, 1477, 1408, 
1382, 1361, 1254, 1212, 1157, 1083, 1068, 1028, 969, 933, 833, 815, 778, 686, 668. 
HRMS (ESI) (C26H38IN2O7Si): calc.: 645.1495; found: 645.1487 (M+H+). 
 
Preparation of Uridine Derivative (32b) 
 
According to TP5 5'-O-tert-butyldimethylsilyl-4-(4-methoxybenzyl)-2',3'-O-isopropylidene uridine 
(24, 111 mg, 0.25 mmol, 1.0 equiv) was dissolved in dry THF and TMPMgCl·LiCl (5, 0.27 mL, 1.1 M 
in THF, 0.3 mmol, 1.2 equiv) was added dropwise at -30 °C and the reaction mixture was stirred for 
36 h at this temperature. Subsequently, the allylation reaction was accomplished according to TP2 
with CuCN·2LiCl (0.3 mL, 0.3 mmol, 1.0 M in THF, 1.2 equiv) and allyl bromide (36 mg, 0.3 mmol, 
1.2 equiv) and allowed to warm to 25 °C in 16 h. The mixture was quenched with sat. aq. NH4Cl 
(5 mL), extracted with CH2Cl2 (3 x 5 mL), dried over MgSO4, filtered and concentrated in vacuo. 
Purification by flash chromatography on silica gel (ihexane:EtOAc:NEt3, 9:1:0.05) afforded 32b (110 
mg, 79%) as a colorless oil. 
 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.46 – 7.41 (m, 2H), 7.18 (t, J = 1.1 Hz, 1H), 6.79 (d, J = 8.7 
Hz, 2H), 5.88 – 5.78 (m, 1H), 5.77 (d, J = 2.7 Hz, 1H), 5.14 – 4.95 (m, 4H), 4.77 (dd, J = 6.3, 2.7 Hz, 
1H), 4.72 (dd, J = 6.3, 2.9 Hz, 1H), 4.27 (dt, J = 4.0, 3.0 Hz, 1H), 3.83 (dd, J = 11.4, 3.2 Hz, 1H), 3.75 
(m, 4H), 3.12 – 2.99 (m, 2H), 1.56 (d, J = 0.7 Hz, 3H), 1.34 (d, J = 0.8 Hz, 3H), 0.84 (s, 9H), 0.03 (d, 
J = 6.7 Hz, 6H). 
13C-NMR (150 MHz, CDCl3): δ / ppm = 162.70, 159.02, 150.69, 135.14, 134.55, 130.81, 129.04, 
117.10, 113.95, 113.62, 112.25, 94.07, 86.91, 85.11, 80.78, 63.39, 55.18, 43.80, 31.50, 27.20, 25.82, 
25.34, 18.27, -5.38, -5.51. 
IR (Diamond-ATR, neat): ~  / cm-1 = 2987, 2951, 2931, 2856, 1720, 1678, 1659, 1594, 1453, 1410, 
1384, 1362, 1351, 1321, 1288, 1272, 1252, 1212, 1158, 1122, 1090, 1053, 1021, 990, 969, 919, 872, 
860, 833, 814, 780. 
HRMS (ESI) (C29H43N2O7Si): calc.: 559.2841; found: 559.2835 (M+H+). 
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Preparation of Uridine Derivative (32c) 
 
According to TP5 5'-O-tert-butyldimethylsilyl-4-(4-methoxybenzyl)-2',3'-O-isopropylidene uridine 
(24, 111 mg, 0.25 mmol, 1.0 equiv) was dissolved in dry THF and TMPMgCl·LiCl (5, 0.27 mL, 1.1 M 
in THF, 0.3 mmol, 1.2 equiv) was added dropwise at -30 °C and the reaction mixture was stirred for 
36 h at this temperature. Subsequently, the cross-coupling was accomplished according to TP3 with 
ZnCl2 (0.3 mL, 1.0 M in THF, 0.3 mmol, 1.2 equiv), Pd(dba)2 (2.7 mg, 2 mol%) and P(2-furyl)3 (2.2 
mg, 4 mol%) and iodobenzene (61 mg, 0.3 mol, 1.2 equiv) at 25 °C in 6 h. The mixture was quenched 
with sat. aq. NH4Cl (5 mL), extracted with CH2Cl2 (3 x 5 mL), dried over MgSO4, filtered and 
concentrated in vacuo. Purification by flash chromatography on silica gel (ihexane:EtOAc:NEt3, 
9:1:0.05) afforded 32c (107 mg, 72%) as a colorless oil. 
 
1H-NMR (600 MHz, CDCl3): δ / ppm = 7.58 (s, 1H), 7.53 – 7.50 (m, 2H), 7.45 – 7.42 (m, 2H), 7.37 – 
7.33 (m, 3H), 7.31 – 7.28 (m, 1H), 6.82 – 6.79 (m, 2H), 5.91 (d, J = 2.8 Hz, 1H), 5.16 (d, J = 13.6 Hz, 
1H), 5.08 (d, J = 13.5 Hz, 1H), 4.80 (dd, J = 6.3, 2.8 Hz, 1H), 4.73 (dd, J = 6.3, 2.7 Hz, 1H), 4.35 (dt, 
J = 3.6, 2.6 Hz, 1H), 3.87 (dd, J = 11.5, 2.7 Hz, 1H), 3.75 (s, 3H), 1.60 (s, 3H), 1.37 (s, 3H), 0.73 (d, J 
= 0.7 Hz, 9H), -0.07 (s, 3H), -0.15 (s, 3H). 
13C-NMR (150 MHz, CDCl3): δ / ppm = 161.76, 159.08, 150.52, 135.75, 133.15, 131.13, 129.04, 
128.53, 128.36, 127.78, 114.56, 113.95, 113.62, 94.04, 87.04, 85.61, 80.71, 63.38, 55.20, 44.02, 
27.22, 25.73, 25.31, 18.19, -5.65. 
IR (Diamond-ATR, neat): ~  / cm-1 = 2990, 2962, 2856, 1727, 1688, 1659, 1594, 1453, 1410, 1400, 
1362, 1355, 1272, 1252, 1218, 1158, 1122, 1053, 1021, 994, 969, 919, 872, 833, 780. 
HRMS (ESI) (C31H39N2O7Si): calc.: 579.2527; found: 579.2520 (M-Me). 
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2.5. Deprotection of Uridine 
 
Preparation of 4-(Methoxymethyl)-2',3'-O-isopropylidene uridine (33) 
 
33 was prepared from uridine derivative 23 (111 mg, 0.25 mmol), dissolved in conc. HCl (0.5 ml) and 
stirred for 16 h at room temperature. The crude product was concentrated in vacuo. Purification by 
flash chromatography on silica gel (CHCl3:MeOH 10:1) afforded 33 (64 mg, 88%) as a colorless oil. 
 
1H-NMR (400 MHz, DMSO-d6): δ / ppm = 7.91 (d, J = 8.2 Hz, 1H), 5.74 – 5.69 (m, 2H), 5.13 – 5.06 
(m, 2H), 3.96 (t, J = 5.0 Hz, 1H), 3.89 (t, J = 4.7 Hz, 1H), 3.78 (dt, J = 4.2, 3.1 Hz, 1H), 3.56 (dd, J = 
12.1, 3.1 Hz, 1H), 3.48 (dd, J = 12.1, 3.2 Hz, 1H), 3.19 (s, 3H). 
13C-NMR (101 MHz, DMSO-d6): δ / ppm = 162.46, 151.42, 140.51, 101.43, 89.30, 85.33, 74.17, 
71.74, 70.13, 61.10, 57.40. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3010, 2945, 2935, 2924, 2874, 2360, 2255, 2120, 1680, 1651, 
1588, 1534, 1512, 1430, 1400, 1363, 1333, 1268, 1178, 1133, 1079, 1060, 1019, 975, 955, 942, 869, 
774, 684, 652. 
HRMS (ESI) (C11H16N2O7): calc.: 288.0958, found: 288.0944 (M+). 
 
Preparation of 5-Iodo-4-(methoxymethyl)-2',3'-O-isopropylidene uridine (33a) 
 
33a was prepared from uridine derivative 28a (90 mg, 0.16 mmol), dissolved in conc. HCl (0.5 ml) 
and stirred for 16 h at room temperature. The crude product was concentrated in vacuo. Purification by 
flash chromatography on silica gel (CHCl3:MeOH 12:1) afforded 33 (51 mg, 77%) as a colorless oil. 
 
1H-NMR (800 MHz, DMSO-d6): δ / ppm = 8.62 (s, 1H), 5.74 (d, J = 4.1 Hz, 1H), 5.47 (d, J = 5.2 Hz, 
1H), 5.32 (t, J = 4.6 Hz, 1H), 5.25 – 5.20 (m, 2H), 5.09 (d, J = 5.6 Hz, 1H), 4.05 (q, J = 4.8 Hz, 1H), 
4.00 (q, J = 5.3 Hz, 1H), 3.89 (dt, J = 5.3, 2.6 Hz, 1H), 3.72 (ddd, J = 12.0, 4.8, 2.8 Hz, 1H), 3.61 – 
3.57 (m, 1H), 3.28 (s, 3H). 
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13C-NMR (200 MHz, DMSO-d6): δ / ppm = 158.96, 149.82, 143.82, 88.84, 83.93, 73.40, 72.19, 
68.32, 67.53, 59.16, 56.42. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3414, 3325, 3086, 3077, 3008, 2948, 2935, 2923, 2874, 2824, 
2454, 2360, 2253, 2126, 1696, 1651, 1610, 1558, 1539, 1522, 1506, 1438, 1402, 1363, 1346, 1331, 
1268, 1227, 1208, 1176, 1172, 1135, 1102, 1079, 1063, 1042, 1019, 973, 955, 942, 931, 901, 868, 
826, 774, 766, 754, 724, 718, 684, 670, 652. 
HRMS (ESI) (C11H16IN2O7): calc.: 412.0004; found: 414.9999 (M+H+). 
 
Preparation of 5-(Cyclopropanecarbonyl)-4-(methoxymethyl)-2',3'-O-isopropylidene uridine 
(33b) 
 
33b was prepared from uridine derivative 28c (82 mg, 0.16 mmol), dissolved in conc. HCl (0.5 ml) 
and stirred for 16 h at room temperature. The crude product was concentrated in vacuo. Purification by 
flash chromatography on silica gel (CHCl3:MeOH 10:1) afforded 33b (41 mg, 72%) as a colorless 
solid. 
 
m.p.: 87.3 - 88.9 °C. 
1H-NMR (400 MHz, DMSO-d6): δ / ppm = 8.83 (s, 1H), 5.82 (d, J = 3.8 Hz, 1H), 5.52 (d, J = 5.2 Hz, 
1H), 5.29 – 5.22 (m, 2H), 5.18 (t, J = 4.4 Hz, 1H), 5.13 (d, J = 5.6 Hz, 1H), 4.10 (q, J = 4.5 Hz, 1H), 
3.98 (q, J = 5.1 Hz, 1H), 3.93 (dt, J = 5.4, 2.7 Hz, 1H), 3.70 (ddd, J = 11.7, 4.4, 2.6 Hz, 1H), 3.61 – 
3.54 (m, 1H), 3.32 (s, 3H), 3.11 (tt, J = 6.7, 5.5 Hz, 1H), 1.01 – 0.91 (m, 4H). 
13C-NMR (200 MHz, DMSO-d6): δ / ppm = 195.12, 159.78, 149.55, 144.98, 111.14, 89.37, 84.11, 
73.64, 71.13, 68.53, 59.41, 56.44, 18.24, 10.99. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3485, 3389, 3269, 3092, 3069, 2990, 2952, 2933, 2827, 2714, 
2253, 2129, 1723, 1677, 1620, 1557, 1524, 1454, 1433, 1408, 1350, 1300, 1273, 1259, 1235, 1200, 
1175, 1157, 1135, 1104, 1095, 1082, 1064, 1045, 1021, 1003, 990, 958, 918, 910, 898, 881, 872, 853, 
822, 802, 790, 763, 744, 719, 689, 676, 667. 
HRMS (ESI) (C15H20N2NaO8): calc.: 379.1112; found: 379.1112 (M+Na+). 
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Preparation of 6-(4-Chlorophenyl)-4-(methoxymethyl)-2',3'-O-isopropylidene uridine (33c) 
 
33c was prepared from uridine derivative 30b (103 mg, 0.18 mmol), dissolved in conc. HCl (0.5 ml) 
and stirred for 16 h at room temperature. The crude product was concentrated in vacuo. Purification by 
flash chromatography on silica gel (CHCl3:MeOH 12:1) afforded 33c (54 mg, 74%) as a colorless oil. 
 
1H-NMR (800 MHz, DMSO-d6): δ / ppm = 7.65 – 7.61 (m, 2H), 7.57 – 7.54 (m, 2H), 5.73 (s, 1H), 
5.23 – 5.18 (m, 2H), 5.08 (d, J = 5.2 Hz, 1H), 5.03 (d, J = 3.7 Hz, 1H), 4.89 (d, J = 6.3 Hz, 1H), 4.64 
(t, J = 5.7 Hz, 1H), 4.56 (ddd, J = 6.2, 5.2, 3.8 Hz, 1H), 4.04 (q, J = 6.1 Hz, 1H), 3.62 – 3.56 (m, 2H), 
3.48 – 3.43 (m, 1H), 3.32 (s, 3H). 
13C-NMR (200 MHz, DMSO-d6): δ / ppm = 160.39, 153.39, 149.86, 134.59, 130.94, 128.30, 102.48, 
93.75, 84.30, 78.50, 70.69, 70.21, 69.24, 61.43, 56.48. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3364, 3091, 2938, 2830, 2360, 2342, 1716, 1700, 1695, 1661, 
1622, 1616, 1592, 1576, 1569, 1564, 1558, 1549, 1539, 1533, 1525, 1521, 1517, 1506, 1491, 1472, 
1442, 1418, 1404, 1387, 1353, 1245, 1201, 1188, 1144, 1088, 1046, 1023, 1014, 950, 902, 823, 782, 
765, 730, 712, 673, 668, 661. 
HRMS (ESI) (C17H20ClN2O7): calc.: 399.0961; found: 399.0955 (M+H+). 
 
Preparation of 6-(4-benzonitril)-4-(methoxymethyl)-2',3'-O-isopropylidene uridine (33d) 
 
33d was prepared from uridine derivative 30c (86 mg, 0.16 mmol), dissolved in conc. HCL (0.5 ml) 
and stirred for 16 h at room temperature. The crude product was concentrated in vacuo. Purification by 
flash chromatography on silica gel (CHCl3:MeOH 12:1) afforded 33d (50 mg, 82%) as a colorless oil. 
 
1H-NMR (400 MHz, DMSO-d6): δ / ppm = 8.03 – 7.98 (m, 2H), 7.64 – 7.60 (m, 2H), 5.75 (s, 1H), 
5.21 (d, J = 1.4 Hz, 2H), 5.10 (d, J = 5.2 Hz, 1H), 5.04 (d, J = 3.6 Hz, 1H), 4.90 (d, J = 6.3 Hz, 1H), 
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4.68 (t, J = 5.6 Hz, 1H), 4.56 (ddd, J = 6.3, 5.2, 3.6 Hz, 1H), 4.04 (q, J = 6.2 Hz, 1H), 3.64 – 3.53 (m, 
2H), 3.46 (dt, J = 10.8, 6.0 Hz, 1H), 3.33 (s, 3H). 
13C-NMR (100 MHz, DMSO-d6): δ / ppm = 167.40, 161.49, 154.96, 150.96, 136.31, 135.71, 128.29, 
103.50, 94.95, 85.38, 71.80, 71.36, 70.32, 62.55, 57.57, 46.08. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3401, 3333, 3086, 3077, 3006, 2948, 2936, 2826, 2360, 2327, 
2253, 2126, 1697, 1654, 1651, 1612, 1559, 1521, 1506, 1438, 1402, 1362, 1349, 1269, 1227, 1207, 
1177, 1100, 1079, 1059, 1042, 1019, 998, 974, 954, 942, 931, 901, 867, 825, 766, 754, 735, 724, 718, 
670, 658, 653. 
HRMS (ESI) (C18H20N3O7): calc.: 390.1296; found: 390.1258 (M+H+). 
 
 
2.6. Functionalization and Deprotection of Cytidine 
 
Preparation of Cytidine Derivative (35a) 
 
5'-O-tert-Butyldimethylsilyl-4-(bis(tert-butoxycarbonylamino))-2',3'-O-isopropylidene cytidine (26, 
149 mg, 0.25 mmol, 1.0 equiv) was dissolved in dry THF and TMP2Zn·2MgCl2·2LiCl (0.21 ml, 
0.15 mmol, 0.71 M, 0.6 equiv) was added dropwise at -30 °C and the reaction mixture was stirred for 
4 h at this temperature. The reaction mixture was quenched with iodine (77 mg, 0.3 mmol, 1.2 equiv) 
and warmed up to 25 °C within 2 h. The mixture was quenched with sat. aq. Na2S2O3 (5 mL), extracted 
with CH2Cl2 (3 x 5 mL), dried over MgSO4, filtered and concentrated in vacuo. Purification by flash 
chromatography on silica gel (ihexane:EtOAc:NEt3, 9:1:0.05) afforded 35a (129 mg, 61%) as a 
colorless oil. 
 
1H-NMR (400 MHz, Acetone-d6): δ / ppm = 7.65 (s, 1 H), 6.23 (d, J = 0.98 Hz, 1 H), 5.26 (dd, J = 
6.46, 1.17 Hz, 1 H), 5.26 (dd, J = 6.46, 1.17 Hz, 1 H), 4.87 (dd, J = 6.36, 3.81 Hz, 1 H), 4.16 (td, 
J=6.55, 3.72 Hz, 1 H), 3.85 (s, 1 H), 3.83 (d, J=1.17 Hz, 1 H), 1.54 (s, 18 H), 1.50 (s, 3 H), 1.32 
(s, 3 H), 0.87 (s, 9 H), 0.02 (s, J = 1.17, 3 H), 0.02 (s, J=1.17, 3 H). 
13C-NMR (100 MHz, Acetone-d6): δ / ppm = 161.3, 151.5, 149.0, 118.3, 112.8, 109.8, 103.0, 90.9, 
84.8, 84.4, 82.9, 64.1, 26.9, 26.5, 25.4, 24.5, 18.0, -5.8, -6.0. 
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IR (Diamond-ATR, neat): ~  / cm-1 = 3426, 3265, 2977, 2934, 1710, 1638, 1549, 1495, 1421, 
1369, 1273, 1254, 1146, 1102, 1065, 1043, 1013, 868, 803, 767, 734, 661. 
HRMS (ESI) (C28H47IN3O9Si): calc.: 724.2126; found: 724.2122 (M+). 
 
Preparation of Cytidine Derivative (35b) 
 
5'-O-tert-Butyldimethylsilyl-4-(bis(tert-butoxycarbonylamino))-2',3'-O-isopropylidene cytidine (26, 
149 mg, 0.25 mmol, 1.0 equiv) was dissolved in dry THF and TMP2Zn·2MgCl2·2LiCl (0.21 ml, 
0.15 mmol, 0.71 M, 0.6 equiv) was added dropwise at -30 °C and the reaction mixture was stirred for 
4 h at this temperature. Subsequently, the cross-coupling was accomplished according to TP3 Pd(dba)2 
(2.7 mg, 2 mol%) and P(2-furyl)3 (2.2 mg, 4 mol%) and iodobenzene (61 mg, 0.3 mol, 1.2 equiv) at 25 
°C in 12 h. The mixture was quenched with sat. aq. NH4Cl (5 mL), extracted with CH2Cl2 (3 x 5 mL), 
dried over MgSO4, filtered and concentrated in vacuo. Purification by flash chromatography on silica 
gel (ihexane:EtOAc:NEt3, 9:1:0.05) afforded 35b (72 mg, 43%) as a colorless oil. 
 
1H-NMR (300 MHz, Acetone-d6): δ / ppm = 7.62 (s, 5 H). 5.63 (s, 1 H), 6.91 (s, 1 H), 5.28 (dd, J = 
6.50, 1.24 Hz, 1 H), 4.88 (dd, J = 6.36, 3.87 Hz, 1 H), 4.01 - 4.12 (m, 1 H), 3.94 (s, 1 H), 3.91 (s, 1 H), 
1.57 (s, 18 H), 1.32 (s, 3 H), 1.27 (s, 3 H), 0.91 (s, 9 H),0.07 (s, 3 H), 0.07 (s, 3 H). 
13C-NMR (300 MHz, Acetone-d6): δ / ppm = 161.62, 160.71, 153.9, 149.4, 133.6, 130.7, 129.0, 
128.5, 112.5, 97.5, 93.9, 90.6, 84.5, 84.2, 83.1, 64.3, 27.0, 26.4, 25.4, 22.4, 18.0, -5.8, -5.9. 
IR (Diamond-ATR, neat): ~  / cm-1 = 2980, 2952, 2932, 2929, 2887, 2856, 1781, 1745, 1685, 1608, 
1596, 1574, 1537, 1492, 1467, 1461, 1413, 1395, 1370, 1308, 1284, 1251, 1209, 1159, 1131, 1092, 
1057, 1033, 973, 879, 837, 816, 789, 776, 701. 
HRMS (ESI) (C34H52N3O9Si): calc.: 674.3467; found: 674.3465 (M+H+). 
 
Preparation of 5-Phenyl-cytidine (36) 
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36 was prepared from cytidine derivative 35b (67 mg, 0.10 mmol), dissolved in trifluoroacetic acid 
(1 ml, 70% in H2O) and stirred for 16 h at room temperature. The crude product was concentrated in 
vacuo. Purification by flash chromatography on silica gel (CHCl3:MeOH 12:1) afforded 35b (27 mg, 
85%) as a colorless solid. 
 
 
m.p.: 85.5 - 87.3 °C  
1H-NMR (400 MHz, DMSO-d6): δ / ppm = 7.54 – 7.51 (m, 3H), 7.49 – 7.47 (m, 2H), 7.34 (d, J = 9.2 
Hz, 2H), 5.61 (s, 1H), 5.12 (d, J = 4.3 Hz, 1H), 4.98 (d, J = 5.4 Hz, 1H), 4.82 (dd, J = 7.6, 3.8 Hz, 1H), 
4.77 (d, J = 5.8 Hz, 1H), 4.64 (td, J = 5.9, 4.4 Hz, 1H), 4.08 (q, J = 5.7 Hz, 1H), 3.63 – 3.58 (m, 2H), 
3.45 (ddd, J = 11.5, 7.6, 4.8 Hz, 1H). 
13C-NMR (100 MHz, DMSO-d6): δ / ppm = 165.27, 157.37, 156.25, 134.50, 130.33, 129.23, 128.51, 
96.82, 93.94, 85.78, 71.20, 70.82, 62.85. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3346, 3212, 1678, 1635, 1530, 1494, 1444, 1426, 1382, 1265, 
1202, 1178, 1128, 1049, 1024, 1000, 904, 825, 800, 765, 719, 703, 668. 
HRMS (ESI) (C15H18N3O5): calc.: 320.1241; found: 320.1243 (M+H+). 
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3. PREPARATION OF FUNCTIONALIZED PYRROLO(2,3-
D)PYRIMIDINE VIA AN INTRAMOLECULAR COPPER-MEDIATED 
CARBOMAGNESIATION OF YNAMIDES 
3.1. Typical Procedures 
 
Typical Procedure for Halogen-Magnesium-Exchange Reactions (TP1): 
A dry and argon flushed Schlenk-flask, equipped with a magnetic stirrer and a septum was charged 
with the starting aryl iodine in THF (0.2-1.0 M solution) and cooled to the indicated temperature. Then 
iPrMgCl·LiCl was added and the reaction mixture was stirred for the indicated time (the completion of 
the reaction was checked by HPLC analysis of reaction aliquots quenched with half concentrated 
aqueous NH4Cl-solution). 
 
Typical Procedure for the Copper-Mediated Cyclization Reaction (TP2): 
After the completion of the iodine/magnesium-exchange (TP1), THF was added (0.05-0.2 M solution), 
CuCN·2LiCl solution (1.1 equiv, 1.0 M in THF) was added to the reaction mixture at the indicated 
temperature and stirred for the indicated time (the completion of the reaction was checked by HPLC 
analysis of reaction aliquots quenched with sat. aqueous NH4Cl/NH3-solution; typically two peaks 
with slightly differing retention time could be detected, corresponding to the open-chain and cyclized 
form).  
 
Typical Procedure for Allylation or Acylation Reactions (TP3): 
To the freshly prepared magnesium reagent was added CuCN·2LiCl (1.1 equiv, 1.0 M in THF) and the 
reaction mixture was stirred for 15 min at the indicated temperature unless copper was already present 
in the mixture from the cyclization step. The respective allyl bromide or acyl chloride was added and 
the reaction mixture was stirred for the indicated time at the indicated temperature. The reaction 
mixture was quenched with concentrated aqueous NH4Cl:NH3-solution (19:1), extracted three times 
with EtOAc, the organic layers dried (MgSO4) and concentrated in vacuo. The crude residue was 
purified by flash column chromatography on silica gel. 
 
Typical Procedure for the Conversion of the TMS-Group to Iodide (TP4): 
To the respective TMS-substituted compound (approx. 0.2 M in CH2Cl2) was added iodine 
monochloride (1.1 equiv) at 0 °C and the mixture was stirred for 15 min. The reaction mixture was 
quenched with sat. Na2S2O3-solution, extracted three times with CH2Cl2, the organic layers dried 
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(MgSO4) and concentrated in vacuo. The crude residue was purified by flash column chromatography 
on silica gel. 
 
Typical Procedure for Cross-Coupling Reactions (TP5): 
To the freshly prepared magnesium reagent was added ZnCl2 (1.1 equiv, 1.0 M in THF) and the 
reaction mixture was stirred for 15 min at 25 °C. The catalytic system and the heteroaryl iodide (1.0 
equiv) were added and the reaction mixture was warmed to 50 °C. After stirring for the indicated time, 
the reaction mixture was quenched with half concentrated aqueous NH4Cl-solution, extracted three 
times with EtOAc, the organic layers dried (MgSO4) and concentrated in vacuo. The crude residue was 
purified by flash column chromatography on silica gel. 
 
3.2. Preparation of Functionalized Ynamides 
 
4,5-Diiodo-2,6-dimethoxypyrimidine (44) 
 
2,4-Dimethoxypyrimidine (43, 14.0 g, 100 mmol, 1.0 equiv) was dissolved in dry THF (100 ml). 
TMPMgCl·LiCl (98 ml, 110 mmol, 1.13 M, 1.1 equiv) was added dropwise at room temperature and 
the reaction mixture was stirred for 2 h at this temperature. After the completion of the metalation 
iodine (28.0 g, 110 mmol, 1.1 equiv) was added dropwise at −30 °C and the mixture was stirred 1.5 h 
at this temperature. Afterwards TMPMgCl·LiCl (133 ml, 150 mmol, 1.13 M, 1.5 equiv) was added 
dropwise. The mixture was warmed to 0 °C and stirred for 2 h. Iodine (51.4 g, 200 mmol, 2.0 equiv) 
dissolved in 50 mL THF was added at 25 °C and the mixture was stirred for 12 h at room temperature. 
The mixture was quenched with sat. aq. Na2S2O3 (50 mL) at 0 °C, extracted with Et2O (3 x 200 mL), 
dried over Na2SO4, filtered and concentrated in vacuo. Purification by flash chromatography on silica 
gel (ihexane:EtOAc, 8:1) afforded 44 (25.48 g, 65%) as a pale yellow solid. 
 
m.p.: 145.4 - 147.0 °C. 
1H-NMR (600 MHz, CDCl3): δ / ppm = 3.97 (s, 3H), 3.95 (s, 3H). 
13C-NMR (151 MHz, CDCl3): δ / ppm = 168.9, 163.6, 141.9, 84.2, 55.9, 55.7. 
IR (ATR): ṽ [cm-1] = 3025, 2994, 2948, 2864, 1517, 1477, 1450, 1378, 1340, 1293, 1222, 1196, 1102, 
1020, 997, 930, 807, 774. 
MS (EI, 70 eV): m/z (%) = 392(100), 391(25), 363(10), 362(17), 265(10), 250(29), 208(11), 193(14). 
HRMS (C6H6I2N2O2): calc.: 391.8519; found: 391.8533 (M+). 
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N-(5-Iodo-2,4-dimethoxypyrimidin-6-yl)-6-methylbenzenesulfonamide (45) 
 
A dry and argon flushed Schlenk-flask, equipped with a magnetic stirrer and a septum was charged 
with 5,6-diiodopyrimidine (44, 1.4 g, 3.6 mmol, 1.02 equiv), toluolsulfonamine (623 mg, 3.5 mmol, 
1.0 equiv), cesium carbonate (1.04 g, 5.4 mmol, 1.5 equiv) and CuI (33.2 mg, 0.175 mmol, 0.05 equiv) 
in dry MeCN (50 mL). The mixture was heated under reflux for 3 h, cooled to 25 °C and NaOH 
(25 mL, 2 M) was added. The organic phase was washed with H2O (3 x 25 mL) and the collected 
aqueous phase was treated with HCL (50 mL, 2 M) and the crude product was seperated by filtration 
to yield N-(5-iodo-2,6-dimethoxypyrimidin-4-yl)-4-methylbenzenesulfonamide 45 as a white solid. 
The aqueous phase was extracted three times with CH2Cl2 (3 x 50 mL), dried over Na2SO4, 
concentrated in vacuo. Flash column chromatographical purification on silica gel 
(ihexane:EtOAc:NEt3 = 4:1:0.1) afforded N-(5-iodo-2,4-dimethoxypyrimidin-6-yl)-6-
methylbenzenesulfonamide (45, 1.06 g, 68%) as a white powder.  
 
m.p.: 192.0 - 194.5 °C. 
1H-NMR (600 MHz, CDCl3): δ / ppm = 7.95 (d, J = 8.3 Hz, 2H), 7.74 (s, 1H), 7.29 (d, J = 7.4 Hz, 
2H), 3.92 (s, 3H), 3.80 (s, 3H), 2.41 (s, 3H). 
13C-NMR (151 MHz, CDCl3): δ / ppm = 169.51, 164.84, 158.27, 144.62, 136.43, 129.38, 128.35, 
55.41, 53.29, 21.62. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3344, 3016, 2999, 2959, 2923, 2898, 2867, 1557, 1488, 1460, 
1424, 1373, 1316, 1267, 1203, 1186, 1160, 1116, 1081, 1042, 1021 1000, 968, 943, 869, 815, 778, 
714, 696, 675, 653. 
MS (EI, 70 eV): m/z (%) = 458 (9), 435 (100), 223 (7), 103 (6). 
HRMS (C13H14IN3NaO4S): calc.: 457.9750; found: 457.9641 (M+Na+). 
 
N-(5-Iodo-2,4-dimethoxypyrimidin-6-yl)-6-methyl-N-((trimethylsilyl)ethynyl)-
benzenesulfonamide (42) 
 
In a dry and argon flushed Schlenk-flask, equipped with a magnetic stirrer and a septum, potassium 
hexamethyldisilazane (14.3 mL, 10.0 mmol, 0.7 M in toluene) was added to a solution of N-(5-iodo-
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2,4-dimethoxypyrimidin-6-yl)-6-methylbenzenesulfonamide (45, 4.35 g, 10.0 mmol, 1.0 equiv) in 
toluene (100 mL) at 0 °C. After 1 h, phenyl((trimethylsilyl)-ethynyl)iodonium triflate (5.39 g, 
12.0 mmol, 1.2 equiv) was added in several portions. The resulting mixture was stirred for 16 h at 
25 °C. Flash column chromatographical purification on silica gel (ihexane:EtOAc = 10:1) afforded N-
(5-iodo-2,4-dimethoxypyrimidin-6-yl)-6-methyl-N-((trimethylsilyl)ethynyl)benzenesulfon-amide (42, 
3.56 g, 67%) as a white solid. 
 
m.p.: 148.0 - 149.4 °C. 
1H-NMR (300 MHz, CDCl3): δ / ppm = 7.84 – 7.78 (m, 2H), 7.21 (d, J = 8.1 Hz, 2H), 3.90 (s, 3H), 
3.70 (s, 3H), 2.32 (s, 3H), 0.00 (s, 9H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 171.73, 165.17, 161.41, 145.24, 135.00, 129.31, 129.18, 
127.81, 91.63, 68.94, 56.09, 55.52, 21.82, 0.00. 
IR (Diamond-ATR, neat): ~  / cm-1 = 2961, 2164, 1596, 1564, 1535, 1485, 1457, 1372, 1352, 1306, 
1249, 1173, 1106, 1088, 1053, 1019, 992, 934, 842, 812, 760, 724, 703. 
MS (EI, 70 eV): m/z (%) = 531 (9), 515 (23), 467 (78), 452 (78), 436 (14), 376 (25), 362 (46), 325 
(13), 310 (10), 234 (16), 213 (15), 181 (15), 149 (100), 124 (34), 100 (26), 91 (67), 89 (64), 73 (34). 
HRMS (C18H22IN3O4SSi): calc.: 531.0145; found: 531.0141 (M+). 
 
 
3.3. Preparation of Pyrrolo(2,3-d)pyrimidine Derivatives 
 
2,4-Dimethoxy-7-tosyl-5-(trimethylsilyl)-7H-pyrrolo[2,3-d]pyrimidine (46a) 
 
The title compound was prepared from N-(5-iodo-2,4-dimethoxypyrimidin-6-yl)-6-methyl-N-
((trimethylsilyl)ethynyl)benzenesulfonamide (42, 266 mg, 0.5 mmol, 1.0 equiv). A Br/Mg-exchange 
was performed according to TP1 with iPrMgCl·LiCl (0.45 mL, 1.22 M, 0.55 mmol, 1.1 equiv) at 
-40 °C within 2 h (1.0 M). After addition of THF (5 mL), CuCN·2LiCl (0.55 mL, 0.55 mmol, 
1.1 equiv) mediated cyclization was performed according to TP2 at 25 °C in 24 h. The reaction 
mixture was quenched with concentrated aqueous NH4Cl:NH3-solution (19:1), extracted three times 
with EtOAc, the organic layers dried (MgSO4) and concentrated in vacuo. Flash column 
chromatographical purification on silica gel (ihexane:EtOAc = 19:1) afforded 2,4-dimethoxy-7-tosyl-
5-(trimethylsilyl)-7H-pyrrolo[2,3-d]pyrimidine (46a, 136 mg, 67%) as a white solid. 
 
m.p.: 131.2 - 131.9 °C. 
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1H-NMR (300 MHz, Acetone- d6): δ / ppm = 8.17 – 8.08 (m, 2H), 7.51 – 7.43 (m, 2H), 7.39 (d, J = 
0.7 Hz, 1H), 4.06 (d, J = 0.8 Hz, 3H), 4.00 (d, J = 0.8 Hz, 3H), 2.41 (s, 3H), 0.30 (s, 9H). 
13C-NMR (75 MHz, Acetone- d6): δ / ppm = 165.12, 162.62, 153.97, 146.04, 134.94, 129.78, 128.43, 
127.14, 113.28, 105.75, 54.40, 53.32, 20.63, -1.77. 
IR (Diamond-ATR, neat): ~  / cm-1 = 2956, 2931, 2900, 1741, 1596, 1566, 1495, 1471, 1402, 1357, 
1285, 1247, 1222, 1177, 1125, 1086, 1041, 985, 948, 870, 838, 813, 792, 758, 703. 
MS (EI, 70 eV): m/z (%) = 405 (66), 390 (5), 360 (9), 341 (11), 326 (12), 250 (100), 235 (20), 220 
(20), 178 (7), 155 (11), 149 (9), 100 (9), 89 (29). 
HRMS (C18H23N3O4SSi): calc.: 405.1179; found: 405.1171 (M+). 
 
6-Allyl-2,4-dimethoxy-7-tosyl-5-(trimethylsilyl)-7H-pyrrolo[2,3-d]pyrimidine (46b) 
 
The title compound was prepared from N-(5-iodo-2,4-dimethoxypyrimidin-6-yl)-6-methyl-N-
((trimethylsilyl)ethynyl)benzenesulfonamide (42, 266 mg, 0.5 mmol, 1.0 equiv). A Br/Mg-exchange 
was performed according to TP1 with iPrMgCl·LiCl (0.45 mL, 1.22 M, 0.55 mmol, 1.1 equiv) at 
-40 °C within 2 h (1.0 M). After addition of THF (5 mL), CuCN·2LiCl (0.55 mL, 0.55 mmol, 
1.1 equiv) mediated cyclization was performed according to TP2 at 25 °C in 24 h and a subsequent 
allylation reaction was performed according to TP3 using allyl bromide (73 mg, 0.6 mmol, 1.2 equiv) 
at -20 °C. The reaction mixture was allowed to warm slowly to 25 °C within 12 h. Flash column 
chromatographical purification on silica gel (ihexane:EtOAc:NEt3 = 8:1:0.1) afforded the 6-allyl-2,4-
dimethoxy-7-tosyl-5-(trimethylsilyl)-7H-pyrrolo[2,3-d]pyrimidine (46b, 158 mg, 71%) as a colorless 
oil. 
 
1H-NMR (300 MHz, Acetone- d6): δ / ppm = 8.14 – 8.11 (m, 2H), 7.46 – 7.43 (m, 2H), 6.18 (ddt, J = 
17.3, 10.2, 5.0 Hz, 1H), 5.17 (dq, J = 10.3, 1.8 Hz, 1H), 4.90 (dq, J = 17.3, 1.9 Hz, 1H), 4.05 (m, 5H), 
3.97 (s, 3H), 2.42 (s, 3H), 0.36 (s, 9H). 
13C-NMR (75 MHz, Acetone- d6): δ / ppm = 162.93, 160.56, 154.91, 144.45, 139.15, 136.45, 135.19, 
128.23, 127.50, 113.94, 110.37, 103.52, 53.27, 51.91, 19.51, -0.78. 
IR (Diamond-ATR, neat): ~  / cm-1 = 2954, 2155, 1593, 1570, 1521, 1469, 1361, 1278, 1242, 1192, 
1148, 1090, 1020, 993, 921, 890, 839, 795, 736, 703. 
MS (EI, 70 eV): m/z (%) = 445 (34), 290 (100), 275 (33), 260 (8), 218 (5), 89 (24), 73 (15). 
HRMS (C21H27N3O4SSi): calc.: 445.1492; found: 445.1485 (M+). 
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6-(Cyclohex-2-en-1-yl)-2,4-dimethoxy-7-tosyl-5-(trimethylsilyl)-7H-pyrrolo[2,3-d]pyrimidine 
(46c) 
 
The title compound was prepared from N-(5-iodo-2,4-dimethoxypyrimidin-6-yl)-6-methyl-N-
((trimethylsilyl)ethynyl)benzenesulfonamide (42, 266 mg, 0.5 mmol, 1.0 equiv). A Br/Mg-exchange 
was performed according to TP1 with iPrMgCl·LiCl (0.45 mL, 1.22 M, 0.55 mmol, 1.1 equiv) at 
-40 °C within 2 h (1.0 M). After addition of THF (5 mL), CuCN·2LiCl (0.55 mL, 0.55 mmol, 
1.1 equiv) mediated cyclization was performed according to TP2 at 25 °C in 24 h and a subsequent 
allylation reaction was performed according to TP3 using 2-cyclohexenyl bromide (97 mg, 
0.6 mmol, 1.2 equiv) at -20 °C. The reaction mixture was allowed to warm slowly to 25 °C within 
12 h. Flash column chromatographical purification on silica gel (ihexane:EtOAc:NEt3 = 8:1:0.1) 
afforded the 6-allyl-2,4-dimethoxy-7-tosyl-5-(trimethylsilyl)-7H-pyrrolo[2,3-d]pyrimidine (46c, 150 
mg, 62%) as a colorless oil. 
 
1H-NMR (600 MHz, CDCl3): δ / ppm = 8.04 – 7.99 (m, 2H), 7.27 – 7.23 (m, 2H), 5.79 (dddd, J = 
8.1, 5.2, 3.6, 1.6 Hz, 1H), 5.71 (dtt, J = 10.0, 2.6, 1.2 Hz, 1H), 4.33 (ddd, J = 12.7, 6.0, 3.2 Hz, 1H), 
3.98 (s, 3H), 3.92 (s, 3H), 2.53 (q, J = 12.7 Hz, 1H), 2.38 (s, 3H), 2.30 – 2.19 (m, 1H), 2.11 – 2.01 (m, 
1H), 2.01 – 1.88 (m, 2H), 1.80 – 1.63 (m, 1H), 0.32 (s, 9H). 
13C-NMR (150 MHz, CDCl3): δ / ppm = 164.02, 161.27, 156.33, 147.36, 144.71, 136.87, 129.21, 
129.08, 128.47, 126.79, 112.29, 105.13, 54.92, 53.38, 38.23, 29.29, 24.24, 23.35, 21.62, 1.81. 
IR (Diamond-ATR, neat): ~  / cm-1 = 2954, 2930, 1592, 1569, 1496, 1470, 1361, 1308, 1289, 1236, 
1212, 1192, 1176, 1146, 1129, 1090, 1046, 1018, 982, 949, 919, 892, 839, 813, 764, 730, 703. 
MS (EI, 70 eV): m/z (%) = 485 (4), 405 (3), 330 (67), 315 (4), 264 (3), 250 (4), 88 (6), 73 (11), 70 
(13), 61 (17), 45 (16), 43 (100). 
HRMS (C24H31N3O4SSi): calc.: 485.1805; found: 485.1791 (M+). 
 
(2,4-Dimethoxy-7-tosyl-5-(trimethylsilyl)-7H-pyrrolo[2,3-d]pyrimidin-6-yl)(phenyl)methanone 
(46d) 
 
The title compound was prepared from N-(5-iodo-2,4-dimethoxypyrimidin-6-yl)-6-methyl-N-
((trimethylsilyl)ethynyl)benzenesulfonamide (42, 266 mg, 0.5 mmol, 1.0 equiv). A Br/Mg-exchange 
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was performed according to TP1 with iPrMgCl·LiCl (0.45 mL, 1.22 M, 0.55 mmol, 1.1 equiv) at 
-40 °C within 2 h (1.0 M). After addition of THF (5 mL), CuCN·2LiCl (0.55 mL, 0.55 mmol, 
1.1 equiv) mediated cyclization was performed according to TP2 at 25 °C in 24 h and a subsequent 
acylation reaction was performed according to TP3 using benzylcarbonyl chloride (84.6 mg, 
0.6 mmol, 1.2 equiv) at -20 °C. The reaction mixture was allowed to warm slowly to 25 °C within 
12 h. Flash column chromatographical purification on silica gel (ihexane:EtOAc:NEt3 = 10:1:0.1) 
afforded the (2,4-dimethoxy-7-tosyl-5-(trimethylsilyl)-7H-pyrrolo[2,3-d]pyrimidin-6-
yl)(phenyl)methanone (46d, 171 mg, 67%) as a colorless solid. 
 
m.p.: 199.2 - 200.2°C 
1H-NMR (300 MHz, CDCl3): δ / ppm = 7.94 – 7.87 (m, 2H), 7.86 – 7.77 (m, 2H), 7.58 – 7.48 (m, 
1H), 7.40 (td, J = 7.3, 1.2 Hz, 2H), 7.22 – 7.15 (m, 2H), 4.00 (s, 3H), 3.98 (s, 3H), 2.31 (s, 3H), 0.00 
(s, 9H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 190.93, 165.43, 162.71, 154.98, 145.68, 138.53, 136.34, 
134.56, 133.67, 129.57, 129.44, 128.86, 128.68, 113.84, 105.61, 55.13, 53.82, 21.71, 0.03. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3162, 3144, 3067, 3027, 2958, 2924, 2851, 2654, 2608, 2592, 
2544, 1715, 1675, 1593, 1571, 1471, 1450, 1376, 1361, 1315, 1286, 1251, 1193, 1155, 1120, 1086, 
1033, 1009, 944, 841, 813, 797, 766, 733, 682, 608.  
MS (EI, 70 eV): m/z (%) = 509 (74), 494 (35), 354 (100), 339 (22), 310 (7), 297 (23), 280 (5), 135 
(4), 105 (12), 91 (19). 
HRMS (C25H27N3O5SSi): calc.: 509.1441; found: 509.1451 (M+). 
 
(2,4-Dimethoxy-7-tosyl-5-(trimethylsilyl)-7H-pyrrolo[2,3-d]pyrimidin-6-yl)(4-
methoxyphenyl)methanone (46e) 
 
The title compound was prepared from N-(5-iodo-2,4-dimethoxypyrimidin-6-yl)-6-methyl-N-
((trimethylsilyl)ethynyl)benzenesulfonamide (42, 266 mg, 0.5 mmol, 1.0 equiv). A Br/Mg-exchange 
was performed according to TP1 with iPrMgCl·LiCl (0.45 mL, 1.22 M, 0.55 mmol, 1.1 equiv) at 
-40 °C within 2 h (1.0 M). After addition of THF (5 mL), CuCN·2LiCl (0.55 mL, 0.55 mmol, 
1.1 equiv) mediated cyclization was performed according to TP2 at 25 °C in 24 h and a subsequent 
acylation reaction was performed according to TP3 using 4-methoxybenzylcarbonyl chloride (105 mg, 
0.6 mmol, 1.2 equiv) at -20 °C. The reaction mixture was allowed to warm slowly to 25 °C within 
12 h. Flash column chromatographical purification on silica gel (ihexane:EtOAc:NEt3 = 8:1:0.1) 
C. EXPERIMENTAL SECTION 
 
105 
afforded the (2,4-dimethoxy-7-tosyl-5-(trimethylsilyl)-7H-pyrrolo[2,3-d]pyrimidin-6-yl)(4-
methoxyphenyl)-methanone (46e, 191 mg, 71%) as a colorless solid. 
 
m.p.: 208.5 - 210.6 °C. 
1H-NMR (300 MHz, CDCl3): δ / ppm = 7.96 (d, J = 8.0 Hz, 2H), 7.86–7.76 (m, 2H), 7.21 (d, J = 8.1 
Hz, 2H), 6.87 (d, J = 8.5 Hz, 2H), 4.00 (s, 3H), 3.98 (s, 3H), 3.81 (d, J = 1.2 Hz, 3H), 2.31 (s, 3H), 
0.00 (s, 9H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 189.52, 165.34, 164.00, 162.57, 154.89, 145.60, 136.62, 
134.59, 131.91, 131.90, 129.42, 128.84, 113.93, 113.17, 105.52, 55.52, 55.10, 53.79, 21.71, 0.01. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3068, 3054, 3028, 2956, 2925, 2851, 2730, 2661, 2563, 2232, 
1682, 1668, 1598, 1570, 1512, 1495, 1471, 1454, 1427, 1374, 1289, 1257, 1209, 1193, 1165, 1121, 
1086, 1027, 1009, 944, 870, 842, 817, 794, 772, 682, 665, 634, 615. 
MS (EI, 70 eV): m/z (%) = 539 (38), 524 (19), 384 (71), 370 (100), 324 (10), 155 (9), 135 (21), 91 
(40), 77 (6), 65 (9). 
HRMS (C26H29N3O6SSi): calc.: 539.1546; found: 539.1523 (M+). 
 
(3-Chlorophenyl)(2,4-dimethoxy-7-tosyl-5-(trimethylsilyl)-7H-pyrrolo[2,3-d]pyrimidin-6-
yl)methanone (46f) 
 
The title compound was prepared from N-(5-iodo-2,4-dimethoxypyrimidin-6-yl)-6-methyl-N-
((trimethylsilyl)ethynyl)benzenesulfonamide (42, 266 mg, 0.5 mmol, 1.0 equiv). A Br/Mg-exchange 
was performed according to TP1 with iPrMgCl·LiCl (0.45 mL, 1.22 M, 0.55 mmol, 1.1 equiv) at 
-40 °C within 2 h (1.0 M). After addition of THF (5 mL), CuCN·2LiCl (0.55 mL, 0.55 mmol, 
1.1 equiv) mediated cyclization was performed according to TP2 at 25 °C in 24 h and a subsequent 
acylation reaction was performed according to TP3 using 3-chlorobenzylcarbonyl chloride (105 mg, 
0.6 mmol, 1.2 equiv) at -20 °C. The reaction mixture was allowed to warm slowly to 25 °C within 
12 h. Flash column chromatographical purification on silica gel (ihexane:EtOAc:NEt3 = 8:1:0.1) 
afforded the ((3-chlorophenyl)(2,4-dimethoxy-7-tosyl-5-(trimethylsilyl)-7H-pyrrolo[2,3-d]pyrimidin-
6-yl)methanone (46f, 209 mg, 77%) as a colorless solid. 
 
m.p.: 184.1 - 185.6 °C. 
1H-NMR (300 MHz, Acetone- d6): δ / ppm = 7.89 – 7.84 (m, 2H), 7.82 (t, J = 1.9 Hz, 1H), 7.76 (dt, J 
= 7.8, 1.3 Hz, 1H), 7.68 (ddd, J = 8.0, 2.2, 1.1 Hz, 1H), 7.60 – 7.53 (m, 1H), 7.41 – 7.35 (m, 2H), 4.02 
(s, 3H), 3.97 (s, 3H), 2.34 (s, 3H), 0.05 (s, 9H). 
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13C-NMR (75 MHz, Acetone- d6): δ / ppm = 190.56, 167.04, 164.67, 156.72, 148.02, 141.95, 137.31, 
136.18, 135.94, 135.11, 132.38, 131.31, 130.16, 130.09, 129.51, 115.88, 106.77, 56.24, 55.04, 22.26, 
0.90. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3071, 2955, 2928, 2710, 2660, 2596, 2551, 1694, 1592, 1572, 
1471, 1377, 1360, 1292, 1250, 1193, 1157, 1122, 1086, 1033, 1009, 954, 920, 898, 877, 842, 814, 
750, 734, 704, 682, 665, 602. 
MS (EI, 70 eV): m/z (%) = 543 (56), 528 (32), 388 (100), 374 (23), 331 (31), 328 (13), 280 (3), 139 
(7), 91 (11). 
HRMS (C25H26ClN3O5SSi): calc.: 543.1051; found: 543.1029 (M+). 
 
(4-(tert-Butyl)phenyl)(2,4-dimethoxy-7-tosyl-5-(trimethylsilyl)-7H-pyrrolo[2,3-d]pyrimidin-6-
yl)methanone (46g) 
 
The title compound was prepared from N-(5-iodo-2,4-dimethoxypyrimidin-6-yl)-6-methyl-N-
((trimethylsilyl)ethynyl)benzenesulfonamide (42, 266 mg, 0.5 mmol, 1.0 equiv). A Br/Mg-exchange 
was performed according to TP1 with iPrMgCl·LiCl (0.45 mL, 1.22 M, 0.55 mmol, 1.1 equiv) at 
-40 °C within 2 h (1.0 M). After addition of THF (5 mL), CuCN·2LiCl (0.55 mL, 0.55 mmol, 
1.1 equiv) mediated cyclization was performed according to TP2 at 25 °C in 24 h and a subsequent 
acylation reaction was performed according to TP3 using 4-tertbutylbenzylcarbonyl chloride (102 mg, 
0.6 mmol, 1.2 equiv) at -20 °C. The reaction mixture was allowed to warm slowly to 25 °C within 
12 h. Flash column chromatographical purification on silica gel (ihexane:EtOAc:NEt3 = 12:1:0.1) 
afforded the (4-(tert-butyl)phenyl)(2,4-dimethoxy-7-tosyl-5-(trimethylsilyl)-7H-pyrrolo[2,3-
d]pyrimidin-6-yl)-methanone (46g, 150 mg, 53%) as a colorless solid. 
 
m.p.: 197.3 - 198.0 °C 
1H-NMR (300 MHz, CDCl3): δ / ppm = 7.94 – 7.85 (m, 2H), 7.78 – 7.68 (m, 2H), 7.42 – 7.34 (m, 
2H), 7.21 – 7.15 (m, 2H), 4.00 (s, 3H), 3.98 (s, 3H), 2.30 (s, 3H), 1.27 (d, J = 1.4 Hz, 9H), 0.00 (s, 
9H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 190.60, 165.40, 162.65, 157.47, 154.99, 145.58, 136.71, 
136.05, 134.65, 129.39, 128.86, 125.61, 113.58, 105.59, 55.12, 53.79, 35.25, 31.11, 21.70, 0.05. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3172, 3120, 3069, 2961, 2870, 2670, 2600, 2556, 1790, 1715, 
1681, 1593, 1470, 1378, 1317, 1286, 1249, 1213, 1166, 1121, 1087, 1033, 1010, 946, 843, 814, 778, 
734, 706, 682, 663. 
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MS (EI, 70 eV): m/z (%) = 565 (39), 550 (22), 410 (100), 394 (44), 380 (30), 366 (9), 350 (12), 337 
(19), 161 (11), 91 (13).  
HRMS (C29H35N3O5SSi): calc.: 565.2067; found: 565.2042 (M+). 
 
 
6-Allyl-5-iodo-2,4-dimethoxy-7-tosyl-7H-pyrrolo[2,3-d]pyrimidine (47) 
 
According to TP4 iodine monochloride (179 mg, 1.1 mmol, 1.1 equiv) was added at 0 °C to a solution 
of 6-allyl-2,4-dimethoxy-7-tosyl-5-(trimethylsilyl)-7H-pyrrolo[2,3-d]pyrimidine (46b, 445 mg, 
1.0 mmol, 1.0 equiv) in dry CH2Cl2 (5 mL) and stirred for 10 min at this temperature. The reaction 
mixture was quenched with sat. Na2S2O3-solution, extracted three times with CH2Cl2, the organic 
layers dried (MgSO4) and concentrated in vacuo. The crude residue was purified by flash column 
chromatography on silica gel (ihexane:EtOAc:NEt3 = 8:1:0.1) to afforded 6-allyl-5-iodo-2,4-
dimethoxy-7-tosyl-7H-pyrrolo[2,3-d]pyrimidine (47, 371 mg, 74%) as a colorless solid. 
 
m.p.: 167.9 - 170.1 °C. 
1H-NMR (300 MHz, CDCl3): δ / ppm = 7.97 – 7.94 (m, 2H), 7.32 – 7.29 (m, 2H), 5.05 (dddd, J = 
9.2, 7.3, 5.7, 4.9 Hz, 1H), 4.07 (s, 3H), 4.01 (s, 3H), 3.98 (dd, J = 11.6, 7.4 Hz, 1H), 3.90 (dd, J = 15.1, 
5.8 Hz, 1H), 3.72 (dd, J = 15.1, 9.2 Hz, 1H), 2.42 (s, 3H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 162.91, 160.75, 153.49, 144.80, 133.97, 133.79, 128.49, 
127.17, 102.32, 64.60, 54.05, 53.17, 49.58, 36.19, 29.47, 20.61. 
IR (Diamond-ATR, neat): ~  / cm-1 = 2992, 2955, 2924, 2852, 1577, 1469, 1394, 1372, 1317, 1296, 
1275, 1221, 1177, 1142, 1084, 1050, 1020, 998, 942, 909, 858, 817, 789, 750, 734, 694, 681. 
MS (EI, 70 eV): m/z (%) = 499 (26), 381 (27), 379 (45), 345 (41), 344 (100), 317 (12), 252 (17), 216 
(40), 202 (13), 188 (12), 159 (9), 145 (13), 127 (11), 91 (37), 65 (15), 43 (67). 
HRMS (C18H18IN3O4S): calc.: 499.0063; found: 499.0079 (M+). 
 
Ethyl 4-(6-allyl-2,4-dimethoxy-7-tosyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)benzoate (48a) 
 
(4-(Ethylester)phenyl)magnesium chloride/lithium chloride was prepared by adding iPrMgCl·LiCl 
(0.16 mL, 0.17 mmol, 1.05 M in THF, 1.1 equiv) to a solution of (4-iodophenyl)ethylester (42 mg, 
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0.15 mmol, 1.0 equiv) in dry THF (0.2 mL) at 0 °C and stirring the reaction mixture at this 
temperature for 1 h. The title compound was prepared according to TP5 with ZnCl2 (0.18 mL, 
0.18 mmol, 1.0 M in THF, 1.1 equiv), 6-allyl-5-iodo-2,4-dimethoxy-7-tosyl-7H-pyrrolo[2,3-
d]pyrimidine (47, 75 mg, 0.15 mmol, 1.0 equiv) and PEPPSI-IPr (3.1 mg, 3 mol%) at 50 °C in 24 h. 
Flash column chromatographical purification on silica gel (ihexane:EtOAc = 9:1) afforded 48a 
(47 mg, 60%) as a pale yellow oil. 
 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.14 – 8.13 (m, 2H), 8.09 – 8.08 (m, 2H), 7.45 – 7.44 (m, 
2H), 7.33 – 7.32 (m, 2H), 6.19 – 6.15 (m, 1H), 5.19 (dq, J = 10.2, 1.6 Hz, 1H), 4.98 (dq, J = 17.3, 1.7 
Hz, 1H), 4.43 (q, J = 7.0 Hz, 2H), 4.05 (s, 3H), 3.87 (s, 3H), 3.80 (dt, J = 5.3, 1.7 Hz, 2H), 2.44 (s, 
3H), 1.44 (t, J = 7.0 Hz, 3H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 165.41, 163.07, 160.65, 153.18, 144.30, 136.40, 135.42, 
134.88, 131.23, 129.18, 128.32, 128.16, 127.81, 127.68, 116.89, 115.24, 59.90, 53.97, 52.85, 28.76, 
28.58, 20.60, 13.26. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3066, 2956, 2925, 2854, 1716, 1598, 1581, 1472, 1369, 1335, 
1270, 1175, 1147, 1091, 1015, 966, 926, 859, 814, 795, 754, 704, 667. 
MS (EI, 70 eV): m/z (%) = 521 (10), 366 (32), 338 (3), 326 (3), 293 (4), 267 (3), 91 (6), 61 (18), 45 
(15), 43 (100). 
HRMS (C27H27N3O6S): calc.: 521.1621; found: 521.1624 (M+). 
 
6-Allyl-5-(3-((tert-butyldimethylsilyl)oxy)phenyl)-2,4-dimethoxy-7-tosyl-7H-pyrrolo[2,3-
d]pyrimidine (48b) 
 
(3-((tert-Butyldimethylsilyl)oxy)phenyl)magnesium chloride/lithium chloride was prepared by adding 
iPrMgCl·LiCl (0.21 mL, 0.22 mmol, 1.05 M in THF, 1.1 equiv) to a solution of 
(3-bromophenoxy)(tert-butyl)dimethylsilane (57 mg, 0.20 mmol, 1.0 equiv) in dry THF (0.2 mL) at 
0 °C and stirring the reaction mixture at this temperature for 1 h. The title compound was prepared 
according to TP5 with ZnCl2 (0.22 mL, 0.22 mmol, 1.0 M in THF, 1.1 equiv), 6-allyl-5-iodo-2,4-
dimethoxy-7-tosyl-7H-pyrrolo[2,3-d]pyrimidine (47, 100 mg, 0.20 mmol, 1.0 equiv) and PEPPSI-IPr 
(4.1 mg, 3 mol%) at 50 °C in 24 h. Flash column chromatographical purification on silica gel 
(ihexane:EtOAc = 12:1) afforded 48b (60 mg, 52%) as a pale yellow oil. 
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1H-NMR (400 MHz, CDCl3): δ / ppm = 7.83 - 7.77 (m, 2H), 7.10 - 7.03 (m, 3H), 6.71 - 6.62 (m, 3H), 
5.89 - 5.81 (m, 1H), 4.97 - 4.88 (m, 1H), 4.68 - 4.62 (m, 1H), 3.80 - 3.73 (m, 4 H), 3.62 (s, 3H), 3.49 - 
3.44 (m, 1H), 2.20 (s, 3H), 0.78 (s, 9H), 0.00 (s, 6H). 
13C-NMR (150 MHz, CDCl3): δ / ppm = 164.57, 162.05, 155.23, 154.79, 145.52, 135.58, 134.06, 
133.52, 131.34, 129.48, 129.32, 128.91, 128.62, 128.54, 128.20, 119.73, 116.78, 101.47, 55.05, 54.02, 
50.49, 34.73, 25.68, 21.68, -4.29. 
IR (Diamond-ATR, neat): ~  / cm-1 = 2954, 2928, 2856, 1725, 1666, 1594, 1574, 1473, 1365, 1284, 
1250, 1225, 1191, 1172, 1146, 1088, 1002, 963, 905, 829, 812, 782, 732, 665. 
MS (EI, 70 eV): m/z (%) = 579 (3), 499 (9), 459 (8), 424 (14), 344 (24), 304 (32), 290 (9), 212 (10), 
139 (17), 91 (28), 61 (21), 45 (15), 43 (100). 
HRMS (C30H37N3O5SSi): calc.: 579.2223; found: 579.2204 (M+). 
 
6-Allyl-5-(4-fluorophenyl)-2,4-dimethoxy-7-tosyl-7H-pyrrolo[2,3-d]pyrimidine (48c) 
 
(4-fluoro-phenyl)magnesium chloride/lithium chloride was prepared by adding iPrMgCl·LiCl (0.21 
mL, 0.22 mmol, 1.05 M in THF, 1.1 equiv) to a solution of 1-fluoro-4-iodobenzene (44 mg, 
0.20 mmol, 1.0 equiv) in dry THF (0.2 mL) at 0 °C and stirring the reaction mixture at this 
temperature for 1 h. The title compound was prepared according to TP5 with ZnCl2 (0.22 mL, 
0.22 mmol, 1.0 M in THF, 1.1 equiv), 6-allyl-5-iodo-2,4-dimethoxy-7-tosyl-7H-pyrrolo[2,3-
d]pyrimidine (47, 100 mg, 0.20 mmol, 1.0 equiv) and PEPPSI-IPr (4.1 mg, 3 mol%) at 50 °C in 24 h. 
Flash column chromatographical purification on silica gel (ihexane:EtOAc = 12:1) afforded 48c 
(59 mg, 63%) as a colorless oil. 
 
1H-NMR (600 MHz, CDCl3): δ / ppm = 8.12 – 8.07 (m, 2H), 7.32 – 7.27 (m, 4H), 7.09 – 7.03 (m, 
2H), 6.14 (ddt, J = 17.3, 10.4, 5.3 Hz, 1H), 5.15 (dq, J = 10.2, 1.6 Hz, 1H), 4.94 (dq, J = 17.2, 1.7 Hz, 
1H), 4.02 (s, 3H), 3.83 (s, 3H), 3.75 (dt, J = 5.3, 1.8 Hz, 2H), 2.41 (s, 3H). 
 13C-NMR (150 MHz, CDCl3): δ / ppm = 164.19, 162.26 (d, J = 247.1 Hz), 161.67, 154.16, 145.29, 
136.68, 136.07, 132.00, 131.88 (d, J = 10.2 Hz), 129.23, 128.75, 128.53, 117.82, 116.17, 114.69 (d, J 
= 22.8 Hz), 101.08, 55.03, 53.91, 29.81, 21.67. 
19F-NMR (375 MHz, CDCl3) δ / ppm = -114.75. 
IR (Diamond-ATR, neat): ~  / cm-1 = 2957, 2927, 2854, 1724, 1596, 1576, 1508, 1473, 1386, 1372, 
1334, 1294, 1264, 1222, 1192, 1145, 1091, 1013, 994, 912, 838, 813, 794, 759, 703, 667. 
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MS (EI, 70 eV): m/z (%) = 467 (21), 312 (100), 296 (4), 265 (4), 239 (7), 216 (3), 172 (2), 145 (2), 91 
(7), 72 (3), 65 (3), 43 (6). 
HRMS (C24H22FN3O4S): calc.: 467.1315; found: 467.1313 (M+). 
 
3.4. Synthesis of Rigidin A 
 
(5-Iodo-2,4-dimethoxy-7-tosyl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)(4-methoxyphenyl)methanone 
(49) 
 
According to TP4 iodine monochloride (393 mg, 2.42 mmol, 1.1 equiv) was added at 0 °C to a 
solution of (2,4-dimethoxy-7-tosyl-5-(trimethylsilyl)-7H-pyrrolo[2,3-d]pyrimidin-6-yl)(4-
methoxyphenyl)-methanone (46e, 1.19 g, 2.2 mmol, 1.0 equiv) in dry CH2Cl2 (10 mL) and stirred for 
10 min at this temperature. The reaction mixture was quenched with sat. Na2S2O3-solution, extracted 
three times with CH2Cl2, the organic layers dried (MgSO4) and concentrated in vacuo. The crude 
residue was purified by flash column chromatography on silica gel (ihexane:EtOAc:NEt3 = 6:1:0.1) to 
afford (5-iodo-2,4-dimethoxy-7-tosyl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)(4-methoxyphenyl)methanone 
(49, 1.16 g, 89%) as a colorless solid. 
 
m.p.: 200.1 - 201.1 °C. 
1H-NMR (300 MHz, CDCl3): δ / ppm = 8.06 (d, J=8.1 Hz, 2H), 7.88 (d, J=8.4 Hz, 2H), 7.27 (d, 
J=8.1 Hz, 2H), 6.93 (d, J=8.4 Hz, 2H), 4.03 (s, 3H), 4.01 (s, 3H), 3.84 (s, 3H), 2.36 (s, 3H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 187.11, 165.14, 164.49, 162.78, 153.97, 146.10, 134.19, 
133.86, 132.60, 129.64, 129.62, 129.05, 114.26, 103.61, 59.79, 55.63, 55.34, 54.44, 21.81. 
IR (Diamond-ATR, neat): ~  / cm-1 = 2935, 1653, 1593, 1574, 1506, 1475, 1456, 1421, 1401, 1380, 
1361, 1306, 1279, 1260, 1214, 1166, 1152, 1121, 1089, 1059, 1026, 972, 932, 907, 866, 850, 814, 
790, 756, 731, 702, 682, 667. 
MS (EI, 70 eV): m/z (%) = 593 (5), 439 (35), 313 (36), 299 (24), 246 (12), 152 (28), 142 (55), 135 
(100), 126 (25), 123 (15), 108 (12), 91 (55), 77 (31), 65 (21). 
HRMS (C23H20IN3O6S): calc.: 593.0117; found: 593.0117 (M+). 
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(5-Iodo-2,4-dimethoxy-7H-pyrrolo[2,3-d]pyrimidin-6-yl)(4-methoxyphenyl)methanone (50) 
 
In a 50 mL flasked, equipped with a magnetic stirrer and a septum, (5-iodo-2,4-dimethoxy-7-tosyl-7H-
pyrrolo[2,3-d]pyrimidin-6-yl)(4-methoxyphenyl)methanone (49, 356 mg, 0.6 mmol, 1.0 equiv) and 
KOH (202 mg, 3.6 mmol, 6.0 equiv) were dissolved in THF:MeOH (2:1, 10 mL) and stirred at 25 °C 
for 2 h. The reaction mixture was quenched with sat. NH4Cl-solution, extracted three times with 
CH2Cl2, the organic layers dried (Na2SO4) and concentrated in vacuo. The crude residue was purified 
by flash column chromatography on silica gel (ihexane:EtOAc:NEt3 = 4:1:0.05) to afford (5-iodo-2,4-
dimethoxy-7H-pyrrolo[2,3-d]pyrimidin-6-yl)(4-methoxyphenyl)methanone (50, 161 mg, 61%) as a 
colorless solid. 
 
m.p.: 198.3 - 200.1 °C. 
1H-NMR (300 MHz, CDCl3): δ / ppm = 9.74 (s, 1H), 7.74 (d, J=8.5 Hz, 2H), 6.90 (d, J=8.5 Hz, 2H), 
4.08 (s, 3H), 3.94 (s, 3H), 3.83 (s, 3H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 186.67, 166.43, 163.66, 163.45, 153.75, 132.48, 132.28, 
129.31, 113.80, 105.32, 60.59, 55.56, 55.05, 54.31. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3140, 3075, 3000, 2945, 2910, 2870, 2842, 2805, 1636, 1616, 
1597, 1478, 1447, 1422, 1388, 1358, 1318, 1282, 1254, 1192, 1169, 1149, 1111, 1085, 1028, 976, 
932, 843, 788, 767, 743, 702, 676. 
MS (EI, 70 eV): m/z (%) = 439 (100), 407 (15), 330 (14), 312 (70), 281 (9), 204 (10), 176 (8), 135 
(54), 92 (12), 77 (17). 
HRMS (C16H14IN3O4): calc.: 439.0029; found: 439.0032 (M+). 
 
(2,4-dimethoxy-5-(4-methoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-6-yl)(4-
methoxyphenyl)methanone (51) 
 
In a dry and argon flushed Schlenk-flask, equipped with a magnetic stirrer and a septum, (5-iodo-2,4-
dimethoxy-7H-pyrrolo[2,3-d]pyrimidin-6-yl)(4-methoxyphenyl)methanone (50, 155 mg, 0.35 mmol, 
1.0 equiv), Pd(PPh3)4 (8 mg, 0.017 mmol, 5 mol%), K2CO3 (193 mg, 1.40 mmol, 4.0 equiv) and 
(4-methoxyphenyl)boronic acid (64 mg, 0.42 mmol, 1.2 equiv) were dissolved in 1,4-Dioxane:H2O 
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(10:1, 11 ml). The resulting mixture was stirred for 24 h at 70 °C. Flash column chromatographical 
purification on silica gel (ihexane:EtOAc:MeOH = 2:1:0.05) afforded (2,4-dimethoxy-5-(4-
methoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-6-yl)(4-methoxyphenyl)methanone (51, 84 mg, 57%) as 
a white solid. 
 
m.p.: 155.2 - 158.0 °C. 
1H-NMR (300 MHz, CDCl3): δ / ppm = 9.29 (s, 1H), 7.38 (d, J=8.5 Hz, 2H), 7.05 (d, J=8.3 Hz, 2H), 
6.57 (d, J=8.3 Hz, 2H), 6.50 (d, J=8.5 Hz, 2H), 3.99 (s, 3H), 3.92 (s, 3H), 3.67 (s, 3H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 187.18, 167.05, 163.86, 162.45, 158.92, 153.40, 132.62, 
131.65, 129.66, 127.98, 125.21, 124.08, 112.93, 112.87, 101.09, 55.35, 55.24, 54.97, 54.13. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3265, 3076, 6053, 3002, 2985, 2939, 2836, 1596, 1565, 1532, 
1511, 1496, 1476, 1457, 1437, 1424, 1391, 1365, 1278, 1245, 1215, 1196, 1162, 1140, 1112, 1079, 
1035, 1018, 987, 956, 932, 866, 846, 832, 797, 773, 744, 724, 667. 
MS (EI, 70 eV): m/z (%) = 419 (100), 402 (5), 388 (5), 269 (6), 209 (4), 135 (32), 77 (9). 
HRMS (C23H21N3O5): calc.: 419.1481; found: 419.1477 (M+). 
 
Rigidine A (37a) 
 
In a dry and argon flushed Schlenk-flask, equipped with a magnetic stirrer and a septum, (2,4-
dimethoxy-5-(4-methoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-6-yl)(4-methoxyphenyl)methanone (51, 
80 mg, 0.19 mmol, 1.0 equiv) were dissolved in dry CH2Cl2 (25 ml) and cooled to -78°C. A solution 
of boron tribromide (3.81 mL, 1.0 M in CH2Cl2, 3.81 mmol, 20.0 equiv) was added to the reaction 
mixture slowly over 5 min. The reaction mixture was warmed to 40 °C and then stirred for 24 h at this 
temperature. After cooling the reaction mixture to -78 °C an additional amount of boron tribromide 
solution (0.95 mL, 1.0 M in CH2Cl2, 0.95 mmol, 5.0 equiv) was added slowly over 3 min and the 
reaction mixture was allowed to warm to 25 °C and stirred for 20 h. The reaction mixture was cooled 
in an ice/water bath and quenched with slow addition of methanol (10 ml). This mixture was stirred in 
an ice bath for 5 h and 20 mL of water was added followed by the careful addition of 5% aqueous 
NaOH (5 mL) to a pH of 6. This solution was allowed to warm to 25 °C and stirred for 16 h. The 
solvents were removed in vacuo and the resulting aqueous mixture was extracted three times with 
CH2Cl2, the organic layers dried (Na2SO4) and concentrated in vacuo. The crude residue was purified 
by reverse phase column chromatography with acetonitrile/water gradient to afford rigidine A (37a, 
22 mg, 0.061 mmol, 32%) as a light yellow solid. 
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m.p.: > 320 °C (decomp.). 
1H-NMR (300 MHz, DMSO-d6): δ / ppm = 11.73 (br s, 1H), 11.17 (br s, 1H), 10.62 (br s, 1H), 9.99 
(br s, 1H), 9.72 (br s, 1H), 7.30 (d, J = 9.0 Hz, 2H), 6.95 (d, J = 9.0 Hz, 2H), 6.48 (d, J = 9.0 Hz, 2H), 
6.45 (d, J = 9.0 Hz, 2H). 
13C-NMR (75 MHz, DMSO-d6): δ / ppm = 185.7, 161.2, 160.2, 156.9, 151.1, 141.6, 132.7, 132.0, 
129.1, 128.5, 125.4, 123.2, 114.8, 114.3, 98.6. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3215, 1695, 1568, 1434, 1413, 1258. 
HRMS (ESI, C19H12N3O5): calc.: 362.0855; found: 362.0774 (M +). 
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4. REGIOSELECTIVE PREPARATION OF TETRASUBSTITUTED 
FLUOROBENZENES 
4.1. Typical Procedures 
 
Typical Procedure for the Metalation using s-BuLi (TP1): 
A dry and argon flushed Schlenk-flask, equipped with a magnetic stirrer and a septum was charged 
with freshly sublimated KOtBu (2.5 equiv) and freshly destilled PMDTA (N,N,N′,N′′,N′′-
pentamethyldiethylenetriamine) (2.5 equiv) in dry Et2O (0.5 M solution) and stirred for 10 min at 
25 °C. The slurry mixture was cooled to -65 °C and s-Buli (2.5 equiv) was added slowly and stirred 
for 15 min at the same temperature. Then the bissilylbenzene was added and the reaction mixture was 
stirred for 20 h at -65 °C (the completion of the reaction was checked by GC analysis of reaction 
aliquots quenched with dimethyl disulfide in Et2O). 
 
Typical Procedure for Halogen-Lithium Exchange Reactions (TP2): 
A dry and argon flushed Schlenk-flask, equipped with a magnetic stirrer and a septum was charged 
with the starting aryl bromide in THF (0.5-1.0 M solution) and cooled to -78 °C. Then n-BuLi 
(1.1 equiv) was added and the reaction mixture was stirred for the indicated time (the completion of 
the reaction was checked by GC analysis of reaction aliquots quenched with saturated aqueous NH4Cl-
solution).  
 
Typical Procedure for Allylation or Acylation Reactions (TP3): 
To the freshly prepared lithium/magnesium reagent was added CuCN·2LiCl (1.2 equiv, 1.0 M in THF) 
and the reaction mixture was stirred for 30 min at the indicated temperature. The respective allyl 
bromide or acyl chloride was added and the reaction mixture was stirred for the indicated time at the 
indicated temperature. The reaction mixture was quenched with concentrated aqueous 
NH4Cl:NH3-solution (19:1), extracted three times with EtOAc, the organic layers dried (MgSO4) and 
concentrated in vacuo. The crude residue was purified by flash column chromatography on silica gel. 
 
Typical Procedure for Cross-Coupling Reactions (TP4): 
To the freshly prepared lithium/magnesium reagent was added ZnCl2 (1.2 equiv, 1.0 M in THF) and 
the reaction mixture was stirred for 30 min at the indicated temperature. The catalytic system and the 
aryl iodide/bromide (1.2 equiv) were added and the reaction mixture was warmed to 25 °C. After 
stirring for the indicated time, the reaction mixture was quenched with half concentrated aqueous 
NH4Cl-solution, extracted three times with EtOAc, the organic layers dried (MgSO4) and concentrated 
in vacuo. The crude residue was purified by flash column chromatography on silica gel. 
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Typical Procedure for the Conversion of the TES-Group to Iodide (TP5): 
To the respective TES-substituted compound (approx. 0.2 M in CH2Cl2) was added iodine 
monochloride (1.1 equiv) at 0 °C and the mixture was stirred for 20 h. The reaction mixture was 
quenched with saturated aqueous Na2S2O3-solution, extracted three times with CH2Cl2, the organic 
layers dried (MgSO4) and concentrated in vacuo. The crude residue was purified by flash column 
chromatography on silica gel. 
 
Typical Procedure for Halogen-Magnesium Exchange Reactions (TP6): 
A dry and argon flushed Schlenk-flask, equipped with a magnetic stirrer and a septum was charged 
with the starting aryl iodine in THF (0.2-1.0 M solution) and cooled to the indicated temperature. Then 
iPrMgCl·LiCl was added and the reaction mixture was stirred for the indicated time (the completion of 
the reaction was checked by GC analysis of reaction aliquots quenched with saturated aqueous NH4Cl-
solution). 
 
4.2. Preparation of Bis Silylbenzene Derivatives 
 
(2-Fluorophenyl)triisopropylsilane (53) 
 
A solution of 1-bromo-2-fluorobenzene (52, 6.56 g, 37.5 mmol, 1.0 equiv) in THF (40 mL) was added 
to a dry and argon-flushed Schlenk flask, equipped with a septum and a magnetic stirring bar, cooled 
to -78 °C and t-BuLi (50.0 ml, 1.65 M in ihexane, 82.5 mmol, 2.2 equiv) was added dropwise. The 
reaction mixture was stirred for 1.5 h at -78 °C. Afterwards triisopropylsilyl chloride (7.96 g, 
41.3 mmol, 1.1 equiv) was added slowly and the solution was allowed to warm to 25 °C within 16 h. 
After complete conversion, the mixture was quenched with sat. aq. NH4Cl (10 mL) and extracted with 
EtOAc (3 × 50 mL). The combined organic extracts are dried over anhydrous MgSO4, filtered and 
concentrated in vacuo. Flash column chromatographical purification on silica gel (pentane) afforded 
the compound 53 (5.86 g, 62%) as a colorless oil.  
 
1H-NMR (300 MHz, CDCl3): δ / ppm = 7.53 (m, 1H), 7.42 (m, 1H), 7.22 (t, J = 7.3 Hz, 1H), 7.09 (t, 
J = 7.4 Hz, 1H), 1.58 (hept, J = 7.6 Hz, 3H), 1.20 (d, J = 7.9 Hz, 18H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 167.57 (d, J = 241.0 Hz), 136.85 (d, J = 12.2 Hz), 131.00 (d, 
J = 8.5 Hz), 123.62 (d, J = 2.7 Hz), 115.03 (d, J = 27.3 Hz), 18.7, 11.4. 
19F-NMR (375 MHz, CDCl3): δ / ppm = -96.5. 
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IR (Diamond-ATR, neat): ~  / cm-1 = 3071, 3014, 2944, 2891, 2866, 2727, 1915, 1795, 1698, 1600, 
1563, 1468, 1432, 1384, 1367, 1332, 1284, 1256, 1202, 1156, 1115, 1078, 1018, 996, 941, 920, 882, 
856, 820, 756, 730, 717, 673. 
MS (EI, 70 eV): m/z (%) = 252 (1), 209 (3), 167 (24), 139 (100), 125 (22), 91 (12), 77 (19), 63 (12), 
47 (25), 43 (28).  
HRMS (C15H25FSi): calc.: 252.1710, found: 252.1703 (M+). 
 
Trimethyl(2-fluoro-3-(triisopropylsilyl)phenyl)silane (54) 
 
A dry and argon-flushed Schlenk flask, equipped with a septum and a magnetic stirring bar, was filled 
with TMPH (182 mg, 1.3 mmol, 1.3 equiv) dissolved in THF (2 mL) and cooled to -20 °C. n-BuLi 
(59, 0.50 mL, 1.2 mmol, 1.2 equiv, 2.40 M in ihexane) was added dropwise and the reaction mixture 
was stirred for 20 min at -20 °C and then 15 min at 0 °C. After cooling to -78 °C 
(2-fluorophenyl)triisopropylsilane (53, 252 mg, 1.0 mmol, 1.0 equiv) dissolved in THF (15 mL) was 
added and the suspension was stirred for 4 h at -78 °C. Then trimethylsilyl chloride (141 mg, 
1.5 mmol, 1.5 equiv) solved in THF (5 mL) was added and the mixture was allowed to warm to 25 °C 
for 16 h. The suspension was quenched with sat. aq. NH4Cl solution (10 mL), extracted with ihexane 
(3 × 50 mL), washed with brine (50 mL), dried over anhydrous MgSO4 and concentrated in vacuo. 
Flash column chromatographical purification on silica gel (pentane) afforded the compound 54 
(240 mg, 74%) as a colorless oil.  
 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.51 – 7.40 (m, 2H), 7.15 (td, J = 7.2, 1.7 Hz, 1H), 1.12 (d, J 
= 7.5 Hz, 18H), 0.34 (s, 3H), 0.33 (s, 9H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 172.10 (d, J = 236.2 Hz), 138.31 (d, J = 12.6 Hz), 136.24 (d, 
J = 11.9 Hz), 125.36 (d, J = 36.9 Hz), 123.31 (d, J = 2.6 Hz), 119.95 (d, J = 37.1 Hz), 18.63 (d, J = 1.0 
Hz), 11.36 (d, J = 1.7 Hz), -1.10 (d, J = 1.8 Hz). 
19F NMR (375 MHz, CDCl3): δ / ppm = -115.07 
IR (Diamond-ATR, neat): ~  / cm-1 = 2946, 2892, 2866, 1586, 1554, 1464, 1381, 1249, 1215, 1191, 
1151, 1128, 1072, 1018, 996, 920, 882, 838, 762, 694, 676, 646, 597, 578, 555. 
MS (EI, 70 eV): m/z (%) = 324 (3), 239 (57), 225 (2), 211 (100), 197 (18), 189 (20), 161 (9), 147 
(43), 133 (10), 119 (5), 105 (2), 98 (3), 77 (12), 73 (57), 59 (10). 
HRMS (C18H33FSi2): calc.: 324.2105, found: 324.2102 (M+). 
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Triethyl(2-fluoro-3-(triisopropylsilyl)phenyl)silane (55) 
 
A dry and argon-flushed Schlenk flask, equipped with a septum and a magnetic stirring bar, was filled 
with TMPH (1.28 g, 9.01 mmol, 1.3 equiv) dissolved in THF (9 mL) and cooled to -20 °C. n-BuLi 
(59, 3.47 mL, 8.32 mmol, 1.2 equiv, 2.40 M in ihexane) was added dropwise and the reaction mixture 
was stirred for 20 min at -20 °C and then 15 min at 0 °C. After cooling to -78 °C 
(2-fluorophenyl)triisopropylsilane (53, 1.75, 6.93 mmol, 1.0 equiv) dissolved in THF (15 mL) was 
added and the suspension was stirred for 4 h at -78 °C. Then triethylsilyl chloride (1.57 g, 10.4 mmol, 
1.5 equiv) suspended in THF (5 mL) was added and the mixture was allowed to warm to 25 °C within 
16 h. The suspension was quenched with sat. aq. NH4Cl solution (10 mL), extracted with ihexane (3 × 
50 mL), washed with brine (50 mL), dried over anhydrous MgSO4 and concentrated in vacuo. Flash 
column chromatographical purification on silica gel (pentane) afforded the compound (55, 2.20 g, 
86%) as a colorless oil.  
 
1H-NMR (300 MHz, CDCl3): δ / ppm = 7.48 (m, 2H), 7.18 (t, J = 7.2 Hz, 1H), 1.52 (spt, J = 7.6 Hz, 
3H), 1.14 (d, J = 7.7 Hz, 18H) 1.10 – 0.87 (m, 15H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 172.14 (d, J = 236.1 Hz), 138.20 (d, J = 12.6 Hz), 137.24 (d, 
J = 12.4 Hz), 123.35 (d, J = 2.6 Hz), 122.35 (d, J = 38.1 Hz), 119.87 (d, J = 37.6 Hz), 18.66, 11.39, 
11.37, 7.45, 3.56, 3.54. 
19F-NMR (375 MHz, CDCl3): δ / ppm = -81.6. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3043, 2951, 2889, 2867, 2729, 1936, 1885, 1696, 1579, 1554, 
1462, 1417, 1380, 1281, 1255, 1239, 1214, 1189, 1150, 1122, 1072, 1017, 1004, 972, 920, 882, 818, 
801, 767, 747, 729, 721, 696, 676. 
MS (EI, 70 eV): m/z (%) = 366 (1), 295 (100), 281 (18), 267 (97), 253 (42), 239 (87), 189 (19), 169 
(31), 161 (36), 147 (24), 133 (26), 115 (15), 105 (43), 87 (20), 77 (50), 59 (27), 43 (15). 
HRMS (C21H39FSi2): calc.: 366.2574, found: 366.2590 (M+). 
 
(2-Fluoro-1,3-phenylene)bis(triethylsilane) (57) 
 
In a dry and argon-flushed Schlenk-flask, equipped with a magnetic stirrer and a septum, was charged 
with fluorobenzene (56, 1.92 g, 20 mmol, 1.0 equiv) and TES-Cl (7.53 g, 50 mmol, 2.5 equiv) in 
30 mL THF. The solution was cooled down to -78 °C and TMPLi (4, 67.7 ml, 0.65 M in hexane, 
44 mmol, 2.2 equiv) was added dropwise. The reaction mixture was allowed to warm to 25 °C within 
8 h, quenched with sat. aq. NH4Cl (100 mL) and extracted with ihexane (3 × 50 mL). The combined 
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organic extracts are dried over anhydrous MgSO4, filtered and concentrated in vacuo. Flash column 
chromatographical purification on silica gel (pentane) afforded (2-fluoro-1,3-
phenylene)bis(triethylsilane (57, 5.77 g, 89%) as a colorless oil.  
 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.33 (dd, J = 7.2, 5.7 Hz, 2H), 7.05 (td, J = 7.2, 1.7 Hz, 1H), 
0.89 (t, J = 7.6 Hz, 18H), 0.81 – 0.71 (m, 12H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 172.16 (d, J = 236.0 Hz), 137.33 (d, J = 12.3 Hz), 123.43 (d, 
J = 2.7 Hz), 122.11 (d, J = 37.1 Hz), 7.40, 3.55, 3.54. 
19F NMR (376 MHz, CDCl3): δ / ppm = -84.72. 
IR (Diamond-ATR, neat): ~  / cm-1 = 2954, 2911, 2876, 1582, 1555, 1458, 1417, 1384, 1278, 1239, 
1215, 1190, 1150, 1126, 1004, 973, 818, 773, 748, 718, 684. 
MS (EI, 70 eV): m/z (%) = 324 (5), 295 (2), 267 (85), 239 (100), 225 (6), 211 (55), 183 (11), 161 
(34), 133 (24), 119 (12), 105 (37), 91 (19), 77 (22), 59 (13). 
HRMS (C18H33FSi2): calc.: 324.2105, found: 324.2118 (M+). 
 
1,3-Bis(triethylsilyl)benzene (60) 
 
In a dry and argon-flushed Schlenk-flask, equipped with a magnetic stirrer and a septum, was charged 
with 1,3-dibromobenzene (58, 7.02 g, 30 mmol, 1.0 equiv) and TES-Cl (11.29 g, 75 mmol, 2.5 equiv) 
in 50 mL THF. The solution was cooled down to -78 °C and n-BuLi (59, 31.4 ml, 2.1 M in hexane, 
66 mmol, 2.2 equiv) was added dropwise. The reaction mixture was allowed to warm to 25 °C within 
8 h, quenched with sat. aq. NH4Cl (100 mL) and extracted with ihexane (3 × 50 mL). The combined 
organic extracts are dried over anhydrous MgSO4, filtered and concentrated in vacuo. Flash column 
chromatographical purification on silica gel (pentane) afforded 1,3-bis(triethylsilyl)benzene (60, 
8.54 g, 93%) as a colorless oil. 
 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.55 (td, J = 1.3, 0.8 Hz, 1H), 7.42 (dd, J = 1.4, 0.5 Hz, 1H), 
7.40 (d, J = 1.3 Hz, 1H), 7.26 (ddd, J = 7.7, 6.9, 0.7 Hz, 1H), 0.96 – 0.86 (m, 18H), 0.78 – 0.67 (m, 
12H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 140.17, 136.11, 134.52, 126.90, 7.42, 3.42. 
IR (Diamond-ATR, neat): ~  / cm-1 = 2953, 2910, 2875, 1458, 1416, 1361, 1237, 1106, 1003, 779, 
729, 714, 685. 
MS (EI, 70 eV): m/z (%) = 306 (5), 277 (100), 249 (67), 235 (4), 221 (55), 207 (2), 191 (9), 177 (3), 
165 (11), 149 (2), 137 (15), 124 (3), 110 (13), 96 (22), 82 (17), 68 (10), 55 (8). 
HRMS (C18H34Si2): calc.: 306.2199; found: 306.2194 (M+). 
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4.3. Functionalization in para-Position via Metalation with s-BuLi 
 
(5-Deuterium-2-fluoro-1,3-phenylene)bis(triethylsilane) (62a) 
 
The title compound was prepared according to TP1 from KOtBu (280.5 mg, 2.5 mmol, 2.5 equiv), 
PMDTA (434 mg, 2.5 mmol, 2.5 equiv), s-BuLi (1.85 ml, 1.35 M in ihexane, 2.5 mmol, 2.5 equiv) 
and (2-fluoro-1,3-phenylene)bis(triethylsilane) (57, 324 mg, 1.0 mmol, 1.0 equiv) at -65 °C in 20 h. 
The reaction mixture was quenched with MeOD-d4 (108 mg, 3.0 mmol, 3.0 equiv) and allowed to 
warm to 25 °C in 16 h. After complete conversion, the mixture was quenched with sat. aq. NH4Cl 
(10 mL) and extracted with EtOAc (3 × 10 mL). The combined organic extracts are dried over 
anhydrous MgSO4, filtered and concentrated in vacuo. Flash column chromatographical purification 
on silica gel (pentane) afforded a mixture of (2-fluoro-1,3-phenylene)bis(triethylsilane) (57, 71 mg, 
22%) and (5-deuterium-2-fluoro-1,3-phenylene)bis(triethylsilane) (62a, 252 mg, 78%) as a colorless 
oil.  
 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.32 (dd, J = 6.5, 3.0 Hz, 2H), 7.04 (td, J = 7.1, 1.7 Hz, 0.22 
H), 0.88 (t, J = 7.7 Hz, 18H), 0.82 – 0.72 (m, 12H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 172.16 (d, J = 236.1 Hz), 137.23 (d, J = 12.3 Hz), 123.53 – 
121.78 (m), 7.40, 3.55, 3.54. 
19F NMR (375 MHz, CDCl3): δ / ppm = -84.73. 
IR (Diamond-ATR, neat): ~  / cm-1 = 2954, 2911, 2875, 2124, 1582, 1545, 1457, 1417, 1377, 1334, 
1281, 1239, 1214, 1190, 1150, 1122, 1061, 1004, 973, 914, 901, 856, 816, 749, 719, 684, 648, 583, 
555. 
MS (EI, 70 eV): m/z (%) = 325 (8), 296 (4), 268 (100), 240 (93), 212 (60), 184 (9), 162 (38), 156 
(30), 134 (26), 115 (6), 105 (35), 91 (18), 77 (28), 71 (7), 59 (12). 
HRMS (C18H32DFSi2): calc.: 325.2168, found: 325.2182 (M+). 
 
(2-Fluoro-5-(methylthio)-1,3-phenylene)bis(triethylsilane) (62b) 
 
The title compound was prepared according to TP1 from KOtBu (280.5 mg, 2.5 mmol, 2.5 equiv), 
PMDTA (434 mg, 2.5 mmol, 2.5 equiv), s-BuLi (1.85 ml, 1.35 M in ihexane, 2.5 mmol, 2.5 equiv) 
and (2-fluoro-1,3-phenylene)bis(triethylsilane) (57, 324 mg, 1.0 mmol, 1.0 equiv) at -65 °C in 20 h. 
C. EXPERIMENTAL SECTION 
 
120 
The reaction mixture was quenched with dimethyl disulfide (283 mg, 3.0 mmol, 3.0 equiv) and 
allowed to warm to 25 °C in 16 h. After complete conversion, the mixture was quenched with sat. aq. 
NH4Cl (10 mL) and extracted with EtOAc (3 × 10 mL). The combined organic extracts are dried over 
anhydrous MgSO4, filtered and concentrated in vacuo. Flash column chromatographical purification 
on silica gel (pentane) afforded (2-fluoro-5-(methylthio)-1,3-phenylene)bis(triethylsilane) (62b, 
262 mg, 71%) as a colorless oil.  
 
1H-NMR (300 MHz, CDCl3): δ / ppm = 7.24 (s, 1H), 7.23 (s, 1H), 2.40 (s, 3H), 0.94 – 0.84 (m, 18H), 
0.82 – 0.70 (m, 12H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 170.68 (d, J = 235.4 Hz), 136.81 (d, J = 12.6 Hz), 132.14 (d, 
J = 2.9 Hz), 123.34 (d, J = 38.4 Hz), 17.54, 7.38, 3.49, 3.48. 
19F NMR (375 MHz, CDCl3): δ / ppm = -89.80. 
IR (Diamond-ATR, neat): ~  / cm-1 = 2954, 2910, 2874, 1566, 1458, 1418, 1386, 1270, 1220, 1196, 
1144, 1092, 1004, 968, 858, 786, 742, 668. 
MS (EI, 70 eV): m/z (%) = 370 (100), 313 (18), 285 (53), 227 (6), 221 (5), 201 (30), 179 (30), 142 
(9), 128 (16), 114 (18), 105 (33), 87 (11), 77 (31), 59 (12). 
HRMS (C19H35FSSi2): calc.: 370.1982, found: 370.1981 (M+). 
 
(2,5-Difluoro-1,3-phenylene)bis(triethylsilane) (62c) 
 
The title compound was prepared according to TP1 from KOtBu (280.5 mg, 2.5 mmol, 2.5 equiv), 
PMDTA (434 mg, 2.5 mmol, 2.5 equiv), s-BuLi (1.85 ml, 1.35 M in ihexane, 2.5 mmol, 2.5 equiv) 
and (2-fluoro-1,3-phenylene)bis(triethylsilane) (57, 324 mg, 1.0 mmol, 1.0 equiv) at -65 °C in 20 h. 
The reaction mixture was quenched with N-fluorobenzenesulfonimide (946 mg, 3.0 mmol, 3.0 equiv) 
and allowed to warm to 25 °C in 16 h. After complete conversion, the mixture was quenched with sat. 
aq. NH4Cl (10 mL) and extracted with EtOAc (3 × 10 mL). The combined organic extracts are dried 
over anhydrous MgSO4, filtered and concentrated in vacuo. Flash column chromatographical 
purification on silica gel (pentane) afforded (2,5-difluoro-1,3-phenylene)bis(triethylsilane) (62c, 
172 mg, 50%) as a colorless oil.  
 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.04 (dd, J = 8.0, 3.9 Hz, 2H), 1.02 – 0.92 (m, 18H), 0.90 – 
0.79 (m, 12H). 
 13C-NMR (100 MHz, CDCl3): δ / ppm = 167.44 (dd, J = 231.5, 1.2 Hz), 158.89 (dd, J = 244.5, 2.2 
Hz), 137.33 (d, J = 12.3 Hz), 124.71 (dd, J = 41.3, 3.7 Hz), 122.79 (dd, J = 22.0, 13.6 Hz), 7.31, 3.35, 
3.33. 
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19F NMR (300 MHz, CDCl3): δ / ppm = -92.73, -122.12. 
IR (Diamond-ATR, neat): ~  / cm-1 = 2954, 2911, 2876, 2833, 2813, 1757, 1712, 1694, 1659, 1642, 
1592, 1575, 1515, 1457, 1417, 1386, 1313, 1277, 1239, 1192, 1174, 1126, 1094, 1061, 1004, 974, 
881, 819, 785, 741, 718, 689. 
MS (EI, 70 eV): m/z (%) = 342 (4), 285 (34), 257 (46), 231 (25), 188 (27), 173 (18), 155 (9), 149 
(11), 141 (14), 133 (24), 127 (14), 111 (27), 105 (10), 97 (36), 95 (18), 85 (51), 77 (18), 71 (76), 57 
(100), 43 (57). 
HRMS (C18H32F2Si2): calc.: 342.2011; found: 342.1996 (M+). 
 
(5-Chloro-2-fluoro-1,3-phenylene)bis(triethylsilane) (62d) 
 
The title compound was prepared according to TP1 from KOtBu (280.5 mg, 2.5 mmol, 2.5 equiv), 
PMDTA (434 mg, 2.5 mmol, 2.5 equiv), s-BuLi (1.85 ml, 1.35 M in ihexane, 2.5 mmol, 2.5 equiv) 
and (2-fluoro-1,3-phenylene)bis(triethylsilane) (57, 324 mg, 1.0 mmol, 1.0 equiv) at -65 °C in 20 h. 
The reaction mixture was quenched with 1,1,1,3,3,3-hexachloroacetone (794 mg, 3.0 mmol, 3.0 equiv) 
and allowed to warm to 25 °C in 16 h. After complete conversion, the mixture was quenched sat. aq. 
NH4Cl (10 mL) and extracted with EtOAc (3 × 10 mL). The combined organic extracts are dried over 
anhydrous MgSO4, filtered and concentrated in vacuo. Flash column chromatographical purification 
on silica gel (pentane) afforded (5-chloro-2-fluoro-1,3-phenylene)bis(triethylsilane) (62d, 197 mg, 
55%) as a colorless oil.  
 
1H-NMR (300 MHz, CDCl3): δ / ppm = 7.29 (s, 1H), 7.28 (s, 1H), 0.95 (dd, J = 9.6, 6.1 Hz, 18H), 
0.86 – 0.79 (m, 12H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 170.22 (d, J = 235.9 Hz), 137.31 (d, J = 13.8 Hz), 136.48 (d, 
J = 14.9 Hz), 129.27, 125.02 (d, J = 40.7 Hz), 7.28, 3.32. 
19F NMR (300 MHz, CDCl3): δ / ppm = -89.26. 
IR (Diamond-ATR, neat): ~  / cm-1 = 2954, 2911, 2876, 1573, 1549, 1457, 1417, 1379, 1321, 1296, 
1271, 1239, 1210, 1192, 1135, 1112, 1086, 1061, 1004, 974, 884, 855, 818, 781, 744, 722, 675. 
MS (EI, 70 eV): m/z (%) = 358 (21), 301 (80), 273 (100), 267 (19), 245 (60), 239 (16), 211 (14), 195 
(20), 189 (50), 166 (22), 161 (16), 133 (24), 122 (17), 115 (14), 105 (48), 87 (21), 77 (45). 59 (18). 
HRMS (C18H32ClFSi2): calc.: 358.1715; found: 358.1712 (M+). 
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(5-Bromo-2-fluoro-1,3-phenylene)bis(triethylsilane) (62e) 
 
The title compound was prepared according to TP1 from KOtBu (280.5 mg, 2.5 mmol, 2.5 equiv), 
PMDTA (434 mg, 2.5 mmol, 2.5 equiv), s-BuLi (1.85 ml, 1.35 M in ihexane, 2.5 mmol, 2.5 equiv) 
and (2-fluoro-1,3-phenylene)bis(triethylsilane) (57, 324 mg, 1.0 mmol, 1.0 equiv) at -65 °C in 20 h. 
The reaction mixture was quenched with a solution of bromine (479 mg, 3.0 mmol, 3.0 equiv) in 5 mL 
Et2O and allowed to warm to 25 °C in 16 h. After complete conversion, the mixture was quenched 
with sat. aq. Na2S2O3 (10 mL) and extracted with EtOAc (3 × 10 mL). The combined organic extracts 
are dried over anhydrous MgSO4, filtered and concentrated in vacuo. Flash column chromatographical 
purification on silica gel (pentane) afforded (5-bromo-2-fluoro-1,3-phenylene)bis(triethylsilane) (62e, 
246 mg, 61%) as a colorless oil.  
 
1H-NMR (300 MHz, CDCl3): δ / ppm = 7.36 (s, 1H), 7.35 (s, 1H), 0.91 – 0.86 (m, 18H), 0.80 – 0.71 
(m, 12H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 170.76 (d, J = 236.1 Hz), 139.43 (d, J = 12.9 Hz), 125.80 (d, 
J = 39.7 Hz), 117.60 (d, J = 2.9 Hz), 7.30, 3.37, 3.35. 
19F NMR (300 MHz, CDCl3): δ / ppm = -88.68. 
IR (Diamond-ATR, neat): ~  / cm-1 = 2954, 2911, 2876, 1572, 1458, 1417, 1379, 1270, 1239, 1211, 
1194, 1120, 1078, 1004, 974, 883, 816, 780, 744, 720, 687, 650, 615. 
MS (EI, 70 eV): m/z (%) = 404 (17), 402 (15), 347 (69), 319 (85), 291 (58), 241 (25), 233 (33), 189 
(28), 145 (17), 131 (29), 105 (100), 77 (67). 
HRMS (C18H32BrFSi2): calc.: 402.1210; found: 402.1200 (M+). 
 
(5-Iodo-2-fluoro-1,3-phenylene)bis(triethylsilane) (62f) 
 
The title compound was prepared according to TP1 from KOtBu (280.5 mg, 2.5 mmol, 2.5 equiv), 
PMDTA (434 mg, 2.5 mmol, 2.5 equiv), s-BuLi (1.85 ml, 1.35 M in ihexane, 2.5 mmol, 2.5 equiv) 
and (2-fluoro-1,3-phenylene)bis(triethylsilane) (57, 324 mg, 1.0 mmol, 1.0 equiv) at -65 °C in 20 h. 
The reaction mixture was quenched with a solution of bromine (479 mg, 3.0 mmol, 3.0 equiv) in 5 mL 
Et2O and allowed to warm to 25 °C in 16 h. After complete conversion, the mixture was quenched 
with sat. aq. Na2S2O3 (10 mL) and extracted with EtOAc (3 × 10 mL). The combined organic extracts 
are dried over anhydrous MgSO4, filtered and concentrated in vacuo. Flash column chromatographical 
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purification on silica gel (pentane) afforded (5-iodo-2-fluoro-1,3-phenylene)bis(triethylsilane) (62f, 
288 mg, 64%) as a colorless oil.  
 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.64 (s, 1H), 7.63 (s, 1H), 0.97 (td, J = 8.2, 7.8, 1.2 Hz, 18H), 
0.84 (dtt, J = 7.9, 7.0, 1.0 Hz, 12H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 171.60 (d, J = 236.8 Hz), 145.52 (d, J = 12.5 Hz), 126.54 (d, 
J = 38.9 Hz), 89.50 (d, J = 2.8 Hz), 7.31, 3.37, 3.36. 
19F NMR (375 MHz, CDCl3): δ / ppm = -87.69. 
IR (Diamond-ATR, neat): ~  / cm-1 = 2953, 2910, 2875, 1567, 1457, 1417, 1381, 1308, 1267, 1238, 
1214, 1195, 1115, 1060, 1003, 974, 907, 882, 778, 745, 720, 686. 
MS (EI, 70 eV): m/z (%) = 450 (33), 421 (9), 393 (81), 365 (100), 337 (58), 309 (11), 301 (5), 287 
(31), 279 (9), 259 (25), 209 (5), 181 (7), 168 (15), 154 (14), 133 (10), 115 (10), 105 (45), 87 (17), 77 
(27), 59 (12). 
HRMS (C18H32FISi2): calc.: 450.1071; found: 450.1073 (M+). 
 
4-Fluoro-3,5-bis(triethylsilyl)benzonitrile (62g) 
 
The title compound was prepared according to TP1 from KOtBu (280.5 mg, 2.5 mmol, 2.5 equiv), 
PMDTA (434 mg, 2.5 mmol, 2.5 equiv), s-BuLi (1.85 ml, 1.35 M in ihexane, 2.5 mmol, 2.5 equiv) 
and (2-fluoro-1,3-phenylene)bis(triethylsilane) (57, 324 mg, 1.0 mmol, 1.0 equiv) at -65 °C in 20 h. 
The reaction mixture was quenched with 2,2-dimethylmalononitrile (282 mg, 3.0 mmol, 3.0 equiv) 
and allowed to warm to 25 °C in 16 h. After complete conversion, the mixture was quenched with sat. 
aq. NH4Cl (10 mL) and extracted with EtOAc (3 × 10 mL). The combined organic extracts are dried 
over anhydrous MgSO4, filtered and concentrated in vacuo. Flash column chromatographical 
purification on silica gel (ihexane:EtOAc = 70:1) afforded (4-fluoro-3,5-bis(triethylsilyl)benzonitrile) 
(62g, 175 mg, 50%) as a colorless solid.  
 
m.p.: 26.2 - 26.9 °C. 
1H-NMR (800 MHz, CDCl3): δ / ppm = 7.70 (s, 1H), 7.69 (s, 1H), 1.02 – 0.94 (m, 18H), 0.89 – 0.85 
(m, 12H). 
13C-NMR (200 MHz, CDCl3): δ / ppm = 173.83 (d, J = 245.3 Hz), 141.55 (d, J = 15.0 Hz), 124.86 (d, 
J = 40.3 Hz), 119.20, 108.43 (d, J = 3.9 Hz), 7.24, 3.23, 3.22. 
19F NMR (300 MHz, CDCl3): δ / ppm = -75.62. 
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IR (Diamond-ATR, neat): ~  / cm-1 = 3055, 2953, 2911, 2875, 2361, 2341, 2231, 2183, 1862, 1809, 
1567, 1514, 1456, 1417, 1392, 1309, 1280, 1231, 1200, 1106, 1004, 977, 934, 903, 787, 753, 740, 
719, 694. 
MS (EI, 70 eV): m/z (%) = 349 (4), 320 (25), 292 (77), 264 (100), 236 (43), 194 (3), 180 (36), 158 
(10), 130 (6), 117 (9), 105 (15), 87 (4), 77 (21), 71 (4), 59 (8), 43 (20). 
HRMS (C19H32FNSi2): calc.: 349.2057; found: 349.2055 (M+). 
 
(2-Fluoro-5-methyl-1,3-phenylene)bis(triethylsilane) (62h) 
 
The title compound was prepared according to TP1 from KOtBu (280.5 mg, 2.5 mmol, 2.5 equiv), 
PMDTA (434 mg, 2.5 mmol, 2.5 equiv), s-BuLi (1.85 ml, 1.35 M in ihexane, 2.5 mmol, 2.5 equiv) 
and (2-fluoro-1,3-phenylene)bis(triethylsilane) (57, 324 mg, 1.0 mmol, 1.0 equiv) at -65 °C in 20 h. 
The reaction mixture was quenched with methyl iodine (426 mg, 3.0 mmol, 3.0 equiv) and allowed to 
warm to 25 °C in 16 h. After complete conversion, the mixture was quenched with sat. aq. NH4Cl 
(10 mL) and extracted with EtOAc (3 × 10 mL). The combined organic extracts are dried over 
anhydrous MgSO4, filtered and concentrated in vacuo. Flash column chromatographical purification 
on silica gel (pentane) afforded (2-fluoro-5-methyl-1,3-phenylene)bis(triethylsilane) (62h, 230 mg, 
68%) as a colorless oil.  
 
1H-NMR (600 MHz, CDCl3): δ / ppm = 7.16 (d, J = 0.8 Hz, 1H), 7.15 (d, J = 0.8 Hz, 1H), 2.31 (d, J 
= 1.0 Hz, 3H), 0.99 – 0.93 (m, 18H), 0.83 (pd, J = 7.8, 1.1 Hz, 12H). 
13C-NMR (150 MHz, CDCl3): δ / ppm = 170.48 (d, J = 233.7 Hz), 137.70 (d, J = 12.2 Hz), 132.11, 
123.42, 121.69 (d, J = 36.9 Hz), 20.78, 7.41, 3.53. 
19F NMR (375 MHz, CDCl3): δ / ppm = -90.80. 
IR (Diamond-ATR, neat): ~  / cm-1 = 2952, 2893, 2864, 2727, 1936, 1887, 1696, 1589, 1554, 1462, 
1417, 13802 1266, 1255, 1222, 1214, 1189, 1151, 1114, 1072, 1019, 1004, 972, 924, 878, 816, 801, 
767, 729, 694, 672. 
MS (EI, 70 eV): m/z (%) = 338 (22), 281 (100), 267 (29), 253 (80), 239 (31), 225 (77), 211 (20), 195 
(12), 175 (75), 167 (15), 161 (23), 147 (48), 133 (14), 112 (21), 105 (52), 98 (24), 87 (20), 84 (13), 77 
(51), 59 (20), 43 (36). 
HRMS (EI) (C19H35FSi2): calc.: 338.2261, found: 338.2261 (M+). 
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4.4. Functionalization in meta-Position via Metalation with s-BuLi 
 
(5-Methylthio)-1,3-bis(triethylsilyl)benzene (64a) 
 
The title compound was prepared according to TP1 from KOtBu (280.5 mg, 2.5 mmol, 2.5 equiv), 
PMDTA (434 mg, 2.5 mmol, 2.5 equiv), s-BuLi (1.85 ml, 1.35 M in ihexane, 2.5 mmol, 2.5 equiv) 
and (1,3-bis(triethylsilyl)benzene (60, 306 mg, 1.0 mmol, 1.0 equiv) at -65 °C in 20 h. The reaction 
mixture was quenched with dimethyl disulfide (283 mg, 3.0 mmol, 3.0 equiv) and allowed to warm to 
25 °C in 16 h. After complete conversion, the mixture was quenched with sat. aq. NH4Cl (10 mL) and 
extracted with EtOAc (3 × 10 mL). The combined organic extracts are dried over anhydrous MgSO4, 
filtered and concentrated in vacuo. Flash column chromatographical purification on silica gel 
(pentane) afforded (5-methylthio)-1,3-bis(triethylsilyl)benzene (64a, 201 mg, 57%) as a colorless oil. 
  
1H-NMR (400 MHz, DMSO-d6): δ / ppm = 7.29 – 7.27 (m, 1H), 7.26 (d, J = 1.0 Hz, 2H), 2.43 (s, 
3H), 0.87 (td, J = 7.8, 1.1 Hz, 18H), 0.71 (qd, J = 7.5, 1.4 Hz, 12H). 
13C-NMR (100 MHz, DMSO-d6): δ / ppm = 137.47, 136.78, 136.55, 132.21, 15.16, 7.68, 3.20. 
IR (Diamond-ATR, neat): ~  / cm-1 = 2952, 2909, 2874, 2809, 1548, 1522, 1507, 1457, 1416, 1378, 
1363, 1321, 1310, 1236, 1141, 1119, 1067, 1003, 967, 854, 795, 716, 688. 
MS (EI, 70 eV): m/z (%) = 352 (98), 323 (89), 295 (65), 267 (100), 182 (12), 147 (12), 133 (25), 119 
(29), 111 (9), 105 (27), 97 (14), 91 (14), 85 (38), 71 (48), 57 (67), 43 (41). 
HRMS (C19H36SSi2): calc.: 352.2076; found: 352.2074 (M+). 
 
(5-Iodo)-1,3-bis(triethylsilyl)benzene (64b) 
 
The title compound was prepared according to TP1 from KOtBu (280.5 mg, 2.5 mmol, 2.5 equiv), 
PMDTA (434 mg, 2.5 mmol, 2.5 equiv), s-BuLi (1.85 ml, 1.35 M in ihexane, 2.5 mmol, 2.5 equiv) 
and (1,3-bis(triethylsilyl)benzene (60, 306 mg, 1.0 mmol, 1.0 equiv) at -65 °C in 20 h. The reaction 
mixture was quenched with iodine (768 mg, 3.0 mmol, 3.0 equiv) and allowed to warm to 25 °C in 
16 h. After complete conversion, the mixture was quenched with sat. aq. NH4Cl (10 mL) and extracted 
with EtOAc (3 × 10 mL). The combined organic extracts are dried over anhydrous MgSO4, filtered 
and concentrated in vacuo. Flash column chromatographical purification on silica gel (pentane) 
afforded (5-iodo)-1,3-bis(triethylsilyl)benzene (64b, 199 mg, 46%) as a colorless oil.  
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1H-NMR (400 MHz, CDCl3): δ / ppm = 7.69 (d, J = 1.0 Hz, 2H), 7.45 (t, J = 1.0 Hz, 1H), 0.95 – 0.85 
(m, 18H), 0.77 – 0.65 (m, 12H).  
13C-NMR (100 MHz, CDCl3): δ / ppm = 142.85, 140.14, 138.70, 96.72, 7.32, 3.27. 
IR (Diamond-ATR, neat): ~  / cm-1 = 2951, 2907, 2872, 2828, 2806, 1552, 1528, 1455, 1413, 1366, 
1345, 1307, 1235, 1134, 1099, 1002, 972, 860, 787, 717, 688. 
MS (EI, 70 eV): m/z (%) = 432 (13), 403 (100), 391 (6), 375 (45), 347 (44), 290 (5), 263 (7), 187 
(10), 173 (13), 163 (7), 159 (16), 145 (13), 131 (6), 105 (4), 87 (12), 71 (3), 59 (8). 
HRMS (C18H33ISi2): calc.: 432.1165; found: 432.1161 (M+). 
 
N-Phenyl-3,5-bis(triethylsilyl)benzamide (64c) 
 
The title compound was prepared according to TP1 from KOtBu (280.5 mg, 2.5 mmol, 2.5 equiv), 
PMDTA (434 mg, 2.5 mmol, 2.5 equiv), s-BuLi (1.85 ml, 1.35 M in ihexane, 2.5 mmol, 2.5 equiv) 
and (1,3-bis(triethylsilyl)benzene (60, 306 mg, 1.0 mmol, 1.0 equiv) at -65 °C in 20 h. The reaction 
mixture was quenched with isocyanatobenzene (357 mg, 3.0 mmol, 3.0 equiv) and allowed to warm to 
25 °C in 16 h. After complete conversion, the mixture was quenched with sat. aq. NH4Cl (10 mL) and 
extracted with EtOAc (3 × 10 mL). The combined organic extracts are dried over anhydrous MgSO4, 
filtered and concentrated in vacuo. Flash column chromatographical purification on silica gel 
(pentane) afforded N-phenyl-3,5-bis(triethylsilyl)benzamide (64c, 170 mg, 40%) as a colorless solid.  
 
m.p.: 145.9 - 147.8 °C. 
1H-NMR (800 MHz, CDCl3): δ / ppm = 7.93 (s, 1H), 7.80 (s, 1H), 7.77 (s, 1H), 7.67 (d, J = 7.9 Hz, 
2H), 7.40 (t, J = 7.3 Hz, 2H), 7.18 (t, J = 7.4 Hz, 1H), 1.00 (m, 18H), 0.89 – 0.83 (m, 12H). 
13C-NMR (200 MHz, CDCl3): δ / ppm = 165.90, 142.55, 137.02, 136.29, 132.67, 131.78, 128.05, 
123.47, 119.16, 6.36, 2.30. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3287, 3270, 2953, 2909, 2874, 1640, 1600, 1573, 1537, 1500, 
1442, 1415, 1378, 1331, 1316, 1268, 1238, 1179, 1141, 1103, 1079, 1003, 960, 926, 900, 796, 754, 
717, 687. 
MS (EI, 70 eV): m/z (%) = 425 (22), 396 (41), 368 (25), 340 (17), 333 (100), 310 (2), 221 (5), 196 
(3), 183 (8), 170 (5), 155 (11), 141 (12), 127 (6), 115 (5), 87 (18), 59 (6). 
HRMS (C25H39NOSi2): calc.: 425.2570; found: 425.2564 (M+). 
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Ethyl 3,5-bis(triethylsilyl)benzoate (64d) 
 
The title compound was prepared according to TP1 from KOtBu (280.5 mg, 2.5 mmol, 2.5 equiv), 
PMDTA (434 mg, 2.5 mmol, 2.5 equiv), s-BuLi (1.85 ml, 1.35 M in ihexane, 2.5 mmol, 2.5 equiv) 
and (1,3-bis(triethylsilyl)benzene (60, 306 mg, 1.0 mmol, 1.0 equiv) at -65 °C in 20 h. The reaction 
mixture was quenched with ethyl chloroformate (313 mg, 3.0 mmol, 3.0 equiv) and allowed to warm 
to 25 °C in 16 h. After complete conversion, the mixture was quenched with sat. aq. NH4Cl (10 mL) 
and extracted with EtOAc (3 × 10 mL). The combined organic extracts are dried over anhydrous 
MgSO4, filtered and concentrated in vacuo. Flash column chromatographical purification on silica gel 
(pentane) afforded ethyl 3,5-bis(triethylsilyl)benzoate (64d, 133 mg, 35%) as a colorless oil.  
 
1H-NMR (800 MHz, CDCl3): δ / ppm = 8.15 (d, J = 1.2 Hz, 1H), 7.90 (d, J = 1.2 Hz, 1H), 7.28 (s, 
1H), 4.41 (q, J = 7.1 Hz, 2H), 1.42 (t, J = 7.1 Hz, 3H), 0.95 – 0.85 (m, 18H), 0.86 – 0.79 (m, 12H).  
13C-NMR (200 MHz, CDCl3): δ / ppm = 197.55, 143.46, 139.44, 134.94, 134.48, 59.80, 13.37, 6.35, 
2.29, 2.28. 
IR (Diamond-ATR, neat): ~  / cm-1 = 2952, 2912, 2874, 1748, 1686, 1578, 1456, 1422, 1388, 1292, 
1218, 1160, 1102, 1010, 960, 912, 783, 752, 654. 
MS (EI, 70 eV): m/z (%) = 349 (30), 321 (11), 293 (13), 113 (18), 111 (11), 97 816), 90 (20), 83 (28), 
71 (62), 57 (70), 44 (100), 41 (43). 
HRMS (C19H33O2Si2): calc.: 349.2025; found: 349.2015 (M+-Et). 
 
 
4.5. Functionalization in para-Position via Exchange with n-BuLi 
 
(2-Fluoro-5-(trimethylsilyl)-1,3-phenylene)bis(triethylsilane) (66a) 
 
The title compound was prepared according to TP2 from (5-bromo-2-fluoro-1,3-
phenylene)bis(triethylsilane) (62e, 121 mg, 0.3 mmol, 1.0 equiv) and n-BuLi (59, 0.13 ml, 2.60 M in 
ihexane, 0.33 mmol, 1.1 equiv) at -78 °C in 1 h. The reaction mixture was quenched with 
trimethylsilyl chloride (49 mg, 0.45 mmol, 1.5 equiv) and allowed to warm to 25 °C in 16 h. After 
complete conversion, the mixture was quenched with sat. aq. NH4Cl (10 mL) and extracted with 
EtOAc (3 × 10 mL). The combined organic extracts are dried over anhydrous MgSO4, filtered and 
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concentrated in vacuo. Flash column chromatographical purification on silica gel (pentane) afforded 
(2-fluoro-5-(trimethylsilyl)-1,3-phenylene)bis(triethylsilane) (66a, 109 mg, 92%) as a colorless oil.  
 
1H-NMR (600 MHz, CDCl3): δ / ppm = 7.54 (s, 1H), 7.53 (s, 1H), 0.97 (t, J = 7.7 Hz, 18H), 0.87 – 
0.82 (m, 12H), 0.26 (s, 9H). 
13C-NMR (150 MHz, CDCl3): δ / ppm = 173.17 (d, J = 238.1 Hz), 142.60 (d, J = 13.5 Hz), 134.16, 
121.15 (d, J = 36.3 Hz), 7.42, 3.63, -0.93. 
19F NMR (375 MHz, CDCl3): δ / ppm = -84.30. 
IR (Diamond-ATR, neat): ~  / cm-1 = 2954, 2911, 2876, 1574, 1566, 1458, 1417, 1381, 1237, 1222, 
1198, 1140, 1099, 1011, 972, 823, 777, 748, 719, 674, 620. 
MS (EI, 70 eV): m/z (%) = 396 (4), 381 (31), 353 (16), 339 (71), 311 (48), 283 (52), 275 (20), 246 
(22), 218 (46), 162 (9), 141 (11), 127 (9), 97 (12), 87 (18), 83 (10), 77 (10), 71 (14), 59 (15), 57 (30), 
42 (100), 39 (17). 
HRMS (C21H41FSi3): calc.: 396.2500, found: 396.2498 (M+). 
 
(2-Fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-phenylene)bis(triethylsilane) (66b) 
 
The title compound was prepared according to TP2 from (5-bromo-2-fluoro-1,3-
phenylene)bis(triethylsilane) (62e, 121 mg, 0.3 mmol, 1.0 equiv) and n-BuLi (59, 0.13 ml, 2.60 M in 
ihexane, 0.33 mmol, 1.1 equiv) at -78 °C in 1 h. The reaction mixture was quenched with iPrO-BPin 
(93 mg, 0.45 mmol, 1.5 equiv) and allowed to warm to 25 °C in 16 h. After complete conversion, the 
mixture was quenched with sat. aq. NH4Cl (10 mL) and extracted with EtOAc (3 × 10 mL). The 
combined organic extracts are dried over anhydrous MgSO4, filtered and concentrated in vacuo. Flash 
column chromatographical purification on silica gel (ihexane:EtOAc = 100:1) afforded (2-fluoro-5-
(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-phenylene)bis(triethylsilane) (66b, 119 mg, 88%) as 
a colorless solid.  
 
m.p.: 62.8 - 64.2 °C. 
1H-NMR (600 MHz, CDCl3): δ / ppm = 7.83 (s, 1H), 7.82 (s, 1H), 1.32 (s, 12H), 0.97 – 0.91 (m, 
18H), 0.84 (dt, J = 9.2, 7.4 Hz, 12H). 
13C-NMR (150 MHz, CDCl3): δ / ppm = 174.50 (d, J = 240.5 Hz), 144.62 (d, J = 14.4 Hz), 144.40, 
121.27 (d, J = 37.1 Hz), 83.59, 24.85, 7.39, 3.48.  
19F NMR (375 MHz, CDCl3): δ / ppm = -58.28. 
IR (Diamond-ATR, neat): ~  / cm-1 = 2952, 2909, 2872, 1567, 1455, 1425, 1369, 1345, 1311, 1271, 
1254, 1240, 1220, 1193, 1128, 1004, 964, 911, 852, 832, 787, 755, 723, 701, 667. 
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MS (EI, 70 eV): m/z (%) = 450 (2), 421 (13), 393 (100), 365 (33), 351 (5), 337 (49), 321 (32), 293 
(5), 281 (11), 265 (12), 237 (11), 209 (5), 181 (10), 168 (7), 154 (5), 105 (5), 87 (9), 83 (12), 77 (11), 
59 (6), 41 (6). 
HRMS (C24H44BFO2Si2): calc.: 450.2957, found: 450.2970 (M+). 
 
4-Fluoro-3,5-bis(triethylsilyl)phenol (66c) 
 
The title compound was prepared according to TP2 from (5-bromo-2-fluoro-1,3-
phenylene)bis(triethylsilane) (62e, 121 mg, 0.3 mmol, 1.0 equiv) and n-BuLi (59, 0.13 ml, 2.60 M in 
ihexane, 0.33 mmol, 1.1 equiv) at -78 °C in 1 h. The reaction mixture was quenched with trimethyl 
borate (47 mg, 0.45 mmol, 1.5 equiv) and allowed to warm to 25 °C in 6 h. The reaction mixture was 
cooled to -70°C, NaOH (2 mL, 3 M) and H2O2 (2 mL, 30% in H2O) was added simultaneously and 
allowed to warm to 25 °C within 16 h. The mixture was quenched with sat. aq. NH4Cl (10 mL) and 
extracted with Et2O (3 × 10 mL). The combined organic extracts are dried over anhydrous MgSO4, 
filtered and concentrated in vacuo. Flash column chromatographical purification on silica gel 
(ihexane:EtOAc = 20:1) afforded 4-fluoro-3,5-bis(triethylsilyl)phenol (66c, 82 mg, 80%) as a colorless 
oil.  
 
1H-NMR (400 MHz, DMSO-d6): δ / ppm = 9.17 (s, 1H), 6.76 (d, J = 4.3 Hz, 2H), 0.96 – 0.87 (m, 
18H), 0.81 – 0.70 (m, 12H). 
13C-NMR (150 MHz, DMSO-d6): δ / ppm = 165.09 (d, J = 225.2 Hz), 153.46 (d, J = 1.7 Hz), 123.29 
(d, J = 12.5 Hz), 122.41 (d, J = 39.1 Hz), 7.75, 3.55, 3.53. 
19F NMR (375 MHz, DMSO-d6): δ / ppm = -100.24. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3293, 2954, 2910, 2876, 1593, 1572, 1457, 1416, 1389, 1314, 
1238, 1205, 1183, 1099, 1004, 974, 873, 789, 763, 737, 717, 690. 
MS (EI, 70 eV): m/z (%) = 340 (85), 283 (55), 255 (100), 227 (72), 197 (12), 189 (74), 177 (26), 171 
(39), 160 (14), 149 (35), 133 (31), 113 (16), 105 (19), 99 (17), 87 (17), 77 (30), 59 (16), 43 (17). 
HRMS (C18H33FOSi2): calc.: 340.2054, found: 340.2050 (M+). 
 
4-Fluoro-3,5-bis(triethylsilyl)benzoic acid (66d) 
 
The title compound was prepared according to TP2 from (5-bromo-2-fluoro-1,3-
phenylene)bis(triethylsilane) (62e, 121 mg, 0.3 mmol, 1.0 equiv) and n-BuLi (59, 0.13 ml, 2.60 M in 
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ihexane, 0.33 mmol, 1.1 equiv) at -78 °C in 1 h. The reaction mixture poured on freshly crushed dry 
ice, allowed to warm to 25 °C within 4 h and sat. aq. NH4Cl (10 mL) was added. The mixture was 
extracted with EtOAc (3 × 10 mL) and the combined organic extracts are dried over anhydrous 
MgSO4, filtered and concentrated in vacuo. Flash column chromatographical purification on silica gel 
(ihexane:EtOAc = 10:1) afforded (2-fluoro-5-(methylthio)-1,3-phenylene)bis(triethylsilane) (66d, 
78 mg, 0.66 mmol, 71%) as a colorless solid.  
 
m.p.: 110.5 - 112.2 °C. 
1H-NMR (400 MHz, DMSO-d6): δ / ppm = 12.92 (s, 1H), 7.94 (s, 1H), 7.93 (s, 1H), 0.88 – 0.78 (m, 
18H), 0.79 – 0.69 (m, 12H).  
13C-NMR (101 MHz, DMSO-d6): δ / ppm = 174.51 (d, J = 241.4 Hz), 167.22, 139.57 (d, J = 14.1 
Hz), 127.16 (d, J = 2.5 Hz), 122.44 (d, J = 38.6 Hz), 7.62, 3.41, 3.40. 
19F NMR (375 MHz, DMSO-d6): δ / ppm = -80.38. 
IR (Diamond-ATR, neat): ~  / cm-1 = 2952, 2914, 2874, 2734, 2652, 2554, 1686, 1576, 1456, 1418, 
1382, 1290, 1220, 1162, 1102, 1004, 960, 902, 784, 752, 714, 652. 
HRMS (ESI) (C19H32FO2Si2): calc.: 367.1930, found: 367.1937 (M+-H). 
 
N,N-Diethyl-4-fluoro-3,5-bis(triethylsilyl)benzamide (66e) 
 
The title compound was prepared according to TP2 from (5-bromo-2-fluoro-1,3-
phenylene)bis(triethylsilane) (62e, 121 mg, 0.3 mmol, 1.0 equiv) and n-BuLi (59, 0.13 ml, 2.60 M in 
ihexane, 0.33 mmol, 1.1 equiv) at -78 °C in 1 h. The reaction mixture was quenched with 
diethylcarbamic chloride (61 mg, 0.45 mmol, 1.5 equiv) and allowed to warm to 25 °C in 16 h. After 
complete conversion, the mixture was quenched with sat. aq. NH4Cl (10 mL) and extracted with 
EtOAc (3 × 10 mL). The combined organic extracts are dried over anhydrous MgSO4, filtered and 
concentrated in vacuo. Flash column chromatographical purification on silica gel (ihexane:EtOAc = 
40:1) afforded N,N-diethyl-4-fluoro-3,5-bis(triethylsilyl)benzamide (66e, 108 mg, 85%) as a colorless 
oil.  
 
1H-NMR (600 MHz, CDCl3): δ / ppm = 7.39 (s, 1H), 7.38 (s, 1H), 3.54 (s, 2H), 3.23 (s, 2H), 1.24 (m, 
3H), 1.16 – 1.10 (m, 3H), 0.94 (t, J = 7.7 Hz, 18H), 0.87 – 0.79 (m, 12H).  
13C-NMR (150 MHz, CDCl3): δ / ppm = 172.31 (d, J = 239.7 Hz), 171.47, 135.56 (d, J = 13.0 Hz), 
132.43, 122.47 (d, J = 38.2 Hz), 43.37, 39.43, 14.23, 12.91, 7.33, 3.38. 
19F NMR (375 MHz, CDCl3): δ / ppm = -83.75. 
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IR (Diamond-ATR, neat): ~  / cm-1 = 2954, 2911, 2875, 1634, 1572, 1540, 1522, 1507, 1457, 1426, 
1389, 1348, 1314, 1286, 1239, 1220, 1195, 1116, 1069, 1004, 974, 946, 904, 831, 799, 749, 721, 689. 
MS (EI, 70 eV): m/z (%) = 423 (73), 394 (100), 366 (59), 351 (43), 338 (90), 310 (62), 237 (6), 209 
(14), 175 (5), 161 (10), 153 (6), 140 (7), 133 (14), 126 (6), 105 (8), 87 (10), 77 (13), 59 (9). 
HRMS (C23H42FNOSi2): calc.: 423.2789, found: 423.2787 (M+). 
 
4-Fluoro-3,5-bis(triethylsilyl)benzaldehyde (66f) 
 
The title compound was prepared according to TP2 from (5-bromo-2-fluoro-1,3-
phenylene)bis(triethylsilane) (62e, 121 mg, 0.3 mmol, 1.0 equiv) and n-BuLi (59, 0.13 ml, 2.60 M in 
ihexane, 0.33 mmol, 1.1 equiv) at -78 °C in 1 h. The reaction mixture was quenched with with 
morpholine-4-carbaldehyde (52 mg, 0.45 mmol, 1.5 equiv) and allowed to warm to 25 °C in 16 h. 
After complete conversion, the mixture was quenched with sat. aq. NH4Cl (10 mL) and extracted with 
EtOAc (3 × 10 mL). The combined organic extracts are dried over anhydrous MgSO4, filtered and 
concentrated in vacuo. Flash column chromatographical purification on silica gel (ihexane:EtOAc = 
50:1) afforded 4-fluoro-3,5-bis(triethylsilyl)benzaldehyde (66f, 69 mg, 65%) as a colorless oil.  
 
1H-NMR (600 MHz, CDCl3): δ / ppm = 9.96 (s, 1H), 7.91 (s, 1H), 7.90 (s, 1H), 0.99 – 0.92 (m, 18H), 
0.89 – 0.83 (m, 12H). 
13C-NMR (150 MHz, CDCl3): δ / ppm = 191.46, 175.67 (d, J = 246.5 Hz), 139.89 (d, J = 16.6 Hz), 
132.22 (d, J = 13.3 Hz), 123.89 (d, J = 40.1 Hz), 7.29, 3.30. 
19F NMR (375 MHz, CDCl3): δ / ppm = -75.00. 
IR (Diamond-ATR, neat): ~  / cm-1 = 2954, 2933, 2913, 2876, 1694, 1568, 1458, 1417, 1391, 1365, 
1217, 1194, 1095, 1004, 929, 897, 795, 772, 754, 720, 688. 
MS (EI, 70 eV): m/z (%) = 352 (2), 323 (18), 295 (85), 267 (100), 239 (58), 211 (11), 183 (25), 161 
(10), 133 (8), 105 (17), 77 (13). 
HRMS (C17H28FOSi2): calc.: 323.1663, found: 323.1664 (M+-Et). 
 
(4-Fluoro-3,5-bis(triethylsilyl)phenyl)(4-(methylthio)phenyl)methanol (66g) 
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The title compound was prepared according to TP2 from (5-bromo-2-fluoro-1,3-
phenylene)bis(triethylsilane) (62e, 121 mg, 0.3 mmol, 1.0 equiv) and n-BuLi (59, 0.13 ml, 2.60 M in 
ihexane, 0.33 mmol, 1.1 equiv) at -78 °C in 1 h. The reaction mixture was quenched with 
4-(methylthio)benzaldehyde (69 mg, 0.45 mmol, 1.5 equiv) and allowed to warm to 25 °C in 16 h. 
After complete conversion, the mixture was quenched with sat. aq. NH4Cl (10 mL) and extracted with 
EtOAc (3 × 10 mL). The combined organic extracts are dried over anhydrous MgSO4, filtered and 
concentrated in vacuo. Flash column chromatographical purification on silica gel (ihexane:EtOAc = 
30:1) afforded (4-fluoro-3,5-bis(triethylsilyl)phenyl)(4-(methylthio)phenyl)methanol (66g, 99 mg, 
69%) as a colorless oil.  
 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.38 (d, J = 0.6 Hz, 1H), 7.37 (d, J = 0.6 Hz, 1H), 7.34 – 7.27 
(m, 2H), 7.30 – 7.22 (m, 2H), 5.82 (s, 1H), 2.50 (s, 3H), 0.96 (t, J = 7.7 Hz, 18H), 0.86 – 0.80 (m, 
12H). 
13C-NMR (150 MHz, CDCl3): δ / ppm = 171.66 (d, J = 236.5 Hz), 140.85, 138.16 (d, J = 2.9 Hz), 
137.56, 135.70 (d, J = 12.8 Hz), 126.95, 126.66, 122.35 (d, J = 37.8 Hz), 75.71 (d, J = 1.4 Hz), 15.94, 
7.43, 3.52, 3.51. 
19F NMR (375 MHz, CDCl3): δ / ppm = -87.06. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3277, 2953, 2909, 2874, 1599, 1576, 1494, 1457, 1390, 1316, 
1283, 1237, 1194, 1100, 1006, 968, 922, 902, 824, 788, 748, 715, 688. 
MS (EI, 70 eV): m/z (%) = 476 (57), 460 (14), 445 (16), 419 (61), 403 (17), 391 (88), 375 (35), 363 
(43), 325 (50), 297 (17), 269 (13), 195 (16), 167 (13), 153 (41), 145 (20), 137 (24), 105 (19), 87 (14), 
77 (36), 59 (14), 44 (100). 
HRMS (C26H41FOSSi2): calc.: 476.2401, found: 476.2388 (M+). 
 
(3-Chlorophenyl)(4-fluoro-3,5-bis(triethylsilyl)phenyl)methanol (66h) 
 
The title compound was prepared according to TP2 from (5-bromo-2-fluoro-1,3-
phenylene)bis(triethylsilane) (62e, 121 mg, 0.3 mmol, 1.0 equiv) and n-BuLi (59, 0.13 ml, 2.60 M in 
ihexane, 0.33 mmol, 1.1 equiv) at -78 °C in 1 h. The reaction mixture was quenched with 
3-chlorobenzaldehyde (63 mg, 0.45 mmol, 1.5 equiv) and allowed to warm to 25 °C in 16 h. After 
complete conversion, the mixture was quenched with sat. aq. NH4Cl (10 mL) and extracted with 
EtOAc (3 × 10 mL). The combined organic extracts are dried over anhydrous MgSO4, filtered and 
concentrated in vacuo.  
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Flash column chromatographical purification on silica gel (ihexane:EtOAc = 40:1) afforded (3-
chlorophenyl)(4-fluoro-3,5-bis(triethylsilyl)phenyl)methanol (66h, 103 mg, 74%) as a colorless solid.  
 
m.p.: 59.9 - 61.2 °C. 
1H-NMR (400 MHz, DMSO-d6): δ / ppm = 7.43 – 7.41 (m, 3H), 7.37 – 7.30 (m, 2H), 7.27 (dt, J = 
7.1, 2.1 Hz, 1H), 6.06 (d, J = 4.2 Hz, 1H), 5.76 (d, J = 4.2 Hz, 1H), 0.89 (t, J = 7.7 Hz, 18H), 0.82 – 
0.71 (m, 12H). 
13C-NMR (100 MHz, DMSO-d6): δ / ppm = 175.83 (d, J = 234.2 Hz), 153.41, 145.35 (d, J = 2.7 Hz), 
140.77 (d, J = 12.5 Hz), 138.04, 135.24, 131.82, 131.09, 129.92, 126.07 (d, J = 37.5 Hz), 78.11, 12.45, 
8.36, 8.34.  
19F NMR (375 MHz, DMSO-d6): δ / ppm = -84.48. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3283, 2954, 2909, 2876, 1597, 1576, 1457, 1433, 1417, 1390, 
1312, 1284, 1237, 1195, 1100, 1078, 1006, 973, 928, 880, 855, 785, 750, 720, 688, 654. 
MS (EI, 70 eV): m/z (%) = 464 (12), 407 (100), 379 (70), 351 (55), 333 (7), 313 (66), 303 (7), 277 
(7), 257 (9), 229 (11), 193 (11), 165 (16), 147 (8), 138 (13), 105 (11), 87 (18), 77 (25), 59 (14). 
HRMS (C25H38ClFOSi2): calc.: 464.2134, found: 464.2130 (M+). 
 
Cyclopropyl(4-fluoro-3,5-bis(triethylsilyl)phenyl)methanone (66i) 
 
The title compound was prepared according to TP2 from (5-bromo-2-fluoro-1,3-
phenylene)bis(triethylsilane) (62e, 121 mg, 0.3 mmol, 1.0 equiv) and n-BuLi (59, 0.13 ml, 2.60 M in 
ihexane, 0.33 mmol, 1.1 equiv) at -78 °C in 1 h. Subsequently, the acylation reaction was 
accomplished according to TP3 with CuCN·2LiCl (0.36 mL, 0.36 mmol, 1.0 M in THF, 1.2 equiv) 
and cyclopropanecarbonyl chloride (43 mg, 0.45 mmol, 1.5 equiv) and allowed to warm to 25 °C in 
16 h. After complete conversion, the mixture was quenched with sat. aq. NH4Cl (10 mL) and extracted 
with EtOAc (3 × 10 mL). The combined organic extracts are dried over anhydrous MgSO4, filtered 
and concentrated in vacuo Flash column chromatographical purification on silica gel (ihexane:EtOAc 
= 50:1) afforded cyclopropyl(4-fluoro-3,5-bis(triethylsilyl)phenyl)methanone (66i, 89 mg, 76%) as a 
colorless oil.  
 
1H-NMR (600 MHz, CDCl3): δ / ppm = 8.07 (s, 1H), 8.07 (s, 1H), 2.63 (tt, J = 7.8, 4.5 Hz, 1H), 1.27 
– 1.21 (m, 2H), 1.07 – 1.01 (m, 2H), 0.97 (m, 18H), 0.91 – 0.83 (m, 12H). 
13C-NMR (150 MHz, CDCl3): δ / ppm = 199.89, 174.81 (d, J = 244.0 Hz), 137.96 (d, J = 15.9 Hz), 
133.67, 122.77 (d, J = 39.3 Hz), 16.98, 11.59, 7.33, 3.41. 
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19F NMR (375 MHz, CDCl3): δ / ppm = -78.67. 
IR (Diamond-ATR, neat): ~  / cm-1 = 2954, 2911, 2876, 2812, 2361, 2341, 1751, 1670, 1567, 1521, 
1506, 1457, 1417, 1379, 1289, 1238, 1218, 1144, 1105, 1063, 1043, 1014, 975, 913, 895, 873, 843, 
785, 757, 738, 717, 688. 
MS (EI, 70 eV): m/z (%) = 392 (4), 363 (23), 335 (100), 307 (67), 279 (54), 257 (4), 249 (3), 223 
(15), 201 (5), 153 (3), 139 (9), 128 (3), 125 (6), 110 (3), 105 (5), 87 (9), 77 (15), 69 (9), 59 (10), 41 
(5). 
HRMS (C22H37FOSi2): calc.: 392.2367, found: 392.2363 (M+). 
 
(4-(tert-Butyl)phenyl)(4-fluoro-3,5-bis(triethylsilyl)phenyl)methanone (66j) 
 
The title compound was prepared according to TP2 from (5-bromo-2-fluoro-1,3-
phenylene)bis(triethylsilane) (62e, 121 mg, 0.3 mmol, 1.0 equiv) and n-BuLi (59, 0.13 ml, 2.60 M in 
ihexane, 0.33 mmol, 1.1 equiv) at -78 °C in 1 h. Subsequently, the acylation reaction was 
accomplished according to TP3 with CuCN·2LiCl (0.36 mL, 0.36 mmol, 1.0 M in THF, 1.2 equiv) 
and 4-tert-butylbenzoyl chloride (88 mg, 0.45 mmol, 1.5 equiv) and allowed to warm to 25 °C in 16 h. 
After complete conversion, the mixture was quenched with sat. aq. NH4Cl (10 mL) and extracted with 
EtOAc (3 × 10 mL). The combined organic extracts are dried over anhydrous MgSO4, filtered and 
concentrated in vacuo Flash column chromatographical purification on silica gel (ihexane:EtOAc = 
30:1) afforded (4-(tert-butyl)phenyl)(4-fluoro-3,5-bis(triethylsilyl)phenyl)methanone (66j, 105 mg, 
72%) as a colorless oil.  
 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.88 (s, 1H), 7.86 (s, 1H), 7.82 – 7.74 (m, 2H), 7.54 – 7.49 
(m, 2H), 1.40 (s, 9H), 1.03 – 0.94 (m, 18H), 0.93 – 0.82 (m, 12H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 195.80, 174.46 (d, J = 243.4 Hz), 156.16, 139.89 (d, J = 
14.0 Hz), 134.92, 133.36 (d, J = 2.7 Hz), 130.11, 125.19, 122.58 (d, J = 38.6 Hz), 35.13, 31.16, 7.38, 
3.45, 3.43. 
19F NMR (375 MHz, CDCl3): δ / ppm = -79.11. 
IR (Diamond-ATR, neat): ~  / cm-1 = 2954, 2910, 2875, 2734, 2362, 1657, 1606, 1566, 1459, 1379, 
1314, 1276, 1239, 1222, 1199, 1169, 1100, 1004, 975, 922, 848, 789, 770, 754, 722, 688, 663. 
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MS (EI, 70 eV): m/z (%) = 484 (7), 455 (93), 427 (100), 399 (86), 371 (65), 341 (6), 315 (11), 206 
(8), 192 (26), 178 (29), 164 (11), 161 (12), 150 (23), 136 (14), 105 (7), 87 (5), 77 (13), 57 (18), 44 
(15). 
HRMS (C29H45FOSi2): calc.: 484.2993, found: 484.3003 (M+). 
 
(4-fluoro-3,5-bis(triethylsilyl)phenyl)(4-(methylthio)phenyl)methanone (66k) 
 
The title compound was prepared according to TP2 from (5-bromo-2-fluoro-1,3-
phenylene)bis(triethylsilane) (62e, 121 mg, 0.3 mmol, 1.0 equiv) and n-BuLi (59, 0.13 ml, 2.60 M in 
ihexane, 0.33 mmol, 1.1 equiv) at -78 °C in 1 h. Subsequently, the acylation reaction was 
accomplished according to TP3 with CuCN·2LiCl (0.36 mL, 0.36 mmol, 1.0 M in THF, 1.2 equiv) 
and 4-(thiomethyl)benzoyl chloride (560 mg, 3.0 mmol, 3.0 equiv) and allowed to warm to 25 °C in 
16 h. After complete conversion, the mixture was quenched with sat. aq. NH4Cl (10 mL) and extracted 
with EtOAc (3 × 10 mL). The combined organic extracts are dried over anhydrous MgSO4, filtered 
and concentrated in vacuo. Flash column chromatographical purification on silica gel (ihexane:EtOAc 
= 50:1) afforded (4-fluoro-3,5-bis(triethylsilyl)phenyl)(4-(methylthio)phenyl)methanone (66k, 80 mg, 
56%) as a colorless solid.  
 
m.p.: 71.0 - 72.9 °C 
1H-NMR (600 MHz, CDCl3): δ / ppm = 7.82 (s, 1H), 7.82 (s, 1H), 7.75 – 7.73 (m, 2H), 7.30 – 7.29 
(m, 2H), 2.55 (s, 3H), 0.99 – 0.93 (m, 18H), 0.88 – 0.81 (m, 12H). 
13C-NMR (150 MHz, CDCl3): δ / ppm = 195.16, 174.43 (d, J = 243.6 Hz), 145.12, 139.77 (d, J = 
15.9 Hz), 133.84, 133.22, 130.60, 124.76, 122.68 (d, J = 39.1 Hz), 14.85, 7.34, 3.39. 
19F NMR (375 MHz, CDCl3): δ / ppm = -78.93. 
IR (Diamond-ATR, neat): ~  / cm-1 = 2953, 2909, 2874, 1717, 1646, 1586, 1566, 1456, 1435, 1378, 
1325, 1283, 1269, 1239, 1220, 1196, 1169, 1092, 1003, 969, 919, 840, 786, 762, 750, 719, 686, 660. 
MS (EI, 70 eV): m/z (%) = 474 (4), 445 (7), 417 (7), 389 (8), 361 (7), 225 (6), 197 (8), 183 (7), 155 
(11), 141 (12), 127 (16), 113 (19), 99 (28), 85 (65), 71 (82), 57 (100), 43 (46). 
HRMS (C26H39FOSSi2): calc.: 474.2244, found: 474.2230 (M+). 
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(5-Allyl-2-fluoro-1,3-phenylene)bis(triethylsilane) (66l) 
 
The title compound was prepared according to TP2 from (5-bromo-2-fluoro-1,3-
phenylene)bis(triethylsilane) (62e, 121 mg, 0.3 mmol, 1.0 equiv) and n-BuLi (59, 0.13 ml, 2.60 M in 
ihexane, 0.33 mmol, 1.1 equiv) at -78 °C in 1 h. Subsequently, the allylation reaction was 
accomplished according to TP3 with CuCN·2LiCl (0.36 mL, 0.36 mmol, 1.0 M in THF, 1.2 equiv) 
and allyl bromide (54 mg, 0.45 mmol, 1.5 equiv) and allowed to warm to 25 °C in 16 h. After 
complete conversion, the mixture was quenched with sat. aq. NH4Cl (10 mL) and extracted with 
EtOAc (3 × 10 mL). The combined organic extracts are dried over anhydrous MgSO4, filtered and 
concentrated in vacuo. Flash column chromatographical purification on silica gel (pentane) afforded 
(5-allyl-2-fluoro-1,3-phenylene)bis(triethylsilane) (66l, 95 mg, 87%) as a colorless oil.  
 
1H-NMR (600 MHz, CDCl3): δ / ppm = 7.17 (d, J = 0.8 Hz, 1H), 7.16 (d, J = 0.7 Hz, 1H), 6.03 – 5.90 
(m, 1H), 5.07 (t, J = 1.5 Hz, 1H), 5.07 – 5.02 (m, 1H), 3.36 (m, 2H), 0.96 (dd, J = 8.2, 7.3 Hz, 18H), 
0.86 – 0.79 (m, 12H).  
13C-NMR (150 MHz, CDCl3): δ / ppm = 170.83 (d, J = 234.9 Hz), 137.73, 137.32 (d, J = 14.2 Hz), 
134.29, 121.91 (d, J = 38.2 Hz), 115.55, 39.52, 7.40, 3.53. 
19F NMR (375 MHz, CDCl3): δ / ppm = -89.77. 
IR (Diamond-ATR, neat): ~  / cm-1 = 2954, 2911, 2876, 1640, 1578, 1458, 1417, 1392, 1276, 1238, 
1221, 1194, 1105, 1004, 974, 910, 876, 788, 747, 718, 688. 
MS (EI, 70 eV): m/z (%) = 364 (24), 307 (100), 279 (78), 251 (74), 221 (12), 195 (47), 173 (54), 145 
(25), 111 (19), 105 (49), 87 (20), 77 (58), 71 (19), 59 (21), 57 (37). 
HRMS (C21H37FSi2): calc.: 364.2418, found: 364.2401 (M+). 
 
4'-Fluoro-3',5'-bis(triethylsilyl)-[1,1'-biphenyl]-4-carbonitrile (66m) 
 
The title compound was prepared according to TP2 from (5-bromo-2-fluoro-1,3-
phenylene)bis(triethylsilane) (62e, 121 mg, 0.3 mmol, 1.0 equiv) and n-BuLi (59, 0.13 ml, 2.60 M in 
ihexane, 0.33 mmol, 1.1 equiv) at -78 °C in 1 h. Subsequently, the cross-coupling was accomplished 
according to TP4 with ZnCl2 (0.36 mL, 0.36 mmol, 1.0 M in THF, 1.2 equiv), Pd(dba)2 (5.2 mg, 
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3 mol%) and P(2-furyl)3 (4.2 mg, 6 mol%) and 4-bromobenzonitrile (82 mg, 0.45 mmol, 1.5 equiv) at 
25 °C in 4 h. After complete conversion, the mixture was quenched with sat. aq. NH4Cl (10 mL) and 
extracted with EtOAc (3 × 10 mL). The combined organic extracts are dried over anhydrous MgSO4, 
filtered and concentrated in vacuo. Flash column chromatographical purification on silica gel 
(ihexane:EtOAc = 50:1) afforded 4'-fluoro-3',5'-bis(triethylsilyl)-[1,1'-biphenyl]-4-carbonitrile (66m, 
108 mg, 85%) as a colorless oil. 
 
1H-NMR (600 MHz, CDCl3): δ / ppm = 7.75 – 7.70 (m, 2H), 7.66 – 7.61 (m, 2H), 7.57 (s, 1H), 7.56 
(s, 1H), 1.03 – 0.96 (m, 18H), 0.92 – 0.85 (m, 12H). 
13C-NMR (150 MHz, CDCl3): δ / ppm = 172.62 (d, J = 238.8 Hz), 145.65, 136.26 (d, J = 14.9 Hz), 
134.59, 132.56, 127.70, 123.36 (d, J = 39.0 Hz), 118.98, 110.54, 7.40, 3.49. 
19F NMR (375 MHz, CDCl3): δ / ppm = -85.86. 
IR (Diamond-ATR, neat): ~  / cm-1 = 2954, 2910, 2875, 2228, 1607, 1576, 1507, 1457, 1396, 1314, 
1291, 1279, 1227, 1201, 1180, 1110, 1004, 974, 903, 864, 837, 77, 751, 721, 687, 668. 
MS (EI, 70 eV): m/z (%) = 425 (49), 396 (66), 368 (100), 340 (89), 312 (70), 282 (11), 262 (20), 256 
(80), 234 (31), 206 (29), 170 (8), 155 (21), 141 (18), 127 (17), 105 (46), 87 (13), 77 (47), 59 (16), 57 
(12). 
HRMS (C25H36FNSi2): calc.: 425.2370, found: 425.2364 (M+). 
 
2-(4-Fluoro-3,5-bis(triethylsilyl)phenyl)pyridine (66n) 
 
The title compound was prepared according to TP2 from (5-bromo-2-fluoro-1,3-
phenylene)bis(triethylsilane) (62e, 121 mg, 0.3 mmol, 1.0 equiv) and n-BuLi (59, 0.13 ml, 2.60 M in 
ihexane, 0.33 mmol, 1.1 equiv) at -78 °C in 1 h. Subsequently, the cross-coupling was accomplished 
according to TP4 with ZnCl2 (0.36 mL, 0.36 mmol, 1.0 M in THF, 1.2 equiv), Pd(dba)2 (5.2 mg, 3 
mol%) and P(2-furyl)3 (4.2 mg, 6 mol%) and 2-bromopyridine (71 mg, 0.45 mmol, 1.5 equiv) at 25 °C 
in 4 h. After complete conversion, the mixture was quenched with sat. aq. NH4Cl (10 mL) and 
extracted with EtOAc (3 × 10 mL). The combined organic extracts are dried over anhydrous MgSO4, 
filtered and concentrated in vacuo. Flash column chromatographical purification on silica gel 
(ihexane:EtOAc = 50:1) afforded 2-(4-fluoro-3,5-bis(triethylsilyl)phenyl)pyridine (66n, 89 mg, 74%) 
as a colorless oil. 
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1H-NMR (400 MHz, CDCl3): δ / ppm = 8.71 (ddd, J = 5.0, 1.8, 0.9 Hz, 1H), 8.00 (s, 1H), 7.98 (s, 
1H), 7.77 (td, J = 7.7, 1.8 Hz, 1H), 7.67 (dt, J = 8.0, 1.1 Hz, 1H), 7.28 – 7.20 (m, 1H), 1.01 m, 18H), 
0.92 (m, 12H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 173.01 (d, J = 238.7 Hz), 157.57, 149.50, 136.83, 136.41 (d, 
J = 13.6 Hz), 134.63, 122.62 (d, J = 38.2 Hz), 121.69, 120.68, 7.47, 3.53, 3.51. 
19F NMR (375 MHz, CDCl3): δ / ppm = -85.72. 
IR (Diamond-ATR, neat): ~  / cm-1 = 2953, 2910, 2875, 1578, 1468, 1438, 1416, 1393, 1297, 1265, 
1223, 1196, 1151, 1116, 1070, 1044, 1004, 974, 925, 903, 867, 792, 749, 718, 688. 
MS (EI, 70 eV): m/z (%) = 401 (33), 372 (77), 344 (50), 316 (82), 288 (75), 238 (15), 228 (12), 208 
(26), 181 (14), 143 (12), 129 (18), 115 (14), 111 (11), 104 (12), 97 (22), 85 (21), 77 (34), 57 (61), 44 
(100). 
HRMS (C23H36FNSi2): calc.: 401.2370, found: 401.2365 (M+). 
 
 
4.6. Functionalization in ortho-Position via Exchange with iPrMgCl·LiCl 
 
(5-Bromo-2-fluoro-3-iodophenyl)triethylsilane (67) 
 
The title compound was prepared according to TP5 from (5-bromo-2-fluoro-1,3-
phenylene)bis(triethylsilane) (62e, 4.04 g, 10.0 mmol, 1.0 equiv) and iodine monochloride (1.77 g, 
11 mmol, 1.1 equiv) at 25 °C in 20 h. Flash column chromatographical purification on silica gel 
(pentane) afforded (5-bromo-2-fluoro-3-iodophenyl)triethylsilane (67, 3.56 g, 86%) as a colorless oil. 
 
1H-NMR (300 MHz, CDCl3): δ / ppm = 7.79 (dd, J = 5.7, 2.4 Hz, 1H), 7.31 (dd, J = 4.1, 2.4 Hz, 1H), 
0.88 (td, J = 7.8, 1.3 Hz, 9H), 0.81 – 0.73 (m, 6H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 164.55 (d, J = 240.1 Hz), 142.11 (d, J = 2.2 Hz), 138.32 (d, J 
= 11.5 Hz), 127.15 (d, J = 36.9 Hz), 117.51 (d, J = 3.3 Hz), 82.50 (d, J = 33.2 Hz), 7.22, 3.17. 
19F NMR (300 MHz, CDCl3): δ / ppm = -83.69. 
IR (Diamond-ATR, neat): ~  / cm-1 = 2954, 2910, 2875, 1539, 1456, 1405, 1377, 1261, 1237, 1218, 
1110, 1089, 1074, 1003, 973, 869, 836, 781, 725, 690, 648. 
MS (EI, 70 eV): m/z (%) = 414 (28), 385 (6), 355 (85), 327 (100), 256 (31), 229 (66), 201 (21), 149 
(15), 121 (8), 75 (10). 
HRMS (C12H17BrFISi): calc.: 413.9312; found: 413.9314 (M+). 
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Ethyl 5-bromo-2-fluoro-3-(triethylsilyl)benzoate (69a) 
 
The title compound was prepared according to TP6, where (5-bromo-2-fluoro-3-
iodophenyl)triethylsilane (67, 104 mg, 0.25 mmol, 1.0 equiv) was dissolved in THF (0.5 ml) and 
iPrMgCl·LiCl (1, 0.246 mL, 0.275 mmol, 1.1 equiv, 1.12 M in THF) was added at 0°C and stirred for 
1 h at this temperature. The reaction mixture was quenched with ethyl cyanoformate (37 mg, 
0.375 mmol, 1.5 equiv) and allowed to warm to 25 °C for 6 h. After complete conversion, the mixture 
was quenched with sat. aq. NH4Cl (10 mL) and extracted with EtOAc (3 × 10 mL). The combined 
organic extracts are dried over anhydrous MgSO4, filtered and concentrated in vacuo. Flash column 
chromatographical purification on silica gel (ihexane:EtOAc = 50:1) afforded ethyl 5-bromo-2-fluoro-
3-(triethylsilyl)benzoate (69a, 67 mg, 74%) as a colorless oil.  
 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.99 (dd, J = 6.5, 2.6 Hz, 1H), 7.56 (dd, J = 3.8, 2.6 Hz, 1H), 
4.36 (q, J = 7.1 Hz, 2H), 1.37 (t, J = 7.1 Hz, 3H), 0.98 – 0.89 (m, 9H), 0.85 (ddt, J = 8.2, 6.8, 1.1 Hz, 
6H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 164.87 (d, J = 254.4 Hz), 163.40 (d, J = 4.5 Hz), 142.57 (d, 
J = 13.4 Hz), 135.39 (d, J = 1.6 Hz), 128.85 (d, J = 35.7 Hz), 120.16 (d, J = 15.7 Hz), 116.70 (d, J = 
3.3 Hz), 61.57, 14.20, 7.19, 3.15. 
19F NMR (375 MHz, CDCl3): δ / ppm = -99.36. 
IR (Diamond-ATR, neat): ~  / cm-1 = 2954, 2910, 275, 1736, 1715, 1590, 1455, 1415, 1384, 1364, 
1333, 1283, 1239, 1210, 1172, 1123, 1101, 1004, 975, 891, 862, 833, 786, 729, 693, 657. 
MS (EI, 70 eV): m/z (%) = 360 (10), 331 (12), 315 (17), 303 (100), 275 (57), 247 (14), 229 (10), 216 
(7), 203 (13), 196 (4), 139 (6), 123 (4), 105 (6), 77 (10), 47 (5). 
HRMS (C15H22BrFO2Si): calc.: 360.0556; found: 360.0544 (M+). 
 
5-Bromo-2-fluoro-3-(triethylsilyl)benzonitrile (69b) 
 
The title compound was prepared according to TP6, where (5-bromo-2-fluoro-3-
iodophenyl)triethylsilane (67, 104 mg, 0.25 mmol, 1.0 equiv) was dissolved in THF (0.5 ml) and 
iPrMgCl·LiCl (1, 0.246 mL, 0.275 mmol, 1.1 equiv, 1.12 M in THF) was added at 0°C and stirred for 
1 h at this temperature. The reaction mixture was quenched with 2,2-dimethylmalononitrile (35 mg, 
0.375 mmol, 1.5 equiv) and allowed to warm to 25 °C for 6 h. After complete conversion, the mixture 
C. EXPERIMENTAL SECTION 
 
140 
was quenched with sat. aq. NH4Cl (10 mL) and extracted with EtOAc (3 × 10 mL). The combined 
organic extracts are dried over anhydrous MgSO4, filtered and concentrated in vacuo. Flash column 
chromatographical purification on silica gel (ihexane:EtOAc = 50:1) afforded 5-bromo-2-fluoro-3-
(triethylsilyl)benzonitrile (69b, 62 mg, 79%) as a colorless oil. 
 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.74 (dd, J = 5.7, 2.5 Hz, 1H), 7.68 (dd, J = 4.3, 2.5 Hz, 1H), 
1.04 – 0.94 (m, 9H), 0.95 – 0.83 (m, 6H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 166.13 (d, J = 252.9 Hz), 143.44 (d, J = 12.9 Hz), 136.27, 
128.95 (d, J = 33.0 Hz), 117.21 (d, J = 3.4 Hz), 113.03, 102.89 (d, J = 22.3 Hz), 7.12, 3.05. 
19F NMR (375 MHz, CDCl3): δ / ppm = -99.00. 
IR (Diamond-ATR, neat): ~  / cm-1 = 2956, 2912, 2877, 2237, 1589, 1457, 1422, 1388, 1270, 1222, 
1177, 1004, 975, 878, 828, 737, 710, 682. 
MS (EI, 70 eV): m/z (%) = 313 (7), 284 (32), 256 (55), 228 (100), 208 (4), 201 (3), 176 (5), 149 (8), 
130 (4), 102 (5), 77 (24), 59 (2), 47 (39). 
HRMS (C13H17BrFNSi): calc.: 313.0298; found: 313.0278 (M+). 
 
5-Bromo-2-fluoro-3-(triethylsilyl)benzaldehyde (69c) 
 
The title compound was prepared according to TP6, where (5-bromo-2-fluoro-3-
iodophenyl)triethylsilane (67, 104 mg, 0.25 mmol, 1.0 equiv) was dissolved in THF (0.5 ml) and 
iPrMgCl·LiCl (1, 0.246 mL, 0.275 mmol, 1.1 equiv, 1.12 M in THF) was added at 0°C and stirred for 
1 h at this temperature. The reaction mixture was quenched with morpholine-4-carbaldehyde (43 mg, 
0.375 mmol, 1.5 equiv) and allowed to warm to 25 °C for 6 h. After complete conversion, the mixture 
was quenched with sat. aq. NH4Cl (10 mL) and extracted with EtOAc (3 × 10 mL). The combined 
organic extracts are dried over anhydrous MgSO4, filtered and concentrated in vacuo. Flash column 
chromatographical purification on silica gel (ihexane:EtOAc = 100:1) afforded ethyl 5-bromo-2-
fluoro-3-(triethylsilyl)benzaldehyde (69c, 46 mg, 58%) as a colorless oil.  
 
1H-NMR (400 MHz, CDCl3): δ / ppm = 10.22 (s, 1H), 7.89 (dd, J = 6.2, 2.6 Hz, 1H), 7.59 (dd, J = 
4.3, 2.6 Hz, 1H), 0.96 – 0.86 (m, 9H), 0.86 – 0.75 (m, 6H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 186.47 (d, J = 6.6 Hz), 167.80 (d, J = 252.5 Hz), 144.53 (d, 
J = 13.9 Hz), 132.07 (d, J = 2.5 Hz), 128.91 (d, J = 34.3 Hz), 124.88 (d, J = 13.7 Hz), 118.14 (d, J = 
3.0 Hz), 7.20, 3.22. 
 19F NMR (375 MHz, CDCl3): δ / ppm = -111.83. 
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IR (Diamond-ATR, neat): ~  / cm-1 = 2954, 2910, 2875, 1694, 1659, 1591, 1557, 1455, 1424, 1376, 
1276, 1225, 1191, 1167, 1079, 1003, 976, 898, 830, 732, 690. 
MS (EI, 70 eV): m/z (%) = 316 (15), 287 (13), 259 (79), 231 (100), 203 (13), 196(7), 152 (7), 123 
(11), 116 (58), 103 (8), 85 (11), 77 (32), 71 (15), 57 (20), 47 (53), 45 (10). 
HRMS (C13H18BrFOSi): calc.: 316.0294; found: 316.0282 (M+). 
 
(5-bromo-2-fluoro-3-(triethylsilyl)phenyl)(4-chlorophenyl)methanol (69d) 
 
The title compound was prepared according to TP6, where (5-bromo-2-fluoro-3-
iodophenyl)triethylsilane (67, 104 mg, 0.25 mmol, 1.0 equiv) was dissolved in THF (0.5 ml) and 
iPrMgCl·LiCl (1, 0.246 mL, 0.275 mmol, 1.1 equiv, 1.12 M in THF) was added at 0°C and stirred for 
1 h at this temperature. The reaction mixture was quenched with 4-chlorobenzaldehyde (53 mg, 
0.375 mmol, 1.5 equiv) and allowed to warm to 25 °C for 6 h. After complete conversion, the mixture 
was quenched with sat. aq. NH4Cl (10 mL) and extracted with EtOAc (3 × 10 mL). The combined 
organic extracts are dried over anhydrous MgSO4, filtered and concentrated in vacuo. Flash column 
chromatographical purification on silica gel (ihexane:EtOAc = 10:1) afforded (5-bromo-2-fluoro-3-
(triethylsilyl)phenyl)(4-chlorophenyl)methanol (69d, 43 mg, 40%) as a colorless oil. 
 
1H-NMR (400 MHz, DMSO-d6): δ / ppm = 7.63 – 7.60 (m, 1H), 7.33 – 7.21 (m, 2H), 6.14 (d, J = 7.5 
Hz, 2H), 5.81 (d, J = 7.4 Hz, 2H), 0.83 – 0.73 (m, 9H), 0.74 – 0.64 (m, 6H). 
13C-NMR (100 MHz, DMSO-d6): δ / ppm = 162.74 (d, J = 240.3 Hz), 143.10, 136.91 (d, J = 12.7 
Hz), 134.65 (d, J = 19.9 Hz), 132.21, 132.02 (d, J = 5.1 Hz), 128.72, 128.51 (d, J = 1.3 Hz), 126.50 (d, 
J = 34.9 Hz), 117.37 (d, J = 2.6 Hz), 67.66 (d, J = 2.3 Hz), 7.60, 3.27.  
19F NMR (300 MHz, DMSO-d6): δ / ppm = -107.48. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3387, 2953, 2875, 2740, 2391, 2349, 2256, 2192, 2129, 1905, 
1650, 1489, 1413, 1384, 1327, 1296, 1208, 1154, 1089, 1047, 1023, 994, 898, 880, 824, 762. 
MS (EI, 70 eV): m/z (%) = 428 (30), 399 (32), 381 (57), 371 (100), 276 (58), 255 (21), 244 (13), 227 
(15), 199 (23), 163 (28), 152 (27), 141 (22), 105 (50), 93 (15), 77 (82), 47 (14). 
HRMS (C19H23BrClFOSi): calc.: 428.0374; found: 428.0367 (M+). 
 
(5-bromo-2-fluoro-3-(triethylsilyl)phenyl)(4-methoxyphenyl)methanol (69e) 
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The title compound was prepared according to TP6, where (5-bromo-2-fluoro-3-
iodophenyl)triethylsilane (67, 104 mg, 0.25 mmol, 1.0 equiv) was dissolved in THF (0.5 ml) and 
iPrMgCl·LiCl (1, 0.246 mL, 0.275 mmol, 1.1 equiv, 1.12 M in THF) was added at 0°C and stirred for 
1 h at this temperature. The reaction mixture was quenched with 4-methoxybenzaldehyde (51 mg, 
0.375 mmol, 1.5 equiv) and allowed to warm to 25 °C for 6 h. After complete conversion, the mixture 
was quenched with sat. aq. NH4Cl (10 mL) and extracted with EtOAc (3 × 10 mL). The combined 
organic extracts are dried over anhydrous MgSO4, filtered and concentrated in vacuo. Flash column 
chromatographical purification on silica gel (ihexane:EtOAc = 10:1) afforded (5-bromo-2-fluoro-3-
(triethylsilyl)phenyl)(4-methoxyphenyl)methanol (69e, 47 mg, 44%) as a colorless oil.  
 
1H-NMR (600 MHz, CDCl3): δ / ppm = 7.68 – 7.62 (m, 1H), 7.32 (dd, J = 4.2, 2.5 Hz, 1H), 7.30 – 
7.24 (m, 2H), 6.89 – 6.83 (m, 2H), 6.02 (dd, J = 2.8, 1.4 Hz, 1H), 3.78 (s, 3H), 0.94 – 0.87 (m, 9H), 
0.83 – 0.75 (m, 6H). 
13C-NMR (150 MHz, CDCl3): δ / ppm = 162.98 (d, J = 241.0 Hz), 159.24, 137.27 (d, J = 13.0 Hz), 
134.51, 132.63 (d, J = 19.2 Hz), 131.38, 127.63, 126.60 (d, J = 35.0 Hz), 117.40, 113.96, 69.45, 55.25, 
7.24, 3.28. 
 19F NMR (375 MHz, CDCl3): δ / ppm = -107.82. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3391, 3000, 2953, 2908, 2874, 2834, 1677, 1610, 1510, 1455, 
1413, 1385, 1333, 1303, 1247, 1208, 1155, 1111, 1033, 1005, 975, 898, 880, 828, 778, 725, 685. 
MS (EI, 70 eV): m/z (%) = 424 (81), 377 (100), 365 (68), 349 (12), 273 (39), 257 (10), 165 (9), 138 
(17), 109 (36), 77 (55), 47 (7). 
HRMS (C20H26BrFO2Si): calc.: 424.0869; found: 424.0867 (M+). 
 
(5-Bromo-2-fluoro-3-(triethylsilyl)phenyl)(4-isocyanophenyl)methanol (69f) 
 
The title compound was prepared according to TP6, where (5-bromo-2-fluoro-3-
iodophenyl)triethylsilane (67, 104 mg, 0.25 mmol, 1.0 equiv) was dissolved in THF (0.5 ml) and 
iPrMgCl·LiCl (1, 0.246 mL, 0.275 mmol, 1.1 equiv, 1.12 M in THF) was added at 0°C and stirred for 
1 h at this temperature. The reaction mixture was quenched with 4-formylbenzonitrile (49 mg, 
0.375 mmol, 1.5 equiv) and allowed to warm to 25 °C for 6 h. After complete conversion, the mixture 
was quenched with sat. aq. NH4Cl (10 mL) and extracted with EtOAc (3 × 10 mL). The combined 
organic extracts are dried over anhydrous MgSO4, filtered and concentrated in vacuo. Flash column 
chromatographical purification on silica gel (ihexane:EtOAc = 10:1) afforded (5-bromo-2-fluoro-3-
(triethylsilyl)phenyl)(4-isocyanophenyl)methanol (69f, 67 mg, 64%) as a colorless solid.  
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m.p.: 98.2 - 100.1 °C. 
1H-NMR (800 MHz, DMSO-d6): δ / ppm = 8.07 – 8.03 (m, 2H), 7.91 – 7.88 (m, 2H), 7.85 (dd, J = 
6.2, 2.6 Hz, 1H), 7.72 (dd, J = 3.9, 2.5 Hz, 1H), 6.88 (s, 1H), 0.91 (t, J = 7.8 Hz, 9H), 0.82 (dd, J = 
8.7, 7.4 Hz, 6H). 
13C-NMR (200 MHz, DMSO-d6): δ / ppm = 191.23, 162.92 (d, J = 244.9 Hz), 141.88 (d, J = 13.9 
Hz), 140.21, 134.62 (d, J = 3.7 Hz), 133.38, 130.24, 128.16 (d, J = 35.4 Hz), 127.61 (d, J = 22.0 Hz), 
118.42, 117.66, 116.29, 7.58, 3.18. 
19F NMR (300 MHz, DMSO-d6): δ / ppm = -101.62.  
IR (Diamond-ATR, neat): ~  / cm-1 = 3394, 3093, 3075, 2956, 2912, 2876, 2230, 1664, 1606, 1586, 
1567, 1499, 1455, 1410, 1386, 1351, 1310, 1283, 1261, 1241, 1204, 1180, 1149, 1112, 1048, 1024, 
1002, 971, 918, 888, 858, 836, 796, 775, 759, 733, 690. 
MS (EI, 70 eV): m/z (%) = 419 (27), 388 (79), 360 (50), 340 (48), 332 (52), 314 (25), 304 (24), 252 
(10), 224 (23), 217 (28), 190 (14), 176 (18), 130 (56), 105 (92), 77 (100), 47 (35). 
HRMS (C20H23BrFNOSi): calc.: 419.0716; found: 419.0552 (M+). 
 
(5-bromo-2-fluoro-3-(triethylsilyl)phenyl)(thiophen-2-yl)methanol (69g) 
 
The title compound was prepared according to TP6, where (5-bromo-2-fluoro-3-
iodophenyl)triethylsilane (67, 104 mg, 0.25 mmol, 1.0 equiv) was dissolved in THF (0.5 ml) and 
iPrMgCl·LiCl (1, 0.246 mL, 0.275 mmol, 1.1 equiv, 1.12 M in THF) was added at 0°C and stirred for 
1 h at this temperature. The reaction mixture was quenched with thiophene-2-carbaldehyde (42 mg, 
0.375 mmol, 1.5 equiv) and allowed to warm to 25 °C for 6 h. After complete conversion, the mixture 
was quenched with sat. aq. NH4Cl (10 mL) and extracted with EtOAc (3 × 10 mL). The combined 
organic extracts are dried over anhydrous MgSO4, filtered and concentrated in vacuo. Flash column 
chromatographical purification on silica gel (ihexane:EtOAc = 10:1) afforded ((5-bromo-2-fluoro-3-
(triethylsilyl)phenyl)(thiophen-2-yl)methanol (69g, 20 mg, 20%) as a colorless oil.  
 
1H-NMR (800 MHz, DMSO-d6): δ / ppm = 7.72 (dd, J = 6.5, 2.6 Hz, 1H), 7.42 (dd, J = 5.1, 1.2 Hz, 
1H), 7.38 (dd, J = 4.0, 2.5 Hz, 1H), 6.94 (dd, J = 5.0, 3.5 Hz, 1H), 6.85 (dt, J = 3.5, 1.0 Hz, 1H), 6.45 
(d, J = 4.9 Hz, 1H), 6.13 (d, J = 4.8 Hz, 1H), 0.89 (dd, J = 8.2, 7.3 Hz, 9H), 0.80 (q, J = 8.7, 8.2 Hz, 
6H). 
13C-NMR (200 MHz, DMSO-d6): δ / ppm = 162.65 (d, J = 240.6 Hz), 148.37, 137.10 (d, J = 13.6 
Hz), 134.50 (d, J = 20.4 Hz), 131.81 (d, J = 6.1 Hz), 127.12, 126.59 (d, J = 35.4 Hz), 125.68, 124.38, 
117.28 (d, J = 3.1 Hz), 64.45 (d, J = 3.6 Hz), 7.62, 3.27. 
19F NMR (375 MHz, DMSO-d6): δ / ppm = -108.09. 
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IR (Diamond-ATR, neat): ~  / cm-1 = 3350, 2954, 2910, 2875, 1595, 1456, 1415, 1386, 1319, 1296, 
1270, 1230, 1209, 1158, 1121, 1019, 1004, 880, 854, 829, 770, 725, 696. 
 
MS (EI, 70 eV): m/z (%) = 400 (49), 371 (45), 353 (29), 341 (100), 324 (13), 315 (23), 297 (14), 292 
(20), 263 (12), 251 (28), 233 (31), 171 (39), 115 (18), 111 (14), 105 (88), 85 (27), 77 (84), 45 (16). 
HRMS (C17H22BrFOSSi): calc.: 400.0328; found: 400.0326 (M+). 
 
1-(5-Bromo-2-fluoro-3-(triethylsilyl)phenyl)-2,2-dimethylpropan-1-one (69h) 
 
The title compound was prepared according to TP6, where (5-bromo-2-fluoro-3-
iodophenyl)triethylsilane (67, 104 mg, 0.25 mmol, 1.0 equiv) was dissolved in THF (0.5 ml) and 
iPrMgCl·LiCl (1, 0.246 mL, 0.275 mmol, 1.1 equiv, 1.12 M in THF) was added at 0°C and stirred for 
1 h at this temperature. Subsequently, the acylation reaction was accomplished according to TP3 with 
CuCN·2LiCl (0.30 mL, 0.30 mmol, 1.0 M in THF, 1.2 equiv) and pivaloyl chloride (45 mg, 
0.375 mmol, 1.5 equiv) and allowed to warm to 25 °C in 6 h. After complete conversion, the mixture 
was quenched with sat. aq. NH4Cl (10 mL) and extracted with EtOAc (3 × 10 mL). The combined 
organic extracts are dried over anhydrous MgSO4, filtered and concentrated in vacuo. Flash column 
chromatographical purification on silica gel (ihexane:EtOAc = 50:1) afforded 1-(5-bromo-2-fluoro-3-
(triethylsilyl)phenyl)-2,2-dimethylpropan-1-one (69h, 81 mg, 87%) as a colorless oil.  
 
1H-NMR (400 MHz, DMSO-d6): δ / ppm = 7.60 (dd, J = 6.0, 2.5 Hz, 1H), 7.51 (dd, J = 4.3, 2.5 Hz, 
1H), 1.14 (s, 6H), 0.89 (td, J = 6.9, 1.3 Hz, 9H), 0.86 – 0.76 (m, 6H). 
13C-NMR (100 MHz, DMSO-d6): δ / ppm = 208.12 (d, J = 1.2 Hz), 160.72 (d, J = 238.5 Hz), 138.98 
(d, J = 12.3 Hz), 131.70 (d, J = 5.3 Hz), 130.37 (d, J = 27.5 Hz), 127.30 (d, J = 35.3 Hz), 117.10 (d, J 
= 2.8 Hz), 44.97, 26.37, 7.55, 3.15. 
19F NMR (375 MHz, DMSO-d6): δ / ppm = -104.04. 
IR (Diamond-ATR, neat): ~  / cm-1 = 2956, 2910, 2876, 2736, 1700, 1588, 1458, 1406, 1278, 1224, 
1172, 990, 878, 824, 768, 730, 696. 
MS (EI, 70 eV): m/z (%) = 372 (4), 331 (3), 317 (100), 315 (94), 287 (7), 261 (3), 229 (2), 203 (8), 
142 (7), 105 (16), 87 (9), 77 (22), 57 (19), 41 (10). 
HRMS (C17H26BrFOSi): calc.: 372.0920; found: 372.0912 (M+). 
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Ethyl 2-(5-bromo-2-fluoro-3-(triethylsilyl)benzyl)acrylate (69i) 
 
The title compound was prepared according to TP6, where (5-bromo-2-fluoro-3-
iodophenyl)triethylsilane (67, 104 mg, 0.25 mmol, 1.0 equiv) was dissolved in THF (0.5 ml) and 
iPrMgCl·LiCl (1, 0.246 mL, 0.275 mmol, 1.1 equiv, 1.12 M in THF) was added at 0°C and stirred for 
1 h at this temperature. Subsequently, the allylation reaction was accomplished according to TP3 with 
CuCN·2LiCl (0.30 mL, 0.30 mmol, 1.0 M in THF, 1.2 equiv) and ethyl 2-(bromomethyl)acrylate 
(72 mg, 0.375 mmol, 1.5 equiv) and allowed to warm to 25 °C in 6 h. After complete conversion, the 
mixture was quenched with sat. aq. NH4Cl (10 mL) and extracted with EtOAc (3 × 10 mL). The 
combined organic extracts are dried over anhydrous MgSO4, filtered and concentrated in vacuo. Flash 
column chromatographical purification on silica gel (ihexane:EtOAc = 50:1) afforded ethyl 
2-(5-bromo-2-fluoro-3-(triethylsilyl)benzyl)acrylate (69i, 81 mg, 81%) as a colorless oil.  
 
1H-NMR (800 MHz, CDCl3): δ / ppm = 7.35 (dd, J = 6.8, 2.5 Hz, 1H), 7.32 (dd, J = 4.1, 2.5 Hz, 1H), 
6.30 (q, J = 1.0 Hz, 1H), 5.47 (p, J = 1.2 Hz, 1H), 4.23 (q, J = 7.1 Hz, 2H), 3.62 (d, J = 1.7 Hz, 2H), 
1.31 (t, J = 7.1 Hz, 3H), 0.97 (t, J = 7.9 Hz, 9H), 0.87 – 0.82 (m, 6H). 
13C-NMR (200 MHz, CDCl3): δ / ppm = 165.46, 163.41 (d, J = 241.5 Hz), 137.20, 135.58 (d, J = 
13.1 Hz), 133.84 (d, J = 5.7 Hz), 126.49 (d, J = 22.4 Hz), 125.53, 125.40 (d, J = 35.4 Hz), 115.82 (d, J 
= 3.3 Hz), 59.90, 30.08 (d, J = 3.3 Hz), 13.12, 6.27, 2.30. 
19F NMR (375 MHz, CDCl3): δ / ppm = -107.15. 
IR (Diamond-ATR, neat): ~  / cm-1 = 2954, 2910, 2875, 1716, 1632, 1595, 1556, 1413, 1392, 1368, 
1327, 1300, 1277, 1251, 1193, 1161, 1133, 1004, 948, 910, 870, 830, 816, 724, 662. 
MS (EI, 70 eV): m/z (%) = 400 (20), 371 (12), 312 (41), 296 (16), 254 (53), 240 (100), 223 (15), 206 
(23), 194 (15), 128 (18), 115 (81), 105 (65), 97 (14), 85 (23), 77 (66), 71 (30), 57 (42), 43 (40). 
HRMS (C18H26BrFO2Si): calc.: 400.0869; found: 400.0858 (M+). 
 
(5-Bromo-2-fluoro-4'-methoxy-[1,1'-biphenyl]-3-yl)triethylsilane (69j) 
 
The title compound was prepared according to TP6, where (5-bromo-2-fluoro-3-
iodophenyl)triethylsilane (67, 104 mg, 0.25 mmol, 1.0 equiv) was dissolved in THF (0.5 ml) and 
iPrMgCl·LiCl (1, 0.246 mL, 0.275 mmol, 1.1 equiv, 1.12 M in THF) was added at 0°C and stirred for 
1 h at this temperature. Subsequently, the cross-coupling was accomplished according to TP4 with 
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ZnCl2 (0.30 mL, 0.30 mmol, 1.0 M in THF, 1.2 equiv), Pd(dba)2 (4.3 mg, 3 mol%), P(2-furyl)3 
(3.6 mg, 6 mol%) and 4-iodoanisole (70 mg, 0.30 mmol, 1.2 equiv) at 25 °C in 6 h. After complete 
conversion, the mixture was quenched with sat. aq. NH4Cl (10 mL) and extracted with EtOAc (3 × 
10 mL). The combined organic extracts are dried over anhydrous MgSO4, filtered and concentrated in 
vacuo. Flash column chromatographical purification on silica gel (ihexane:EtOAc = 100:1) afforded 
(5-bromo-2-fluoro-4'-methoxy-[1,1'-biphenyl]-3-yl)triethylsilane (69j, 70 mg, 71%) as a colorless oil.  
 
1H-NMR (600 MHz, CDCl3): δ / ppm = 7.55 – 7.49 (m, 1H), 7.47 – 7.42 (m, 2H), 7.35 (dd, J = 3.9, 
2.5 Hz, 1H), 7.00 – 6.94 (m, 2H), 3.84 (s, 3H), 0.97 (dd, J = 8.3, 7.3 Hz, 9H), 0.89 – 0.82 (m, 6H). 
13C-NMR (150 MHz, CDCl3): δ / ppm = 162.83 (d, J = 241.8 Hz), 159.47, 136.60 (d, J = 14.5 Hz), 
134.13, 130.18, 127.25 (d, J = 7.6 Hz), 127.02, 117.17, 113.94, 55.31, 7.32, 3.35. 
19F NMR (375 MHz, CDCl3): δ / ppm = -107.41. 
IR (Diamond-ATR, neat): ~  / cm-1 = 2956, 2910, 2876, 2736, 1700, 1588, 1458, 1406, 1278, 1224, 
1172, 990, 878, 824, 768, 730, 696. 
MS (EI, 70 eV): m/z (%) = 394 (100), 337 (76), 309 (93), 286 (57), 229 (23), 215 (8), 199 (9), 182 
(10), 178 (12), 165 (16), 155 (24), 139 (21), 77 (26), 47 (11). 
HRMS (C19H24BrFOSi): calc.: 394.0764; found: 394.0764 (M+). 
 
((5'-Bromo-2'-fluoro-3'-(triethylsilyl)-[1,1'-biphenyl]-3-yl)oxy)(tert-butyl)dimethylsilane (69k) 
 
The title compound was prepared according to TP6, where (5-bromo-2-fluoro-3-
iodophenyl)triethylsilane (67, 104 mg, 0.25 mmol, 1.0 equiv) was dissolved in THF (0.5 ml) and 
iPrMgCl·LiCl (1, 0.246 mL, 0.275 mmol, 1.1 equiv, 1.12 M in THF) was added at 0°C and stirred for 
1 h at this temperature. Subsequently, the cross-coupling was accomplished according to TP4 with 
ZnCl2 (0.30 mL, 0.30 mmol, 1.0 M in THF, 1.2 equiv), Pd(dba)2 (4.3 mg, 3 mol%), P(2-furyl)3 
(3.6 mg, 6 mol%) and (3-bromophenoxy)(tert-butyl)dimethylsilane (86 mg, 0.30 mmol, 1.2 equiv) at 
25 °C in 6 h. After complete conversion, the mixture was quenched with sat. aq. NH4Cl (10 mL) and 
extracted with EtOAc (3 × 10 mL). The combined organic extracts are dried over anhydrous MgSO4, 
filtered and concentrated in vacuo. Flash column chromatographical purification on silica gel 
(ihexane) afforded ((5'-bromo-2'-fluoro-3'-(triethylsilyl)-[1,1'-biphenyl]-3-yl)oxy)(tert-
butyl)dimethylsilane (69k, 96 mg, 78%) as a colorless oil.  
 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.46 (dd, J = 7.0, 2.6 Hz, 1H), 7.33 (dd, J = 3.9, 2.5 Hz, 1H), 
7.22 (t, J = 7.9 Hz, 1H), 7.02 (ddt, J = 7.7, 2.4, 1.2 Hz, 1H), 6.91 (q, J = 1.9 Hz, 1H), 6.79 (ddd, J = 
8.2, 2.4, 1.0 Hz, 1H), 0.96 – 0.87 (m, 18H), 0.85 – 0.74 (m, 6H), 0.16 (s, 6H). 
C. EXPERIMENTAL SECTION 
 
147 
13C-NMR (100 MHz, CDCl3): δ / ppm = 162.82 (d, J = 242.6 Hz), 155.68, 137.20 (d, J = 12.7 Hz), 
136.20 (d, J = 1.4 Hz), 134.35 (d, J = 4.0 Hz), 130.40 (d, J = 19.9 Hz), 129.38, 127.32 (d, J = 36.2 
Hz), 122.02 (d, J = 3.0 Hz), 120.84 (d, J = 3.0 Hz), 119.68, 117.16 (d, J = 3.0 Hz), 25.71, 18.24, 7.33, 
3.39, -4.38. 
19F NMR (375 MHz, CDCl3): δ / ppm = -106.76. 
IR (Diamond-ATR, neat): ~  / cm-1 = 2953, 2930, 2909, 2875, 2858, 1602, 1579, 1551, 1485, 1471, 
1443, 1403, 1390, 1361, 1297, 1252, 1225, 1187, 1086, 1061, 1001, 955, 873, 839, 780, 722, 696, 
675. 
MS (EI, 70 eV): m/z (%) = 494 (82), 437 (46), 381 (47), 367 (30), 353 (100), 345 (13), 331 (21), 273 
(11), 252 (11), 190 (16), 177 (63), 165 (17), 87 (26), 77 (21), 73 (48), 59 (14). 
HRMS (C24H36BrFOSi): calc.: 494.1472; found: 494.1463 (M+). 
 
2-(5-Bromo-2-fluoro-3-(triethylsilyl)phenyl)pyrimidine (69l) 
 
The title compound was prepared according to TP6, where (5-bromo-2-fluoro-3-
iodophenyl)triethylsilane (67, 104 mg, 0.25 mmol, 1.0 equiv) was dissolved in THF (0.5 ml) and 
iPrMgCl·LiCl (1, 0.246 mL, 0.275 mmol, 1.1 equiv, 1.12 M in THF) was added at 0°C and stirred for 
1 h at this temperature. Subsequently, the cross-coupling was accomplished according to TP4 with 
ZnCl2 (0.30 mL, 0.30 mmol, 1.0 M in THF, 1.2 equiv), Pd(dba)2 (4.3 mg, 3 mol%), P(2-furyl)3 
(3.6 mg, 6 mol%) and 2-bromopyrimidine (48 mg, 0.30 mmol, 1.2 equiv) at 25 °C in 6 h. After 
complete conversion, the mixture was quenched with sat. aq. NH4Cl (10 mL) and extracted with 
EtOAc (3 × 10 mL). The combined organic extracts are dried over anhydrous MgSO4, filtered and 
concentrated in vacuo. Flash column chromatographical purification on silica gel (ihexane) afforded 
2-(5-bromo-2-fluoro-3-(triethylsilyl)phenyl)pyrimidine (69l, 59 mg, 65%) as a colorless oil.  
 
1H-NMR (800 MHz, CDCl3): δ / ppm = 8.96 (d, J = 4.9 Hz, 2H), 8.12 (dd, J = 6.8, 2.7 Hz, 1H), 7.59 
(dd, J = 3.6, 2.5 Hz, 1H), 7.54 (t, J = 4.9 Hz, 1H), 0.93 (dd, J = 8.2, 7.3 Hz, 9H), 0.88 – 0.83 (m, 6H). 
13C-NMR (200 MHz, CDCl3): δ / ppm =163.92 (d, J = 249.5 Hz), 161.73 (d, J = 6.3 Hz), 158.22, 
139.90 (d, J = 14.0 Hz), 135.69, 129.23 (d, J = 87.1 Hz), 128.31, 128.27 (d, J = 53.1 Hz), 120.81, 
117.05, 7.67, 3.25. 
19F NMR (375 MHz, CDCl3): δ / ppm = -103.77. 
IR (Diamond-ATR, neat): ~  / cm-1 = 2954, 2910, 2875, 1592, 1566, 1549, 143, 1404, 1386, 1306, 
1238, 1204, 1110, 1069, 1004, 976, 908, 884, 846, 814, 717, 680, 653. 
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MS (EI, 70 eV): m/z (%) = 366 (13), 337 (72), 309 (81), 281 (100), 234 (16), 202 (19), 181 (9), 168 
(8), 155 (17), 131 (10), 128 (8), 103 (11), 77 (14), 69 (12), 57 (7), 43 (36). 
HRMS (C16H20BrFN2Si): calc.: 366.0563; found: 366.0548 (M+). 
 
(E)-(5-Bromo-2-fluoro-3-styrylphenyl)triethylsilane (69m) 
 
The title compound was prepared according to TP6, where (5-bromo-2-fluoro-3-
iodophenyl)triethylsilane (67, 104 mg, 0.25 mmol, 1.0 equiv) was dissolved in THF (0.5 ml) and 
iPrMgCl·LiCl (1, 0.246 mL, 0.275 mmol, 1.1 equiv, 1.12 M in THF) was added at 0°C and stirred for 
1 h at this temperature. Subsequently, the cross-coupling was accomplished according to TP4 with 
ZnCl2 (0.30 mL, 0.30 mmol, 1.0 M in THF, 1.2 equiv), Pd(dba)2 (4.3 mg, 3 mol%), P(2-furyl)3 
(3.6 mg, 6 mol%) and (E)-(2-iodovinyl)benzene (69 mg, 0.30 mmol, 1.2 equiv) at 25 °C in 6 h. After 
complete conversion, the mixture was quenched with sat. aq. NH4Cl (10 mL) and extracted with 
EtOAc (3 × 10 mL). The combined organic extracts are dried over anhydrous MgSO4, filtered and 
concentrated in vacuo. Flash column chromatographical purification on silica gel (ihexane) afforded 
(E)-(5-bromo-2-fluoro-3-styrylphenyl)triethylsilane (69m, 83 mg, 85%) as a colorless oil.  
 
1H-NMR (600 MHz, CDCl3): δ / ppm = 7.73 (dd, J = 6.8, 2.5 Hz, 1H), 7.54 – 7.49 (m, 2H), 7.36 (dd, 
J = 8.4, 6.9 Hz, 2H), 7.33 – 7.25 (m, 2H), 7.23 – 7.09 (m, 2H), 0.97 (t, J = 7.8 Hz, 9H), 0.89 – 0.81 
(m, 6H). 
13C-NMR (150 MHz, CDCl3): δ / ppm = 163.47 (d, J = 244.4 Hz), 144.96, 137.00, 136.86 (d, J = 
14.9 Hz), 131.08 (dd, J = 212.0, 3.8 Hz), 128.69 (d, J = 6.3 Hz), 128.33, 128.18, 126.73, 125.95, 
119.92 (d, J = 3.7 Hz), 117.34, 7.28, 3.29. 
19F NMR (375 MHz, CDCl3): δ / ppm = -107.41. 
IR (Diamond-ATR, neat): ~  / cm-1 = 2952, 2908, 2873, 1597, 1551, 1494, 149, 1416, 1396, 1326, 
1301, 1280, 1260, 1238, 1204, 1184, 1159, 1127, 1102, 1075, 1004, 961, 923, 871, 827, 726, 687. 
MS (EI, 70 eV): m/z (%) = 390 (100), 333 (54), 282 (28), 223 (30), 205 (9), 189 (12), 178 (84), 152 
(13), 139 (11), 125 (10), 105 (31), 91 (21), 77 (68), 47 (16). 
HRMS (C20H24BrFSi): calc.: 390.0815; found: 390.0818 (M+). 
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4.7. Desilylation Reactions 
 
1-(5-Bromo-2-fluorophenyl)-2,2-dimethylpropan-1-one (70) 
 
A dry, argon flushed Schlenk-flask equipped with a magnetic stirring bar and a septum was charged 
with 1-(5-bromo-2-fluoro-3-(triethylsilyl)phenyl)-2,2-dimethylpropan-1-one (69h, 162 mg, 
0.43 mmol, 1.0 equiv) and dissolved in dry CH2Cl2 (2 ml). After cooling down to 0 °C, TBAF·3H2O 
(163 mg, 0.52 mmol, 1.2 equiv) was added dropwise and the reaction mixture was stirred for 2 h at 
this temperature. After complete conversion, the mixture was quenched with H2O (5 mL) and 
extracted with DCM (3 × 10 mL). The combined organic extracts are dried over anhydrous MgSO4, 
filtered and concentrated in vacuo. Flash column chromatographical purification on silica gel 
(ihexane:EtOAc = 20:1) 1-(5-bromo-2-fluorophenyl)-2,2-dimethylpropan-1-one (70, 101 mg, 91%) as 
a colorless oil.  
 
1H-NMR (400 MHz, CDCl3): δ / ppm = δ 7.46 (ddd, J = 8.8, 4.6, 2.5 Hz, 1H), 7.27 (dd, J = 5.7, 2.5 
Hz, 1H), 6.97 (t, J = 8.8 Hz, 1H), 1.22 (s, 9H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 208.16 (d, J = 1.3 Hz), 156.90 (d, J = 247.2 Hz), 133.61 (d, 
J = 8.0 Hz), 130.74 (d, J = 21.9 Hz), 130.35 (d, J = 4.9 Hz), 117.71 (d, J = 23.9 Hz), 116.47 (d, J = 3.4 
Hz), 45.00, 26.4. 
19F NMR (300 MHz, CDCl3): δ / ppm = -114.83. 
IR (Diamond-ATR, neat): ~  / cm-1 = 2969, 2935, 2906, 2872, 1697, 1604, 1474, 1386, 1366, 1283, 
1259, 1231, 1175, 1116, 1078, 1035, 971, 940, 880, 816, 771, 738, 701, 679. 
MS (EI, 70 eV): m/z (%) = 258 (7), 201 (19), 97 (12), 94 (10), 83 (19), 71 (20), 69 (23), 61 (11), 57 
(100), 55 (22), 43 (77). 
HRMS (C11H12BrFO): calc.: 258.0056; found: 258.0033 (M+). 
 
1-(5-Bromo-3-chloro-2-fluorophenyl)-2,2-dimethylpropan-1-one (71) 
 
A dry, argon flushed Schlenk-flask equipped with a magnetic stirring bar and a septum was charged 
with 1-(5-bromo-2-fluoro-3-(triethylsilyl)phenyl)-2,2-dimethylpropan-1-one (69h, 414 mg, 1.0 mmol, 
1.0 equiv), hexachloroethane (473 mg, 2.0 mmol, 2.0 equiv) and caesium fluoride (304 mg, 2.0 mmol, 
2.0 equiv) in dry DMF (2 ml). The reaction mixture was stirred for 3 h at 25 °C. After complete 
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conversion, the mixture was quenched with sat. aq. NH4Cl (5 mL) and extracted with EtOAc (3 × 
10 mL). The combined organic extracts are dried over anhydrous MgSO4, filtered and concentrated in 
vacuo. Flash column chromatographical purification on silica gel (ihexane:EtOAc = 50:1) afforded 
1-(5-bromo-3-chloro-2-fluorophenyl)-2,2-dimethylpropan-1-one (71, 257 mg, 88%) as a colorless 
solid. 
 
m.p.: 89.7 - 91.0 °C. 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.61 (dd, J = 6.3, 2.4 Hz, 1H), 7.21 (dd, J = 4.9, 2.4 Hz, 1H), 
1.27 (d, J = 1.0 Hz, 9H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 206.92 (d, J = 1.6 Hz), 152.72 (d, J = 249.0 Hz), 133.71, 
131.52(d, J = 22.1 Hz), 128.59 (d, J = 4.1 Hz), 123.01 (d, J = 20.0 Hz), 116.49 (d, J = 4.2 Hz), 45.17, 
26.41 (d, J = 1.8 Hz). 
19F NMR (300 MHz, CDCl3): δ / ppm = -116.91. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3076, 2967, 2933, 2909, 2870, 1697, 1663, 1594, 1564, 1477, 
1451, 1418, 1390, 1368, 1283, 1244, 1218, 1194, 1172, 1108, 1090, 1040, 992, 938, 898, 866, 832, 
785, 760, 718, 668. 
MS (EI, 70 eV): m/z (%) = 291 (4), 237 (3), 149 (5), 135 (7), 127 (4), 111 (6), 109 (6), 97 (6), 67 (8), 
57 (100), 44 (46), 41 (25). 
HRMS (C11H11BrFClO): calc.: 291.9666; found: 291.9647 (M+). 
 
1-(3,5-Dibromo-2-fluorophenyl)-2,2-dimethylpropan-1-one (72) 
 
A dry, argon flushed Schlenk-flask equipped with a magnetic stirring bar and a septum was charged 
with 1-(5-bromo-2-fluoro-3-(triethylsilyl)phenyl)-2,2-dimethylpropan-1-one (69h, 414 mg, 1.0 mmol, 
1.0 equiv), 1,2-dibromotetrachloroethane (651 mg, 2.0 mmol, 2.0 equiv) and caesium fluoride 
(304 mg, 2.0 mmol, 2.0 equiv) in dry DMF (2 ml). The reaction mixture was stirred for 16 h at 60 °C. 
After complete conversion, the mixture was quenched with sat. aq. NH4Cl (5 mL) and extracted with 
EtOAc (3 × 10 mL). The combined organic extracts are dried over anhydrous MgSO4, filtered and 
concentrated in vacuo. Flash column chromatographical purification on silica gel (ihexane:EtOAc = 
50:1) afforded 1-(3,5-dibromo-2-fluorophenyl)-2,2-dimethylpropan-1-one (72, 279 mg, 83%) as a 
colorless solid. 
 
m.p.: 103.9 - 104.4 °C. 
1H-NMR (600 MHz, CDCl3): δ / ppm = 7.75 – 7.70 (m, 1H), 7.22 (ddd, J = 4.8, 2.4, 1.2 Hz, 1H), 
1.24 (d, J = 1.1 Hz, 9H). 
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13C-NMR (150 MHz, CDCl3): δ / ppm = 206.91, 153.56 (d, J = 247.1 Hz), 136.37, 131.30 (d, J = 
24.3 Hz), 129.29, 116.85, 110.83 (d, J = 24.5 Hz), 45.16, 26.40. 
19F NMR (300 MHz, CDCl3): δ / ppm = -108.85. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3070, 2979, 2938, 2874, 1744, 1690, 2589, 2556, 1481, 1435, 
1399, 1385, 1364, 1340, 1278, 1243, 1224, 1199, 1158, 1039, 1018, 984, 938, 894, 872, 839, 822, 
778, 757, 709, 656. 
MS (EI, 70 eV): m/z (%) = 335 (5), 315 (2), 281 (15), 250 (3), 172 (5), 93 (8), 74 (2), 57 (100), 41 
(18).  
HRMS (C11H11BrFO): calc.: 335.9161; found: 3335.9166 (M+). 
 
1-(5-Bromo-2-fluoro-3-iodophenyl)-2,2-dimethylpropan-1-one (73) 
 
The title compound was prepared according to TP5 from 1-(5-bromo-2-fluoro-3-(triethylsilyl)phenyl)-
2,2-dimethylpropan-1-one (69h, 75 mg, 0.2 mmol, 1.0 equiv) and iodine monochloride (42 mg, 
0.22 mmol, 1.1 equiv). Flash column chromatographical purification on silica gel (ihexane:EtOAc = 
50:1) afforded 1-(5-bromo-2-fluoro-3-iodophenyl)-2,2-dimethylpropan-1-one (73, 68 mg, 88%) as a 
colorless solid. 
 
m.p.: 116.6 - 118.0 °C 
1H-NMR (600 MHz, CDCl3): δ / ppm = 7.89 (dd, J = 5.3, 2.3 Hz, 1H), 7.23 (dd, J = 5.2, 2.3 Hz, 1H), 
1.22 (d, J = 1.3 Hz, 9H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 206.96, 155.99 (d, J = 245.0 Hz), 141.86, 130.44, 130.27, 
117.22, 82.93 (d, J = 29.6 Hz), 45.12, 26.42. 
19F NMR (300 MHz, CDCl3): δ / ppm = -95.56. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3061, 2977, 2955, 2935, 2871, 2730, 2615, 2594, 2471, 1764, 
1742, 1694, 1567, 1549, 1480, 1461, 1427, 1398, 1363, 1347, 1312, 1276, 1237, 1222, 1197, 1152, 
1093, 1038, 1018, 1005, 982, 938, 911, 895, 872, 837, 775, 752, 734, 703, 683, 667. 
MS (EI, 70 eV): m/z (%) = 383 (15), 326 (26), 298 (5), 200 (2), 172 (9), 127 (2), 93 (19), 57 (100), 41 
(20). 
HRMS (C11H11BrFIO): calc.: 383.9022; found: 383.9015 (M+). 
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3-Iodo-5-(triethylsilyl)phenyl acetate (74) 
 
A dry, argon flushed Schlenk-flask equipped with a magnetic stirring bar and a septum was charged 
with (5-iodo)-1,3-bis(triethylsilyl)benzene (64b, 236 mg, 0.54 mmol, 1.0 equiv), PhI(OCOCF3)2 
(352 mg, 0.82 mmol, 1.5 equiv) and Pd(OAc)2 (6.1 mg, 5 mol%) in AcOH (2 ml). The reaction 
mixture was stirred for 20 h at 80 °C. After complete conversion, the mixture was quenched with sat. 
aq. NH4Cl (5 mL) and extracted with EtOAc (3 × 10 mL). The combined organic extracts are dried 
over anhydrous MgSO4, filtered and concentrated in vacuo. Flash column chromatographical 
purification on silica gel (ihexane:EtOAc = 70:1) afforded 3-iodo-5-(triethylsilyl)phenyl acetate (74, 
132 mg, 65%) as a colorless solid.  
 
m.p.: 88.3 - 89.5 °C. 
1H-NMR (800 MHz, CDCl3): δ / ppm = 7.64 (dt, J = 1.6, 0.8 Hz, 1H), 7.47 (td, J = 1.9, 0.8 Hz, 1H), 
7.14 (dt, J = 2.2, 0.9 Hz, 1H), 2.31 (s, 2H), 0.97 (t, J = 7.9 Hz, 9H), 0.84 – 0.76 (m, 6H). 
13C-NMR (200 MHz, CDCl3): δ / ppm = 169.04, 150.40, 142.43, 140.04, 130.91, 126.06, 94.38, 
21.09, 7.24, 3.16. 
IR (Diamond-ATR, neat): ~  / cm-1 = 2954, 2913, 2873, 2853, 1774, 1737, 1656, 1574, 1552, 1454, 
1415, 1367, 1294, 1185, 1125, 1092, 1009, 971, 935, 901, 871, 831, 795, 755, 734, 721, 690. 
MS (EI, 70 eV): m/z (%) = 376 (27), 347 (100), 334 (55), 319 (82), 291 (57), 277 (28), 249 (42), 150 
(18), 121 (17), 97 (11), 85 (21), 83 (13), 71 (31), 61 (14), 55 (22), 43 (94). 
HRMS (C17H21IO2Si): calc.: 376.0355; found: 376.0356 (M+). 
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4.8. Preparation of Tetrasubstituted Fluorobenzene Derivatives 
 
2,5-Difluoro-1,3-diiodobenzene (78) 
 
The title compound was prepared according to TP5 from (2,5-difluoro-1,3-
phenylene)bis(triethylsilane) (62c, 1.71 g, 5.0 mmol, 1.0 equiv) and iodine monochloride (2.45 g, 
15.0 mmol, 3.0 equiv). Flash column chromatographical purification on silica gel (pentane) afforded 
2,5-difluoro-1,3-diiodobenzene (78, 1.59 g, 87%) as a colorless solid.  
 
m.p.: 46.8 - 48.5 °C. 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.50 (d, J = 4.5 Hz, 1H), 7.48 (d, J = 4.4 Hz, 1H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 157.90 (dd, J = 252.5, 3.5 Hz), 157.37 (dd, J = 238.8, 3.4 
Hz), 126.27 (d, J = 1.4 Hz), 126.02 (d, J = 1.4 Hz).  
19F NMR (375 MHz, CDCl3): δ / ppm = -79.44, -116.14. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3085, 1572, 1447, 1433, 1385, 1358, 1345, 1271, 1239, 1226, 
1190, 1146, 1115, 1092, 1069, 1044, 953, 907, 862, 820, 763, 714, 685. 
MS (EI, 70 eV): m/z (%) = 365 (100), 347 (18), 239 (19), 221 (4), 182 (3), 127 (9), 112 (40), 94 (7), 
86 (1), 74 (4), 62 (16), 43 (3). 
HRMS (C6H2F2I2): calc.: 365.8214; found: 365.8204 (M+). 
 
(2,5-difluoro-3-iodophenyl)(phenyl)methanone (79) 
 
The title compound was prepared according to TP6, where 2,5-difluoro-1,3-diiodobenzene (78, 
366 mg, 1.0 mmol, 1.0 equiv) was dissolved in THF (2 ml) and iPrMgCl·LiCl (1, 0.98 mL, 1.1 mmol, 
1.1 equiv, 1.12 M in THF) was added at 0°C and stirred for 1 h at this temperature. Subsequently, the 
acylation reaction was accomplished according to TP3 with CuCN·2LiCl (1.2 mL, 1.2 mmol, 1.0 M in 
THF, 1.2 equiv) and benzoyl chloride (169 mg, 1.5 mmol, 1.2 equiv) and allowed to warm to 25 °C in 
6 h. After complete conversion, the mixture was quenched with sat. aq. NH4Cl (10 mL) and extracted 
with EtOAc (3 × 10 mL). The combined organic extracts are dried over anhydrous MgSO4, filtered 
and concentrated in vacuo. Flash column chromatographical purification on silica gel (ihexane:EtOAc 
= 70:1) afforded (2,5-difluoro-3-iodophenyl)(phenyl)methanone (79, 238 mg, 69%) as a colorless oil.  
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1H-NMR (600 MHz, CDCl3): δ / ppm = 7.88 – 7.80 (m, 2H), 7.72 – 7.62 (m, 2H), 7.58 – 7.48 (m, 
2H), 7.25 (ddd, J = 7.7, 4.8, 3.1 Hz, 1H).  
13C-NMR (150 MHz, CDCl3): δ / ppm = 190.92 (d, J = 2.4 Hz), 158.04 (dd, J = 250.6, 3.1 Hz), 
155.20 (dd, J = 246.5, 2.9 Hz), 136.22, 134.07, 129.83 (d, J = 1.1 Hz), 128.73, 128.49 (d, J = 2.1 Hz), 
127.79 (dd, J = 20.9, 6.5 Hz), 117.10 (dd, J = 24.8, 2.9 Hz), 82.22 (dd, J = 29.8, 8.2 Hz). 
19F NMR (375 MHz, CDCl3): δ / ppm = -98.03, -115.96. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3080, 3062, 3031, 2956, 2924, 2876, 2854, 1649, 1594, 1578, 
1506, 1476, 1439, 1412, 1392, 1312, 1293, 1273, 1239, 1194, 1175, 1116, 1094, 1070, 1027, 996, 
978, 938, 892, 860, 810, 760, 724, 694, 654, 614, 578, 562. 
MS (EI, 70 eV): m/z (%) = 344 (80), 266 (15), 238 (4), 216 (2), 188 (2), 112 (14), 105 (100), 77 (35), 
62 (3), 57 (2), 43 (2). 
HRMS (C13H7F2IO): calc.: 343.9510; found: 343.9504 (M+). 
 
(3-((3-bromophenyl)(hydroxy)methyl)-2,5-difluorophenyl)(phenyl)methanone (75) 
 
The title compound was prepared according to TP6, where (2,5-difluoro-3-
iodophenyl)(phenyl)methanone (79, 172 mg, 0.5 mmol, 1.0 equiv) was dissolved in THF (2 ml) and 
iPrMgCl·LiCl (1, 0.49 mL, 0.55 mmol, 1.1 equiv, 1.12 M in THF) was added at 0°C and stirred for 
1 h at this temperature. The reaction mixture was quenched with 3-bromobenzaldehyde (111 mg, 
0.60 mmol, 1.2 equiv) and allowed to warm to 25 °C for 12 h. After complete conversion, the mixture 
was quenched with sat. aq. NH4Cl (10 mL) and extracted with EtOAc (3 × 10 mL). The combined 
organic extracts are dried over anhydrous MgSO4, filtered and concentrated in vacuo. Flash column 
chromatographical purification on silica gel (ihexane:EtOAc = 10:1) afforded (3-((3-
bromophenyl)(hydroxy)methyl)-2,5-difluorophenyl)(phenyl)methanone (75, 132 mg, 65%) as a 
colorless oil.  
 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.80 – 7.71 (m, 2H), 7.63 – 7.55 (m, 3H), 7.43 (dd, J = 6.2, 
2.6 Hz, 1H), 7.32 – 7.28 (m, 4H), 7.25 – 7.22 (m, 1H), 5.84 (m, 1H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 192.12 (d, J = 2.3 Hz), 160.76 (dd, J = 247.4, 3.1 Hz), 
158.30 (dd, J = 244.5, 2.9 Hz), 146.39, 145.97, 136.57 (dd, J = 22.8, 6.8 Hz), 134.70, 131.12 (dd, J = 
18.6, 7.5 Hz), 130.73, 129.85, 129.44, 129.41, 128.42 (dd, J = 22.9, 6.9 Hz), 125.93, 125.75, 121.98, 
115.80 (dd, J = 18.3, 7.5 Hz), 62.53. 
19F NMR (375 MHz, CDCl3): δ / ppm = -118.25, -121.06. 
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IR (Diamond-ATR, neat): ~  / cm-1 = 3386, 3074, 3060, 3024, 2950, 2933, 2880, 2854, 2190, 2101, 
1651, 1592, 1516, 1480, 1442, 1392, 1312, 1290, 1241, 1194, 1175, 1091, 1066, 1026, 996, 968, 892, 
860, 758, 722, 694, 570, 558. 
MS (EI, 70 eV): m/z (%) = 402 (55), 323 (60), 286 (10), 257 (14), 245 (100), 218 (50), 183 (15), 169 
(12), 157 (13), 140 (13), 119 (11), 105 (96), 84 (12), 77 (81), 66 (10). 
HRMS (C20H13BrF2O2): calc.: 402.0067; found: 402.0055 (M+). 
 
(2,5-Difluoro-3-iodophenyl)triethylsilane (80) 
 
The title compound was prepared according to TP5 from (2,5-difluoro-1,3-
phenylene)bis(triethylsilane) (62c, 3.42 g, 10.0 mmol, 1.0 equiv) and iodine monochloride (1.62 g, 
10.0 mmol, 1.0 equiv). Flash column chromatographical purification on silica gel (pentane) afforded 
(2,5-difluoro-3-iodophenyl)triethylsilane (80, 3.05 g, 86%) as a colorless oil.  
 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.44 (ddd, J = 7.1, 4.9, 3.0 Hz, 1H), 7.02 (dt, J = 7.7, 3.2 Hz, 
1H), 0.96 (td, J = 8.2, 7.7, 1.2 Hz, 9H), 0.90 – 0.78 (m, 6H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 161.60 (dd, J = 235.7, 2.2 Hz), 158.15 (dd, J = 249.3, 2.5 
Hz), 140.52 (d, J = 2.0 Hz), 136.02 (d, J = 11.2 Hz), 126.65 (dd, J = 26.0, 2.6 Hz), 121.70 (dd, J = 
21.3, 11.8 Hz), 7.17, 3.13. 
19F NMR (375 MHz, CDCl3): δ / ppm = -88.11, -118.38. 
IR (Diamond-ATR, neat): ~  / cm-1 = 2952, 2912, 2876, 1538, 1450, 1403, 1374, 1281, 1242, 1224, 
1109, 1084, 1074, 1000, 975, 869, 784, 727, 684. 
MS (EI, 70 eV): m/z (%) = 354 (26), 325 (12), 297 (76), 285 (12), 279 (18), 269 (100), 257 (14), 251 
(17), 198 (29), 173 (9), 169 (79), 151 (13), 141 (18), 102 (10), 87 (11), 77 (25), 75 (30). 
HRMS (C12H17F2ISi): calc.: 354.0112; found: 354.0104 (M+). 
 
Ethyl 3,6-difluoro-2-iodo-4-(triethylsilyl)benzoate (81) 
 
A dry, argon flushed Schlenk-flask equipped with a magnetic stirring bar and a septum was charged 
with (2,5-difluoro-3-iodophenyl)triethylsilane (80, 2.12 g, 6.0 mmol, 1.0 equiv) in dry THF (10 ml), 
TMPMgCl·LiCl (5, 6.55 mL, 7.2 mmol, 1.2 equiv, 1.10 M in THF) was added dropwise at -20 °C and 
stirred for 4 h at this temperature. The reaction mixture was quenched with ethyl cyanoformate 
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(714 mg, 7.2 mmol, 1.2 equiv) and allowed to warm to 25 °C within 2 h. After complete conversion, 
the mixture was quenched with sat. aq. NH4Cl (10 mL) and extracted with EtOAc (3 × 10 mL). The 
combined organic extracts are dried over anhydrous MgSO4, filtered and concentrated in vacuo. Flash 
column chromatographical purification on silica gel (ihexane:EtOAc = 100:1) afforded ethyl 
3,6-difluoro-2-iodo-4-(triethylsilyl)benzoate (81, 1.41 g, 55%) as a colorless oil.  
 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.10 (dd, J = 8.1, 3.5 Hz, 1H), 4.48 (q, J = 7.2 Hz, 2H), 1.44 
(t, J = 7.1 Hz, 3H), 1.02 – 0.93 (m, 9H), 0.92 – 0.81 (m, 6H).  
13C-NMR (100 MHz, CDCl3): δ / ppm = 164.27 (d, J = 2.2 Hz), 161.45 (dd, J = 236.8, 2.3 Hz), 
154.60 (dd, J = 252.8, 2.5 Hz), 130.20 (dd, J = 21.8, 2.2 Hz), 127.56 (dd, J = 39.2, 4.0 Hz), 122.39 
(dd, J = 21.6, 12.2 Hz), 80.81 (dd, J = 37.0, 3.0 Hz), 62.62, 14.12, 7.16, 3.09. 
19F NMR (375 MHz, CDCl3): δ / ppm = -83.89, -118.65. 
IR (Diamond-ATR, neat): ~  / cm-1 = 2956, 2912, 2877, 1737, 1675, 1541, 1507, 1465, 1438, 1375, 
1282, 1238, 1192, 1173, 1124, 1097, 1070, 876, 817, 784, 720, 696, 596, 569. 
MS (EI, 70 eV): m/z (%) = 426 (53), 397 (9), 381 (38), 370 (30), 341 (100), 323 (9), 313 (16), 305 
(12), 295 (7), 277 (6), 255 (4), 241 (18), 214 (27), 197 (6), 169 (15), 141 (16), 127 (7), 87 (7), 77 (9). 
HRMS (C15H21F2IO2Si): calc.: 426.0324; found: 426.0323 (M+). 
 
Ethyl 3,6-difluoro-2-iodobenzoate (82) 
 
A dry, argon flushed Schlenk-flask equipped with a magnetic stirring bar and a septum was charged 
with ethyl 3,6-difluoro-2-iodo-4-(triethylsilyl)benzoate (81, 426 mg, 1.0 mmol, 1.0 equiv) and 
dissolved in dry THF (2 ml). After cooling down to 0 °C, TBAF·3H2O (316 mg, 1.2 mmol, 1.2 equiv) 
was added dropwise and the reaction mixture was stirred for 2 h at this temperature. After complete 
conversion, the mixture was quenched with H2O (5 mL) and extracted with EtOAc (3 × 10 mL). The 
combined organic extracts are dried over anhydrous MgSO4, filtered and concentrated in vacuo. Flash 
column chromatographical purification on silica gel (ihexane:EtOAc = 50:1) afforded ethyl 
3,6-difluoro-2-iodobenzoate (82, 281 mg, 90%) as a colorless oil.  
 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.70 – 7.60 (m, 2H), 4.43 (q, J = 7.1 Hz, 2H), 1.42 (t, J = 7.1 
Hz, 3H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 162.51 (dd, J = 5.0, 2.3 Hz), 157.65 (dd, J = 249.0, 3.4 Hz), 
157.05 (dd, J = 254.6, 3.1 Hz), 130.16 (dd, J = 25.6, 2.4 Hz), 120.01 (dd, J = 15.2, 7.5 Hz), 118.53 (d, 
J = 25.2 Hz), 83.02 (dd, J = 30.3, 8.2 Hz), 62.11, 14.17. 
19F NMR (375 MHz, CDCl3): δ / ppm = -94.93, -116.54. 
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IR (Diamond-ATR, neat): ~  / cm-1 = 2983, 1716, 1610, 1583, 1451, 1422, 1391, 1366, 1298, 1239, 
1188, 1133, 1115, 1077, 1017, 962, 869, 821, 765, 713. 
MS (EI, 70 eV): m/z (%) = 312 (59), 297 (2), 284 (45), 266 (100), 239 (15), 140 (8), 112 (36), 96 (4), 
88 (2), 81 (7), 70 (4), 62 (8), 43 (50). 
HRMS (C9H7F2IO2): calc.: 311.9459; found: 311.9460 (M+). 
 
Ethyl 3,6-difluoro-4'-methoxy-[1,1'-biphenyl]-2-carboxylate (76) 
 
The title compound was prepared according to TP6, where ethyl 3,6-difluoro-2-iodobenzoate (82, 
156 mg, 0.5 mmol, 1.0 equiv) was dissolved in THF (1 ml) and iPrMgCl·LiCl (1, 0.49 mL, 
0.55 mmol, 1.1 equiv, 1.12 M in THF) was added at 0°C and stirred for 1 h at this temperature. 
Subsequently, the cross-coupling was accomplished according to TP4 with ZnCl2 (0.6 mL, 0.6 mmol, 
1.0 M in THF, 1.2 equiv), Pd(dba)2 (8.6 mg, 3 mol%), P(2-furyl)3 (7.2 mg, 6 mol%) and 4-iodoanisole 
(139 mg, 0.60 mmol, 1.2 equiv) at 25 °C in 4 h. After complete conversion, the mixture was quenched 
with sat. aq. NH4Cl (10 mL) and extracted with EtOAc (3 × 10 mL). The combined organic extracts 
are dried over anhydrous MgSO4, filtered and concentrated in vacuo. Flash column chromatographical 
purification on silica gel (ihexane:EtOAc = 40:1) afforded ethyl 3,6-difluoro-4'-methoxy-[1,1'-
biphenyl]-2-carboxylate (76, 100 mg, 68%) as a colorless solid.  
 
m.p.: 52.6 - 54.2 °C. 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.60 – 7.51 (m, 1H), 7.49 (dd, J = 8.8, 1.8 Hz, 2H), 7.31 (dd, 
J = 5.4, 3.2 Hz, 1H), 7.06 – 6.97 (m, 2H), 4.44 (q, J = 7.1 Hz, 2H), 3.89 (s, 3H), 1.43 (t, J = 7.1 Hz, 
3H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 161.30 (dd, J = 247.3, 3.5 Hz), 159.86, 156.34 (dd, J = 
249.8, 2.9 Hz), 153.60 (d, J = 2.7 Hz), 132.01 (dd, J = 27.1, 7.7 Hz), 130.24 (d, J = 3.3 Hz), 126.44 (d, 
J = 1.4 Hz), 121.09 (dd, J = 24.0, 4.3 Hz), 120.79 (dd, J = 23.8, 4.9 Hz), 116.27 (dd, J = 25.4, 1.5 Hz), 
114.11, 61.73, 55.36, 14.22 . 
19F NMR (375 MHz, CDCl3): δ / ppm = -118.21, -121.06. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3401, 3090, 3072, 3017, 2994, 2967, 2940, 2911, 2840, 1764, 
1714, 1610, 1516, 1481, 1459, 1436, 1408, 1393, 1365, 1332, 1286, 1262, 1246, 1218, 1181, 1151, 
1114, 1018, 967, 936, 896, 870, 833, 820, 798, 772, 738, 714, 668. 
MS (EI, 70 eV): m/z (%) = 292 (100), 264 (20), 247 (28), 221 (8), 204 (6), 187 (5), 175 (10), 123 (6), 
57 (2), 43 (2). 
HRMS (C16H14F2O3): calc.: 292.0911; found: 292.0906 (M+). 
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Ethyl 2,5-difluoro-4-(triethylsilyl)benzoate (83) 
 
The title compound was prepared according to TP6, where ethyl 3,6-difluoro-2-iodo-4-
(triethylsilyl)benzoate (81, 639 mg, 1.5 mmol, 1.0 equiv) was dissolved in THF (2 ml) and 
iPrMgCl·LiCl (1, 1.47 mL, 1.65 mmol, 1.1 equiv, 1.12 M in THF) was added at 0°C and stirred for 
1 h at this temperature. The reaction mixture was quenched with sat. aq. NH4Cl (10 mL) and extracted 
with EtOAc (3 × 10 mL). The combined organic extracts are dried over anhydrous MgSO4, filtered 
and concentrated in vacuo. Flash column chromatographical purification on silica gel (ihexane:EtOAc 
= 100:1) afforded ethyl 2,5-difluoro-4-(triethylsilyl)benzoate (83, 415 mg, 92%) as a colorless oil.  
 
1H-NMR (600 MHz, CDCl3): δ / ppm = 7.50 (dd, J = 7.9, 5.3 Hz, 1H), 7.10 (dd, J = 10.1, 3.7 Hz, 
1H), 4.39 (q, J = 7.1 Hz, 2H), 1.39 (t, J = 7.1 Hz, 3H), 0.97 – 0.93 (m, 9H), 0.88 – 0.81 (m, 6H).  
13C-NMR (150 MHz, CDCl3): δ / ppm = 163.46, 162.25 (d, J = 237.9 Hz), 157.57 (d, J = 257.5 Hz), 
132.53 – 131.84 (m), 123.61 (dd, J = 24.9, 13.6 Hz), 120.81 – 120.23 (m), 117.16 (d, J = 32.4 Hz), 
61.53, 14.20, 7.15, 3.08.  
19F NMR (375 MHz, CDCl3): δ / ppm = -94.87, -116.54. 
IR (Diamond-ATR, neat): ~  / cm-1 = 2957, 2912, 2878, 1737, 1719, 1622, 1559, 1469, 1400, 1376, 
1298, 1260, 1241, 1223, 1165, 1100, 1029, 1005, 897, 840, 783, 725, 710, 680, 595. 
MS (EI, 70 eV): m/z (%) = 300 (6), 271 (3), 255 (14), 243 (100), 229 (3), 225 (3), 215 (89), 213 (31), 
197 (21), 187 (14), 171 (4), 142 (8), 71 (22), 43 (38). 
HRMS (C15H22F2O2Si): calc.: 300.1357; found: 300.1347 (M+). 
 
Ethyl 2,5-difluoro-4-iodobenzoate (84) 
 
The title compound was prepared according to TP5 from ethyl 2,5-difluoro-4-(triethylsilyl)benzoate 
(83, 300 mg, 1.0 mmol, 1.0 equiv) and iodine monochloride (178 mg, 1.1 mmol, 1.1 equiv). Flash 
column chromatographical purification on silica gel (ihexane:EtOAc = 50:1) afforded ethyl 2,5-
difluoro-4-iodobenzoate (84, 265 mg, 85%) as a colorless oil.  
 
1H-NMR (600 MHz, CDCl3): δ / ppm = 7.58 (m, 2H), 4.39 (q, J = 7.2 Hz, 2H), 1.39 (t, J = 7.1 Hz, 
3H). 
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13C-NMR (150 MHz, CDCl3): δ / ppm = 162.81, 157.78 (d, J = 243.5 Hz), 157.17 (d, J = 262.1 Hz), 
127.66 (d, J = 28.2 Hz), 87.06 (dd, J = 29.2, 10.2 Hz), 117.29 (d, J = 29.0 Hz), 61.88, 14.15.  
19F NMR (375 MHz, CDCl3): δ / ppm = -99.63, -113.99. 
IR (Diamond-ATR, neat): ~  / cm-1 = 2981, 2932, 1717, 1610, 1477, 1406, 1387, 1300, 1247, 1218, 
1179, 1087, 1019, 971, 895, 863, 838, 765, 680. 
MS (EI, 70 eV): m/z (%) = 312 (39), 284 (49), 267 (100), 239 (14), 221 (14), 183 (5), 157 (3), 140 
(23), 120 (2), 112 (39), 101 (4), 85 (3), 74 (2), 62 (17), 45 (13), 43 (21). 
HRMS (C9H7F2IO2): calc.: 311.9459; found: 311.9446 (M+). 
 
Ethyl 4-allyl-2,5-difluorobenzoate (77) 
 
The title compound was prepared according to TP6, where ethyl 2,5-difluoro-4-iodobenzoate (84, 
156 mg, 0.5 mmol, 1.0 equiv) was dissolved in THF (1 ml) and iPrMgCl·LiCl (1, 0.49 mL, 
0.55 mmol, 1.1 equiv, 1.12 M in THF) was added at 0°C and stirred for 1 h at this temperature. 
Subsequently, the allylation reaction was accomplished according to TP3 with CuCN·2LiCl (0.60 mL, 
0.60 mmol, 1.0 M in THF, 1.2 equiv) and allyl bromide (73 mg, 0.6 mmol, 1.2 equiv) and allowed to 
warm to 25 °C in 6 h. After complete conversion, the mixture was quenched with sat. aq. NH4Cl 
(10 mL) and extracted with EtOAc (3 × 10 mL). The combined organic extracts are dried over 
anhydrous MgSO4, filtered and concentrated in vacuo. Flash column chromatographical purification 
on silica gel (ihexane:EtOAc = 50:1) afforded ethyl 4-allyl-2,5-difluorobenzoate (77, 95 mg, 84%) as 
a colorless oil.  
 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.60 (dd, J = 9.5, 5.9 Hz, 1H), 7.00 (dd, J = 10.7, 5.8 Hz, 
1H), 5.93 (ddt, J = 16.8, 10.1, 6.6 Hz, 1H), 5.24 – 5.09 (m, 2H), 4.41 (q, J = 7.1 Hz, 2H), 3.48 – 3.39 
(m, 2H), 1.41 (t, J = 7.1 Hz, 3H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 163.34 (dd, J = 4.3, 2.1 Hz), 157.87 (dd, J = 256.5, 2.4 Hz), 
156.10 (dd, J = 243.0, 2.6 Hz), 134.34 (d, J = 18.9 Hz), 134.26 (d, J = 18.8 Hz), 133.92, 118.54 (dd, J 
= 25.2, 4.8 Hz), 117.97 (d, J = 1.7 Hz), 117.71, 61.51, 32.94 (dd, J = 2.3, 1.1 Hz), 14.22. 
19F NMR (375 MHz, CDCl3): δ / ppm = -115.37, -123.50. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3083, 2984, 2937, 2910, 2362, 1715, 1632, 1583, 1498, 1424, 
1367, 1322, 1301, 1250, 1203, 1172, 1138, 1096, 1056, 995, 919, 896, 869, 780, 754, 708, 667. 
MS (EI, 70 eV): m/z (%) = 226 (33), 198 (15), 181 (100), 153 (10), 151 (7), 133 (8), 127 (4), 107 (1). 
HRMS (C12H12F2O2): calc.: 226.0805; found: 226.0807 (M+). 
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List of Abbreviations 
Ac Acetyl 
aq. aqueous 
Ar aryl 
Boc tert-butyloxycarbonyl 
calc. calculated 
conc. concentrated 
d doublet (NMR)/ day 
dba trans,trans-dibenzylideneacetone 
dist. distilled 
DMAP 4-dimethylaminopyridine 
DMF N,N-dimethylforamide 
DMSO dimethyl sulfoxide 
δ chemical shifts in ppm 
E electrophile 
EI electron impact ionization 
equiv equivalent 
ESI electrospray ionization 
Et ethyl 
FG functional group 
GC gas chromatography 
h hour 
Hal halogen 
i-hexane iso-hexane 
hex hexyl 
HIV human immunodeficiency virus 
HMDS hexamethyldisilazane 
HRMS high resolution mass spectrometry 
Hz Hertz 
iPr iso-propyl 
IR infra-red 
J coupling constant (NMR) 
LDA lithium N,N-diisopropylamide 
M molarity 
m meta 
m.p. melting point 
Me methyl 
nBu n-butyl 
Nf nonaflate 
MDPM monomethoxydiphenylmethoxymethyl 
min minute 
mmol millimole 
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MOM methoxymethyl acetal 
MS mass spectrometry 
NMR nuclear magnetic resonance 
o ortho 
p para 
PEPPSI-IPr [1,3-bis(2,6-di(isopropyl)-phenyl)imidazol-2-ylidene] (3-chloropyridyl)-
palladium(II) dichloride 
pin pinacol 
PMDTA (N,N,N′,N′′,N′′-pentamethyldiethylenetriamine 
Ph phenyl 
PG protecting group 
Piv pivalyl 
ppm parts per million 
prim primary 
R organic substituent 
sat. saturated 
sec secoundary 
SEM (2-(Trimethylsilyl)ethoxy)methyl acetal  
sBu sec-butyl 
T temperature 
t time 
TBAF tetra-n-butylammonium fluoride 
TBDMS tert-butyldimethylsilyl 
tBu tert-butyl 
TES triethylsilyl 
tf triflate 
tfp tris-(2-furyl)phosphine 
THF tetrahydrofuran 
TIPS tri(isopropylsilyl) 
TLC thin layer chromatography 
TMEDA N,N,N′,N′-Tetramethylethane-1,2-diamine 
TMP 2,2,6,6-tetramethyl-piperidyl 
TMPH 2,2,6,6-tetramethylpiperidine 
TMS trimethylsilyl 
Tol toluene 
Ts 4-toluenesulfonyl 
X halide or pseudohalide 
  
  
  
 
 
